{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "824f7775",
   "metadata": {},
   "outputs": [],
   "source": [
    "!pip install sovai[full]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Clinical Trials"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "import sovai as sov\n",
    "import pandas as pd\n",
    "\n",
    "sov.token_auth(token=\"visit https://sov.ai/profile for your token\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Prediction Data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Loading partitions: 100%|██████████| 1/1 [00:00<00:00,  1.34partition/s]\n"
     ]
    }
   ],
   "source": [
    "df_apps = sov.data(\"clinical/predict\", tickers=[\"PFE\"], start_date = \"2024-01-01\", end_date= \"2025-02-01\",  purge_cache=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th>source</th>\n",
       "      <th>subsidiary</th>\n",
       "      <th>sponsor</th>\n",
       "      <th>trial_id</th>\n",
       "      <th>official_title</th>\n",
       "      <th>success_prediction</th>\n",
       "      <th>economic_effect</th>\n",
       "      <th>duration_prediction</th>\n",
       "      <th>success_composite</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ticker</th>\n",
       "      <th>date</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th rowspan=\"11\" valign=\"top\">PFE</th>\n",
       "      <th>2024-01-02</th>\n",
       "      <td>listed</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NCT06205407</td>\n",
       "      <td>A Single-Dose, Open-Label, Randomized, 2-Way, ...</td>\n",
       "      <td>0.820</td>\n",
       "      <td>0.630</td>\n",
       "      <td>66.000</td>\n",
       "      <td>0.719</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2024-01-05</th>\n",
       "      <td>listed</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NCT06221111</td>\n",
       "      <td>Rimegepant, A Cgrp Antagonist, In The Treatmen...</td>\n",
       "      <td>0.910</td>\n",
       "      <td>0.500</td>\n",
       "      <td>1110.000</td>\n",
       "      <td>0.737</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2024-01-05</th>\n",
       "      <td>listed</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NCT06207799</td>\n",
       "      <td>Pre-Transplant Purging And Post-Transplant Mrd...</td>\n",
       "      <td>0.890</td>\n",
       "      <td>0.490</td>\n",
       "      <td>211.000</td>\n",
       "      <td>0.734</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2024-01-10</th>\n",
       "      <td>listed</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NCT06215118</td>\n",
       "      <td>A Phase 1B, Open-Label Study Of Elranatamab In...</td>\n",
       "      <td>0.910</td>\n",
       "      <td>0.520</td>\n",
       "      <td>386.000</td>\n",
       "      <td>0.726</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2024-01-15</th>\n",
       "      <td>listed</td>\n",
       "      <td>Pfizer Biologics (Hangzhou) Co. Ltd</td>\n",
       "      <td>Hangzhou Grand Biologic Pharmaceutical, Inc.</td>\n",
       "      <td>NCT06250400</td>\n",
       "      <td>A Multicenter, Randomized, Double-Blind, Place...</td>\n",
       "      <td>0.230</td>\n",
       "      <td>0.040</td>\n",
       "      <td>842.000</td>\n",
       "      <td>0.268</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2025-01-23</th>\n",
       "      <td>listed</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NCT06799533</td>\n",
       "      <td>An Open-Label Phase 1 Study To Investigate Pf-...</td>\n",
       "      <td>0.900</td>\n",
       "      <td>0.550</td>\n",
       "      <td>742.000</td>\n",
       "      <td>0.726</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2025-01-27</th>\n",
       "      <td>listed</td>\n",
       "      <td>InnoPharma, Inc</td>\n",
       "      <td>Innopharm LLC</td>\n",
       "      <td>NCT06840158</td>\n",
       "      <td>A Double-Blind Comparative Randomized Trial To...</td>\n",
       "      <td>0.950</td>\n",
       "      <td>0.510</td>\n",
       "      <td>257.000</td>\n",
       "      <td>0.791</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2025-01-29</th>\n",
       "      <td>listed</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NCT06807281</td>\n",
       "      <td>A Phase 3, Multicenter, Long-Term, Open Label ...</td>\n",
       "      <td>0.910</td>\n",
       "      <td>0.510</td>\n",
       "      <td>1073.000</td>\n",
       "      <td>0.759</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2025-01-29</th>\n",
       "      <td>listed</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NCT06807268</td>\n",
       "      <td>A 16-Week, Multicenter, Interventional, Phase ...</td>\n",
       "      <td>0.920</td>\n",
       "      <td>0.500</td>\n",
       "      <td>1073.000</td>\n",
       "      <td>0.761</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2025-01-31</th>\n",
       "      <td>listed</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NCT06813872</td>\n",
       "      <td>Effectiveness Of Abrysvo® Maternal Respiratory...</td>\n",
       "      <td>0.210</td>\n",
       "      <td>0.050</td>\n",
       "      <td>38.000</td>\n",
       "      <td>0.161</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>171 rows × 9 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                   source                           subsidiary  \\\n",
       "ticker date                                                      \n",
       "PFE    2024-01-02  listed                               Pfizer   \n",
       "       2024-01-05  listed                               Pfizer   \n",
       "       2024-01-05  listed                               Pfizer   \n",
       "       2024-01-10  listed                               Pfizer   \n",
       "       2024-01-15  listed  Pfizer Biologics (Hangzhou) Co. Ltd   \n",
       "...                   ...                                  ...   \n",
       "       2025-01-23  listed                               Pfizer   \n",
       "       2025-01-27  listed                      InnoPharma, Inc   \n",
       "       2025-01-29  listed                               Pfizer   \n",
       "       2025-01-29  listed                               Pfizer   \n",
       "       2025-01-31  listed                               Pfizer   \n",
       "\n",
       "                                                        sponsor     trial_id  \\\n",
       "ticker date                                                                    \n",
       "PFE    2024-01-02                                        Pfizer  NCT06205407   \n",
       "       2024-01-05                                        Pfizer  NCT06221111   \n",
       "       2024-01-05                                        Pfizer  NCT06207799   \n",
       "       2024-01-10                                        Pfizer  NCT06215118   \n",
       "       2024-01-15  Hangzhou Grand Biologic Pharmaceutical, Inc.  NCT06250400   \n",
       "...                                                         ...          ...   \n",
       "       2025-01-23                                        Pfizer  NCT06799533   \n",
       "       2025-01-27                                 Innopharm LLC  NCT06840158   \n",
       "       2025-01-29                                        Pfizer  NCT06807281   \n",
       "       2025-01-29                                        Pfizer  NCT06807268   \n",
       "       2025-01-31                                        Pfizer  NCT06813872   \n",
       "\n",
       "                                                      official_title  \\\n",
       "ticker date                                                            \n",
       "PFE    2024-01-02  A Single-Dose, Open-Label, Randomized, 2-Way, ...   \n",
       "       2024-01-05  Rimegepant, A Cgrp Antagonist, In The Treatmen...   \n",
       "       2024-01-05  Pre-Transplant Purging And Post-Transplant Mrd...   \n",
       "       2024-01-10  A Phase 1B, Open-Label Study Of Elranatamab In...   \n",
       "       2024-01-15  A Multicenter, Randomized, Double-Blind, Place...   \n",
       "...                                                              ...   \n",
       "       2025-01-23  An Open-Label Phase 1 Study To Investigate Pf-...   \n",
       "       2025-01-27  A Double-Blind Comparative Randomized Trial To...   \n",
       "       2025-01-29  A Phase 3, Multicenter, Long-Term, Open Label ...   \n",
       "       2025-01-29  A 16-Week, Multicenter, Interventional, Phase ...   \n",
       "       2025-01-31  Effectiveness Of Abrysvo® Maternal Respiratory...   \n",
       "\n",
       "                   success_prediction  economic_effect  duration_prediction  \\\n",
       "ticker date                                                                   \n",
       "PFE    2024-01-02               0.820            0.630               66.000   \n",
       "       2024-01-05               0.910            0.500             1110.000   \n",
       "       2024-01-05               0.890            0.490              211.000   \n",
       "       2024-01-10               0.910            0.520              386.000   \n",
       "       2024-01-15               0.230            0.040              842.000   \n",
       "...                               ...              ...                  ...   \n",
       "       2025-01-23               0.900            0.550              742.000   \n",
       "       2025-01-27               0.950            0.510              257.000   \n",
       "       2025-01-29               0.910            0.510             1073.000   \n",
       "       2025-01-29               0.920            0.500             1073.000   \n",
       "       2025-01-31               0.210            0.050               38.000   \n",
       "\n",
       "                   success_composite  \n",
       "ticker date                           \n",
       "PFE    2024-01-02              0.719  \n",
       "       2024-01-05              0.737  \n",
       "       2024-01-05              0.734  \n",
       "       2024-01-10              0.726  \n",
       "       2024-01-15              0.268  \n",
       "...                              ...  \n",
       "       2025-01-23              0.726  \n",
       "       2025-01-27              0.791  \n",
       "       2025-01-29              0.759  \n",
       "       2025-01-29              0.761  \n",
       "       2025-01-31              0.161  \n",
       "\n",
       "[171 rows x 9 columns]"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_apps"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Loading partitions: 100%|██████████| 2/2 [00:00<00:00,  4.84partition/s]\n"
     ]
    }
   ],
   "source": [
    "df_apps = sov.data(\"clinical/predict\", tickers=[\"PFE\", \"LLY\"], start_date=\"2025-01-20\", purge_cache=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Loading partitions: 100%|██████████| 1/1 [00:00<00:00,  2.52partition/s]\n"
     ]
    }
   ],
   "source": [
    "df_apps = sov.data(\"clinical/predict\", tickers=[\"PFE\"], purge_cache=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th>source</th>\n",
       "      <th>subsidiary</th>\n",
       "      <th>sponsor</th>\n",
       "      <th>trial_id</th>\n",
       "      <th>official_title</th>\n",
       "      <th>success_prediction</th>\n",
       "      <th>economic_effect</th>\n",
       "      <th>duration_prediction</th>\n",
       "      <th>success_composite</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ticker</th>\n",
       "      <th>date</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th rowspan=\"11\" valign=\"top\">PFE</th>\n",
       "      <th>1999-11-01</th>\n",
       "      <td>listed</td>\n",
       "      <td>Wyeth Pharmaceuticals Company</td>\n",
       "      <td>Wyeth is now a wholly owned subsidiary of Pfizer</td>\n",
       "      <td>NCT00003712</td>\n",
       "      <td>A Phase I Study Of The Safety, Tolerability, A...</td>\n",
       "      <td>0.930</td>\n",
       "      <td>0.630</td>\n",
       "      <td>4665.000</td>\n",
       "      <td>0.746</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1999-11-01</th>\n",
       "      <td>listed</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NCT00003131</td>\n",
       "      <td>A Study Of The Efficacy And Safety Of Cma-676 ...</td>\n",
       "      <td>0.950</td>\n",
       "      <td>0.700</td>\n",
       "      <td>823.000</td>\n",
       "      <td>0.831</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1999-11-01</th>\n",
       "      <td>listed</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NCT00003775</td>\n",
       "      <td>A Phase Ii Open Label Study Of Su101 For Patie...</td>\n",
       "      <td>0.950</td>\n",
       "      <td>0.710</td>\n",
       "      <td>2373.000</td>\n",
       "      <td>0.822</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1999-11-01</th>\n",
       "      <td>listed</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NCT00003293</td>\n",
       "      <td>A Phase Iii Randomized Study Of Su101 Versus P...</td>\n",
       "      <td>0.950</td>\n",
       "      <td>0.700</td>\n",
       "      <td>4698.000</td>\n",
       "      <td>0.825</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1999-11-01</th>\n",
       "      <td>listed</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NCT00003343</td>\n",
       "      <td>A Randomized, Double-Blind, Placebo-Controlled...</td>\n",
       "      <td>0.310</td>\n",
       "      <td>0.190</td>\n",
       "      <td>4664.000</td>\n",
       "      <td>0.289</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2025-03-20</th>\n",
       "      <td>listed</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NCT06898047</td>\n",
       "      <td>Correlate-Uk: Consistency Of Response With Rim...</td>\n",
       "      <td>0.190</td>\n",
       "      <td>0.090</td>\n",
       "      <td>731.000</td>\n",
       "      <td>0.150</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2025-03-21</th>\n",
       "      <td>listed</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NCT06899204</td>\n",
       "      <td>A Prospective, Multi-Center Observational Stud...</td>\n",
       "      <td>0.210</td>\n",
       "      <td>0.050</td>\n",
       "      <td>731.000</td>\n",
       "      <td>0.148</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2025-03-28</th>\n",
       "      <td>listed</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NCT06911788</td>\n",
       "      <td>A Phase 1, Open-Label, Fixed Sequence, 2-Perio...</td>\n",
       "      <td>0.860</td>\n",
       "      <td>0.500</td>\n",
       "      <td>742.000</td>\n",
       "      <td>0.687</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2025-04-03</th>\n",
       "      <td>listed</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NCT06921408</td>\n",
       "      <td>Retrospective Identification Of Scintigraphic ...</td>\n",
       "      <td>0.220</td>\n",
       "      <td>0.040</td>\n",
       "      <td>731.000</td>\n",
       "      <td>0.150</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2025-04-03</th>\n",
       "      <td>listed</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NCT06923137</td>\n",
       "      <td>Title Not In Corporate Clinical Trial Registry...</td>\n",
       "      <td>0.220</td>\n",
       "      <td>0.050</td>\n",
       "      <td>731.000</td>\n",
       "      <td>0.154</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>6466 rows × 9 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                   source                     subsidiary  \\\n",
       "ticker date                                                \n",
       "PFE    1999-11-01  listed  Wyeth Pharmaceuticals Company   \n",
       "       1999-11-01  listed                         Pfizer   \n",
       "       1999-11-01  listed                         Pfizer   \n",
       "       1999-11-01  listed                         Pfizer   \n",
       "       1999-11-01  listed                         Pfizer   \n",
       "...                   ...                            ...   \n",
       "       2025-03-20  listed                         Pfizer   \n",
       "       2025-03-21  listed                         Pfizer   \n",
       "       2025-03-28  listed                         Pfizer   \n",
       "       2025-04-03  listed                         Pfizer   \n",
       "       2025-04-03  listed                         Pfizer   \n",
       "\n",
       "                                                            sponsor  \\\n",
       "ticker date                                                           \n",
       "PFE    1999-11-01  Wyeth is now a wholly owned subsidiary of Pfizer   \n",
       "       1999-11-01                                            Pfizer   \n",
       "       1999-11-01                                            Pfizer   \n",
       "       1999-11-01                                            Pfizer   \n",
       "       1999-11-01                                            Pfizer   \n",
       "...                                                             ...   \n",
       "       2025-03-20                                            Pfizer   \n",
       "       2025-03-21                                            Pfizer   \n",
       "       2025-03-28                                            Pfizer   \n",
       "       2025-04-03                                            Pfizer   \n",
       "       2025-04-03                                            Pfizer   \n",
       "\n",
       "                      trial_id  \\\n",
       "ticker date                      \n",
       "PFE    1999-11-01  NCT00003712   \n",
       "       1999-11-01  NCT00003131   \n",
       "       1999-11-01  NCT00003775   \n",
       "       1999-11-01  NCT00003293   \n",
       "       1999-11-01  NCT00003343   \n",
       "...                        ...   \n",
       "       2025-03-20  NCT06898047   \n",
       "       2025-03-21  NCT06899204   \n",
       "       2025-03-28  NCT06911788   \n",
       "       2025-04-03  NCT06921408   \n",
       "       2025-04-03  NCT06923137   \n",
       "\n",
       "                                                      official_title  \\\n",
       "ticker date                                                            \n",
       "PFE    1999-11-01  A Phase I Study Of The Safety, Tolerability, A...   \n",
       "       1999-11-01  A Study Of The Efficacy And Safety Of Cma-676 ...   \n",
       "       1999-11-01  A Phase Ii Open Label Study Of Su101 For Patie...   \n",
       "       1999-11-01  A Phase Iii Randomized Study Of Su101 Versus P...   \n",
       "       1999-11-01  A Randomized, Double-Blind, Placebo-Controlled...   \n",
       "...                                                              ...   \n",
       "       2025-03-20  Correlate-Uk: Consistency Of Response With Rim...   \n",
       "       2025-03-21  A Prospective, Multi-Center Observational Stud...   \n",
       "       2025-03-28  A Phase 1, Open-Label, Fixed Sequence, 2-Perio...   \n",
       "       2025-04-03  Retrospective Identification Of Scintigraphic ...   \n",
       "       2025-04-03  Title Not In Corporate Clinical Trial Registry...   \n",
       "\n",
       "                   success_prediction  economic_effect  duration_prediction  \\\n",
       "ticker date                                                                   \n",
       "PFE    1999-11-01               0.930            0.630             4665.000   \n",
       "       1999-11-01               0.950            0.700              823.000   \n",
       "       1999-11-01               0.950            0.710             2373.000   \n",
       "       1999-11-01               0.950            0.700             4698.000   \n",
       "       1999-11-01               0.310            0.190             4664.000   \n",
       "...                               ...              ...                  ...   \n",
       "       2025-03-20               0.190            0.090              731.000   \n",
       "       2025-03-21               0.210            0.050              731.000   \n",
       "       2025-03-28               0.860            0.500              742.000   \n",
       "       2025-04-03               0.220            0.040              731.000   \n",
       "       2025-04-03               0.220            0.050              731.000   \n",
       "\n",
       "                   success_composite  \n",
       "ticker date                           \n",
       "PFE    1999-11-01              0.746  \n",
       "       1999-11-01              0.831  \n",
       "       1999-11-01              0.822  \n",
       "       1999-11-01              0.825  \n",
       "       1999-11-01              0.289  \n",
       "...                              ...  \n",
       "       2025-03-20              0.150  \n",
       "       2025-03-21              0.148  \n",
       "       2025-03-28              0.687  \n",
       "       2025-04-03              0.150  \n",
       "       2025-04-03              0.154  \n",
       "\n",
       "[6466 rows x 9 columns]"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_apps"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Starting data request for endpoint: clinical/predict\n",
      "Endpoint alias detected: 'clinical/predict' maps to 'clinical/trials' with predefined columns.\n",
      "Enabling full_history due to date range specification\n",
      "Prepared endpoint: /clinical/trials\n",
      "Full URL: https://data.sov.ai/clinical/trials with params: {'columns': 'ticker,date,source,subsidiary,sponsor,trial_id,official_title,success_prediction,economic_effect,duration_prediction,success_composite', 'from_date': '2025-01-20T00:00:00', 'parquet': 'True', 'full_history': 'True'}\n",
      "Cache key: 575c76085f9a4c9592a0032d2ef11fe7fc06064b49ccdce08ea83f8476aaf006\n",
      "Purged cache entry\n",
      "Grabbing S3 Partitioned High client side\n",
      "Calling client-side handler with tickers=None, start_date=2025-01-20, end_date=None\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Loading partitions: 100%|█████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████| 106/106 [00:01<00:00, 60.22partition/s]\n"
     ]
    }
   ],
   "source": [
    "df_apps = sov.data(\"clinical/predict\", start_date=\"2025-01-20\", verbose=True, purge_cache=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th>source</th>\n",
       "      <th>subsidiary</th>\n",
       "      <th>sponsor</th>\n",
       "      <th>trial_id</th>\n",
       "      <th>official_title</th>\n",
       "      <th>success_prediction</th>\n",
       "      <th>economic_effect</th>\n",
       "      <th>duration_prediction</th>\n",
       "      <th>success_composite</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ticker</th>\n",
       "      <th>date</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>000020.KS</th>\n",
       "      <th>2025-02-24</th>\n",
       "      <td>foreign</td>\n",
       "      <td>Dongwha Pharm.Co.,Ltd</td>\n",
       "      <td>Dong Wha Pharmaceutical Co. Ltd.</td>\n",
       "      <td>NCT06875193</td>\n",
       "      <td>Key Finding Of Dm Treatment With Combination, ...</td>\n",
       "      <td>0.250</td>\n",
       "      <td>0.060</td>\n",
       "      <td>293.000</td>\n",
       "      <td>0.293</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"2\" valign=\"top\">000100.KS</th>\n",
       "      <th>2025-03-08</th>\n",
       "      <td>foreign</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>NCT06874894</td>\n",
       "      <td>Thromboembolic And Bleeding Risk During Antico...</td>\n",
       "      <td>0.400</td>\n",
       "      <td>0.150</td>\n",
       "      <td>1023.000</td>\n",
       "      <td>0.287</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2025-03-27</th>\n",
       "      <td>foreign</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>NCT06920719</td>\n",
       "      <td>An Open-Label, Randomized, Fasting, Single-Dos...</td>\n",
       "      <td>0.890</td>\n",
       "      <td>0.500</td>\n",
       "      <td>742.000</td>\n",
       "      <td>0.704</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"2\" valign=\"top\">000105.KS</th>\n",
       "      <th>2025-03-08</th>\n",
       "      <td>foreign</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>NCT06874894</td>\n",
       "      <td>Thromboembolic And Bleeding Risk During Antico...</td>\n",
       "      <td>0.400</td>\n",
       "      <td>0.150</td>\n",
       "      <td>1023.000</td>\n",
       "      <td>0.287</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2025-03-27</th>\n",
       "      <td>foreign</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>NCT06920719</td>\n",
       "      <td>An Open-Label, Randomized, Fasting, Single-Dos...</td>\n",
       "      <td>0.890</td>\n",
       "      <td>0.500</td>\n",
       "      <td>742.000</td>\n",
       "      <td>0.704</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ZSPH</th>\n",
       "      <th>2025-04-02</th>\n",
       "      <td>delisted</td>\n",
       "      <td>ASTRAZENECA</td>\n",
       "      <td>AstraZeneca</td>\n",
       "      <td>NCT06908577</td>\n",
       "      <td>A Multiple Centre, Randomised, Open-Label, Par...</td>\n",
       "      <td>0.870</td>\n",
       "      <td>0.510</td>\n",
       "      <td>742.000</td>\n",
       "      <td>0.696</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"2\" valign=\"top\">ZYDUSLIFE.BO</th>\n",
       "      <th>2025-01-22</th>\n",
       "      <td>foreign</td>\n",
       "      <td>ZYDUS LIFESCIENCES LIMITED</td>\n",
       "      <td>Zydus Lifesciences Limited</td>\n",
       "      <td>NCT06815835</td>\n",
       "      <td>A Prospective, Randomized, Parallel, Three-Arm...</td>\n",
       "      <td>0.910</td>\n",
       "      <td>0.510</td>\n",
       "      <td>1073.000</td>\n",
       "      <td>0.759</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2025-02-09</th>\n",
       "      <td>foreign</td>\n",
       "      <td>ZYDUS LIFESCIENCES LIMITED</td>\n",
       "      <td>Zydus Therapeutics Inc.</td>\n",
       "      <td>NCT06825559</td>\n",
       "      <td>A Phase 1, Open-Label, Single Arm Study To Eva...</td>\n",
       "      <td>0.900</td>\n",
       "      <td>0.580</td>\n",
       "      <td>742.000</td>\n",
       "      <td>0.736</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"2\" valign=\"top\">ZYDUSLIFE.NS</th>\n",
       "      <th>2025-01-22</th>\n",
       "      <td>foreign</td>\n",
       "      <td>ZYDUS LIFESCIENCES LIMITED</td>\n",
       "      <td>Zydus Lifesciences Limited</td>\n",
       "      <td>NCT06815835</td>\n",
       "      <td>A Prospective, Randomized, Parallel, Three-Arm...</td>\n",
       "      <td>0.910</td>\n",
       "      <td>0.510</td>\n",
       "      <td>1073.000</td>\n",
       "      <td>0.759</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2025-02-09</th>\n",
       "      <td>foreign</td>\n",
       "      <td>ZYDUS LIFESCIENCES LIMITED</td>\n",
       "      <td>Zydus Therapeutics Inc.</td>\n",
       "      <td>NCT06825559</td>\n",
       "      <td>A Phase 1, Open-Label, Single Arm Study To Eva...</td>\n",
       "      <td>0.900</td>\n",
       "      <td>0.580</td>\n",
       "      <td>742.000</td>\n",
       "      <td>0.736</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>10974 rows × 9 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                           source                  subsidiary  \\\n",
       "ticker       date                                               \n",
       "000020.KS    2025-02-24   foreign       Dongwha Pharm.Co.,Ltd   \n",
       "000100.KS    2025-03-08   foreign           Yuhan Corporation   \n",
       "             2025-03-27   foreign           Yuhan Corporation   \n",
       "000105.KS    2025-03-08   foreign           Yuhan Corporation   \n",
       "             2025-03-27   foreign           Yuhan Corporation   \n",
       "...                           ...                         ...   \n",
       "ZSPH         2025-04-02  delisted                 ASTRAZENECA   \n",
       "ZYDUSLIFE.BO 2025-01-22   foreign  ZYDUS LIFESCIENCES LIMITED   \n",
       "             2025-02-09   foreign  ZYDUS LIFESCIENCES LIMITED   \n",
       "ZYDUSLIFE.NS 2025-01-22   foreign  ZYDUS LIFESCIENCES LIMITED   \n",
       "             2025-02-09   foreign  ZYDUS LIFESCIENCES LIMITED   \n",
       "\n",
       "                                                  sponsor     trial_id  \\\n",
       "ticker       date                                                        \n",
       "000020.KS    2025-02-24  Dong Wha Pharmaceutical Co. Ltd.  NCT06875193   \n",
       "000100.KS    2025-03-08                 Yuhan Corporation  NCT06874894   \n",
       "             2025-03-27                 Yuhan Corporation  NCT06920719   \n",
       "000105.KS    2025-03-08                 Yuhan Corporation  NCT06874894   \n",
       "             2025-03-27                 Yuhan Corporation  NCT06920719   \n",
       "...                                                   ...          ...   \n",
       "ZSPH         2025-04-02                       AstraZeneca  NCT06908577   \n",
       "ZYDUSLIFE.BO 2025-01-22        Zydus Lifesciences Limited  NCT06815835   \n",
       "             2025-02-09           Zydus Therapeutics Inc.  NCT06825559   \n",
       "ZYDUSLIFE.NS 2025-01-22        Zydus Lifesciences Limited  NCT06815835   \n",
       "             2025-02-09           Zydus Therapeutics Inc.  NCT06825559   \n",
       "\n",
       "                                                            official_title  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24  Key Finding Of Dm Treatment With Combination, ...   \n",
       "000100.KS    2025-03-08  Thromboembolic And Bleeding Risk During Antico...   \n",
       "             2025-03-27  An Open-Label, Randomized, Fasting, Single-Dos...   \n",
       "000105.KS    2025-03-08  Thromboembolic And Bleeding Risk During Antico...   \n",
       "             2025-03-27  An Open-Label, Randomized, Fasting, Single-Dos...   \n",
       "...                                                                    ...   \n",
       "ZSPH         2025-04-02  A Multiple Centre, Randomised, Open-Label, Par...   \n",
       "ZYDUSLIFE.BO 2025-01-22  A Prospective, Randomized, Parallel, Three-Arm...   \n",
       "             2025-02-09  A Phase 1, Open-Label, Single Arm Study To Eva...   \n",
       "ZYDUSLIFE.NS 2025-01-22  A Prospective, Randomized, Parallel, Three-Arm...   \n",
       "             2025-02-09  A Phase 1, Open-Label, Single Arm Study To Eva...   \n",
       "\n",
       "                         success_prediction  economic_effect  \\\n",
       "ticker       date                                              \n",
       "000020.KS    2025-02-24               0.250            0.060   \n",
       "000100.KS    2025-03-08               0.400            0.150   \n",
       "             2025-03-27               0.890            0.500   \n",
       "000105.KS    2025-03-08               0.400            0.150   \n",
       "             2025-03-27               0.890            0.500   \n",
       "...                                     ...              ...   \n",
       "ZSPH         2025-04-02               0.870            0.510   \n",
       "ZYDUSLIFE.BO 2025-01-22               0.910            0.510   \n",
       "             2025-02-09               0.900            0.580   \n",
       "ZYDUSLIFE.NS 2025-01-22               0.910            0.510   \n",
       "             2025-02-09               0.900            0.580   \n",
       "\n",
       "                         duration_prediction  success_composite  \n",
       "ticker       date                                                \n",
       "000020.KS    2025-02-24              293.000              0.293  \n",
       "000100.KS    2025-03-08             1023.000              0.287  \n",
       "             2025-03-27              742.000              0.704  \n",
       "000105.KS    2025-03-08             1023.000              0.287  \n",
       "             2025-03-27              742.000              0.704  \n",
       "...                                      ...                ...  \n",
       "ZSPH         2025-04-02              742.000              0.696  \n",
       "ZYDUSLIFE.BO 2025-01-22             1073.000              0.759  \n",
       "             2025-02-09              742.000              0.736  \n",
       "ZYDUSLIFE.NS 2025-01-22             1073.000              0.759  \n",
       "             2025-02-09              742.000              0.736  \n",
       "\n",
       "[10974 rows x 9 columns]"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_apps"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Starting data request for endpoint: clinical/trials\n",
      "Enabling full_history due to date range specification\n",
      "Prepared endpoint: /clinical/trials\n",
      "Full URL: https://data.sov.ai/clinical/trials with params: {'from_date': '2025-01-20T00:00:00', 'parquet': 'True', 'full_history': 'True'}\n",
      "Cache key: c8e6d606d26a84535235171b4ba2ba073944f10c04ce73741c986ec6e70d08df\n",
      "Grabbing S3 Partitioned High client side\n",
      "Calling client-side handler with tickers=None, start_date=2025-01-20, end_date=None\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Loading partitions: 100%|█████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████| 106/106 [00:02<00:00, 44.76partition/s]\n"
     ]
    }
   ],
   "source": [
    "df_apps = sov.data(\"clinical/trials\", start_date=\"2025-01-20\", verbose=True, purge_cache=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th>source</th>\n",
       "      <th>subsidiary</th>\n",
       "      <th>sponsor</th>\n",
       "      <th>trial_id</th>\n",
       "      <th>official_title</th>\n",
       "      <th>sponsor_study_id</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>lead_sponsor</th>\n",
       "      <th>lead_sponsor_name</th>\n",
       "      <th>sponsor_type</th>\n",
       "      <th>lead_sponsor_type</th>\n",
       "      <th>phase_category</th>\n",
       "      <th>study_type</th>\n",
       "      <th>enrollment_count</th>\n",
       "      <th>number_of_locations</th>\n",
       "      <th>healthy_volunteers</th>\n",
       "      <th>enrollment_type</th>\n",
       "      <th>study_size_category</th>\n",
       "      <th>condition_keywords</th>\n",
       "      <th>primary_condition</th>\n",
       "      <th>intervention_type</th>\n",
       "      <th>primary_intervention</th>\n",
       "      <th>intervention_name</th>\n",
       "      <th>intervention_arm_group_labels</th>\n",
       "      <th>intervention_description</th>\n",
       "      <th>has_data_monitoring_committee</th>\n",
       "      <th>responsible_party_investigator_affiliation</th>\n",
       "      <th>responsible_party_investigator_title</th>\n",
       "      <th>responsible_party_investigator_name</th>\n",
       "      <th>first_posted_date</th>\n",
       "      <th>last_update_posted_date</th>\n",
       "      <th>start_date</th>\n",
       "      <th>study_completion_date</th>\n",
       "      <th>primary_completion_date</th>\n",
       "      <th>study_locations_city</th>\n",
       "      <th>study_locations_country</th>\n",
       "      <th>study_locations_geopoint</th>\n",
       "      <th>study_locations_facility</th>\n",
       "      <th>study_locations_zip</th>\n",
       "      <th>study_locations_state</th>\n",
       "      <th>standard_age_groups</th>\n",
       "      <th>sex</th>\n",
       "      <th>minimum_age</th>\n",
       "      <th>maximum_age</th>\n",
       "      <th>overall_status</th>\n",
       "      <th>status_category</th>\n",
       "      <th>status_verified_date</th>\n",
       "      <th>primary_outcomes_measures</th>\n",
       "      <th>primary_outcomes_timeframes</th>\n",
       "      <th>primary_outcomes_descriptions</th>\n",
       "      <th>secondary_outcomes_measures</th>\n",
       "      <th>secondary_outcomes_timeframes</th>\n",
       "      <th>secondary_outcomes_descriptions</th>\n",
       "      <th>has_results</th>\n",
       "      <th>conditions</th>\n",
       "      <th>brief_summary</th>\n",
       "      <th>detailed_description</th>\n",
       "      <th>masking</th>\n",
       "      <th>allocation</th>\n",
       "      <th>intervention_model</th>\n",
       "      <th>primary_purpose</th>\n",
       "      <th>has_expanded_access</th>\n",
       "      <th>study_duration_days</th>\n",
       "      <th>trial_duration</th>\n",
       "      <th>references_type</th>\n",
       "      <th>references_citation</th>\n",
       "      <th>references_pmid</th>\n",
       "      <th>collaborators_name</th>\n",
       "      <th>collaborators_class</th>\n",
       "      <th>ipd_sharing</th>\n",
       "      <th>success_prediction</th>\n",
       "      <th>economic_effect</th>\n",
       "      <th>duration_prediction</th>\n",
       "      <th>success_composite</th>\n",
       "      <th>class</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ticker</th>\n",
       "      <th>date</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>000020.KS</th>\n",
       "      <th>2025-02-24</th>\n",
       "      <td>foreign</td>\n",
       "      <td>Dongwha Pharm.Co.,Ltd</td>\n",
       "      <td>Dong Wha Pharmaceutical Co. Ltd.</td>\n",
       "      <td>NCT06875193</td>\n",
       "      <td>Key Finding Of Dm Treatment With Combination, ...</td>\n",
       "      <td>DW6012-IV-2</td>\n",
       "      <td>Dm Treatment To Evaluate The Efficacy And Safe...</td>\n",
       "      <td>Dong Wha Pharmaceutical Co. Ltd.</td>\n",
       "      <td>Dong Wha Pharmaceutical Co. Ltd.</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>phase_4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>196</td>\n",
       "      <td>1</td>\n",
       "      <td>False</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Medium</td>\n",
       "      <td>Dapagliflozin; Pioglitazone; DPP-4 inhibitor</td>\n",
       "      <td>Type2Diabetes</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>DW6012(Dasidiem tab. 10/100mg)</td>\n",
       "      <td>DW6012(Dasidiem tab. 10/100mg)</td>\n",
       "      <td>Dasidiem 10/100mg; sitdiem 100mg, Piotazone15mg</td>\n",
       "      <td>Once A Day, Oral Administration</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2025-03-13</td>\n",
       "      <td>2025-03-17</td>\n",
       "      <td>2024-05-28</td>\n",
       "      <td>2025-12-31</td>\n",
       "      <td>2025-12-31</td>\n",
       "      <td>Seoul</td>\n",
       "      <td>Korea, Republic of</td>\n",
       "      <td>lat: 37.566, lon: 126.9784</td>\n",
       "      <td>Kyung Hee University Hospital at Gangdong</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>19</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2025-03-01</td>\n",
       "      <td>Variance in HbA1c from baseline to 24 weeks on...</td>\n",
       "      <td>24 weeks</td>\n",
       "      <td>Change in HbA1c</td>\n",
       "      <td>Variance in HbA1c from baseline to 12 weeks on...</td>\n",
       "      <td>12 weeks; 12, 24 weeks; 12, 24 weeks; 12, 24 w...</td>\n",
       "      <td>Change in HbA1c; Change in Fasting Plasma Gluc...</td>\n",
       "      <td>False</td>\n",
       "      <td>Type2Diabetes</td>\n",
       "      <td>Key Finding Of Dm Treatment With Combination, ...</td>\n",
       "      <td>This Is A Phase 4, Multicenter, Randomized, Op...</td>\n",
       "      <td>NONE</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>SUPPORTIVE_CARE</td>\n",
       "      <td>False</td>\n",
       "      <td>582</td>\n",
       "      <td>582.000</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.250</td>\n",
       "      <td>0.060</td>\n",
       "      <td>293.000</td>\n",
       "      <td>0.293</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"2\" valign=\"top\">000100.KS</th>\n",
       "      <th>2025-03-08</th>\n",
       "      <td>foreign</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>NCT06874894</td>\n",
       "      <td>Thromboembolic And Bleeding Risk During Antico...</td>\n",
       "      <td>CAUH 1992-002-387</td>\n",
       "      <td>Thromboembolic And Bleeding Risks During Antic...</td>\n",
       "      <td>Chung-Ang University Hosptial, Chung-Ang Unive...</td>\n",
       "      <td>Chung-Ang University Hosptial, Chung-Ang Unive...</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>not_specified</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>1100</td>\n",
       "      <td>1</td>\n",
       "      <td>False</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Very Large</td>\n",
       "      <td>Atrial Fibrillation; Stroke; Bleeding</td>\n",
       "      <td>Fibrillation, Atrial</td>\n",
       "      <td>nan</td>\n",
       "      <td>nan</td>\n",
       "      <td>nan</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>True</td>\n",
       "      <td>Chung-Ang University Hosptial, Chung-Ang Unive...</td>\n",
       "      <td>Associate Professor</td>\n",
       "      <td>Ki-Woon Kang</td>\n",
       "      <td>2025-03-13</td>\n",
       "      <td>2025-03-13</td>\n",
       "      <td>2022-05-25</td>\n",
       "      <td>2026-08-30</td>\n",
       "      <td>2025-08-30</td>\n",
       "      <td>Seoul</td>\n",
       "      <td>Korea, Republic of</td>\n",
       "      <td>lat: 37.566, lon: 126.9784</td>\n",
       "      <td>Chung-Ang University Hospital</td>\n",
       "      <td>06973</td>\n",
       "      <td>None</td>\n",
       "      <td>CHILD; ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>2</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>ENROLLING_BY_INVITATION</td>\n",
       "      <td>active</td>\n",
       "      <td>2025-03-01</td>\n",
       "      <td>Clinical ischemic and hemorrhagic events</td>\n",
       "      <td>12 months</td>\n",
       "      <td>Ischemic stroke, systemic embolism, or myocard...</td>\n",
       "      <td>Clinical other events</td>\n",
       "      <td>12 months</td>\n",
       "      <td>Major Adverse Cardiovascular Events: Myocardia...</td>\n",
       "      <td>False</td>\n",
       "      <td>Fibrillation, Atrial</td>\n",
       "      <td>This Study Was Design To Investigate The Effic...</td>\n",
       "      <td>East Asians Have Demonstrated A Higher Bleedin...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>1558</td>\n",
       "      <td>1558.000</td>\n",
       "      <td>RESULT</td>\n",
       "      <td>Lee SH, Kim HK, Ahn JH, Kang MG, Kim KH, Bae J...</td>\n",
       "      <td>36857519</td>\n",
       "      <td>Chung-Ang University Gwangmyeong Hospital; Sam...</td>\n",
       "      <td>OTHER; OTHER; OTHER; OTHER; OTHER; INDUSTRY</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.400</td>\n",
       "      <td>0.150</td>\n",
       "      <td>1023.000</td>\n",
       "      <td>0.287</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2025-03-27</th>\n",
       "      <td>foreign</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>NCT06920719</td>\n",
       "      <td>An Open-Label, Randomized, Fasting, Single-Dos...</td>\n",
       "      <td>YHP2406-101</td>\n",
       "      <td>Bioequivalence Study Betweenyhp2406 And Yhr250...</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>phase_1</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>62</td>\n",
       "      <td>1</td>\n",
       "      <td>True</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Small</td>\n",
       "      <td>Pharmacokinetics; Bioequivalence</td>\n",
       "      <td>Healthy Subject</td>\n",
       "      <td>DRUG; DRUG</td>\n",
       "      <td>YHP2406</td>\n",
       "      <td>YHP2406; YHR2501</td>\n",
       "      <td>A(RT); B(TR); A(RT); B(TR)</td>\n",
       "      <td>Test Drug: Yhp2406, Comparator: Yhr2501; Test ...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2025-04-10</td>\n",
       "      <td>2025-04-10</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>Seoul</td>\n",
       "      <td>Korea, Republic of</td>\n",
       "      <td>lat: 37.566, lon: 126.9784</td>\n",
       "      <td>H Plus Yangji Hospital</td>\n",
       "      <td>08779</td>\n",
       "      <td>None</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>19</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2025-04-01</td>\n",
       "      <td>Area under the plasma drug concentration-time ...</td>\n",
       "      <td>0-8 hours; 0-8 hours</td>\n",
       "      <td>Area under the plasma drug concentration-time ...</td>\n",
       "      <td>Area under the plasma drug concentration-time ...</td>\n",
       "      <td>0-8 Hours; 0-8 Hours; 0-8 Hours; 0-8 Hours</td>\n",
       "      <td>Area under the plasma drug concentration-time ...</td>\n",
       "      <td>False</td>\n",
       "      <td>Healthy Subject</td>\n",
       "      <td>A Randomized, Open-Label, Single-Dose, 2-Seque...</td>\n",
       "      <td>62 Healthy Subjects Will Be Randomized To One ...</td>\n",
       "      <td>NONE</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>CROSSOVER</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.890</td>\n",
       "      <td>0.500</td>\n",
       "      <td>742.000</td>\n",
       "      <td>0.704</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"2\" valign=\"top\">000105.KS</th>\n",
       "      <th>2025-03-08</th>\n",
       "      <td>foreign</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>NCT06874894</td>\n",
       "      <td>Thromboembolic And Bleeding Risk During Antico...</td>\n",
       "      <td>CAUH 1992-002-387</td>\n",
       "      <td>Thromboembolic And Bleeding Risks During Antic...</td>\n",
       "      <td>Chung-Ang University Hosptial, Chung-Ang Unive...</td>\n",
       "      <td>Chung-Ang University Hosptial, Chung-Ang Unive...</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>not_specified</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>1100</td>\n",
       "      <td>1</td>\n",
       "      <td>False</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Very Large</td>\n",
       "      <td>Atrial Fibrillation; Stroke; Bleeding</td>\n",
       "      <td>Fibrillation, Atrial</td>\n",
       "      <td>nan</td>\n",
       "      <td>nan</td>\n",
       "      <td>nan</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>True</td>\n",
       "      <td>Chung-Ang University Hosptial, Chung-Ang Unive...</td>\n",
       "      <td>Associate Professor</td>\n",
       "      <td>Ki-Woon Kang</td>\n",
       "      <td>2025-03-13</td>\n",
       "      <td>2025-03-13</td>\n",
       "      <td>2022-05-25</td>\n",
       "      <td>2026-08-30</td>\n",
       "      <td>2025-08-30</td>\n",
       "      <td>Seoul</td>\n",
       "      <td>Korea, Republic of</td>\n",
       "      <td>lat: 37.566, lon: 126.9784</td>\n",
       "      <td>Chung-Ang University Hospital</td>\n",
       "      <td>06973</td>\n",
       "      <td>None</td>\n",
       "      <td>CHILD; ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>2</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>ENROLLING_BY_INVITATION</td>\n",
       "      <td>active</td>\n",
       "      <td>2025-03-01</td>\n",
       "      <td>Clinical ischemic and hemorrhagic events</td>\n",
       "      <td>12 months</td>\n",
       "      <td>Ischemic stroke, systemic embolism, or myocard...</td>\n",
       "      <td>Clinical other events</td>\n",
       "      <td>12 months</td>\n",
       "      <td>Major Adverse Cardiovascular Events: Myocardia...</td>\n",
       "      <td>False</td>\n",
       "      <td>Fibrillation, Atrial</td>\n",
       "      <td>This Study Was Design To Investigate The Effic...</td>\n",
       "      <td>East Asians Have Demonstrated A Higher Bleedin...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>1558</td>\n",
       "      <td>1558.000</td>\n",
       "      <td>RESULT</td>\n",
       "      <td>Lee SH, Kim HK, Ahn JH, Kang MG, Kim KH, Bae J...</td>\n",
       "      <td>36857519</td>\n",
       "      <td>Chung-Ang University Gwangmyeong Hospital; Sam...</td>\n",
       "      <td>OTHER; OTHER; OTHER; OTHER; OTHER; INDUSTRY</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.400</td>\n",
       "      <td>0.150</td>\n",
       "      <td>1023.000</td>\n",
       "      <td>0.287</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2025-03-27</th>\n",
       "      <td>foreign</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>NCT06920719</td>\n",
       "      <td>An Open-Label, Randomized, Fasting, Single-Dos...</td>\n",
       "      <td>YHP2406-101</td>\n",
       "      <td>Bioequivalence Study Betweenyhp2406 And Yhr250...</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>phase_1</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>62</td>\n",
       "      <td>1</td>\n",
       "      <td>True</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Small</td>\n",
       "      <td>Pharmacokinetics; Bioequivalence</td>\n",
       "      <td>Healthy Subject</td>\n",
       "      <td>DRUG; DRUG</td>\n",
       "      <td>YHP2406</td>\n",
       "      <td>YHP2406; YHR2501</td>\n",
       "      <td>A(RT); B(TR); A(RT); B(TR)</td>\n",
       "      <td>Test Drug: Yhp2406, Comparator: Yhr2501; Test ...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2025-04-10</td>\n",
       "      <td>2025-04-10</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>Seoul</td>\n",
       "      <td>Korea, Republic of</td>\n",
       "      <td>lat: 37.566, lon: 126.9784</td>\n",
       "      <td>H Plus Yangji Hospital</td>\n",
       "      <td>08779</td>\n",
       "      <td>None</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>19</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2025-04-01</td>\n",
       "      <td>Area under the plasma drug concentration-time ...</td>\n",
       "      <td>0-8 hours; 0-8 hours</td>\n",
       "      <td>Area under the plasma drug concentration-time ...</td>\n",
       "      <td>Area under the plasma drug concentration-time ...</td>\n",
       "      <td>0-8 Hours; 0-8 Hours; 0-8 Hours; 0-8 Hours</td>\n",
       "      <td>Area under the plasma drug concentration-time ...</td>\n",
       "      <td>False</td>\n",
       "      <td>Healthy Subject</td>\n",
       "      <td>A Randomized, Open-Label, Single-Dose, 2-Seque...</td>\n",
       "      <td>62 Healthy Subjects Will Be Randomized To One ...</td>\n",
       "      <td>NONE</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>CROSSOVER</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.890</td>\n",
       "      <td>0.500</td>\n",
       "      <td>742.000</td>\n",
       "      <td>0.704</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ZSPH</th>\n",
       "      <th>2025-04-02</th>\n",
       "      <td>delisted</td>\n",
       "      <td>ASTRAZENECA</td>\n",
       "      <td>AstraZeneca</td>\n",
       "      <td>NCT06908577</td>\n",
       "      <td>A Multiple Centre, Randomised, Open-Label, Par...</td>\n",
       "      <td>D9180C00006</td>\n",
       "      <td>An Accessorised Prefilled Syringe To An Autoin...</td>\n",
       "      <td>AstraZeneca</td>\n",
       "      <td>Astrazeneca</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>phase_1</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>252</td>\n",
       "      <td>0</td>\n",
       "      <td>True</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Medium</td>\n",
       "      <td>Anti-Interleukin (IL)-33 antibody; Human immun...</td>\n",
       "      <td>Healthy Participants</td>\n",
       "      <td>DRUG; DEVICE; DEVICE</td>\n",
       "      <td>Tozorakimab</td>\n",
       "      <td>Tozorakimab; Autoinjector (AI) Device; Accesso...</td>\n",
       "      <td>Treatment A: Tozorakimab (Test); Treatment B: ...</td>\n",
       "      <td>Tozorakimab Will Be Administered As A Single S...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2025-04-03</td>\n",
       "      <td>2025-04-03</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>55</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2025-03-01</td>\n",
       "      <td>Area under concentration-time curve from time ...</td>\n",
       "      <td>From Day 1 to Day 113; From Day 1 to Day 113; ...</td>\n",
       "      <td>To compare the PK exposure following single SC...</td>\n",
       "      <td>Time to reach maximum observed concentration (...</td>\n",
       "      <td>From Day 1 to Day 113; From Day 1 to Day 113; ...</td>\n",
       "      <td>To assess additional PK parameters following s...</td>\n",
       "      <td>False</td>\n",
       "      <td>Healthy Participants</td>\n",
       "      <td>The Purpose Of This Study Is To Compare The Ph...</td>\n",
       "      <td>This Is A Multiple Center, Randomized, Open-La...</td>\n",
       "      <td>NONE</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Parexel</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>YES</td>\n",
       "      <td>0.870</td>\n",
       "      <td>0.510</td>\n",
       "      <td>742.000</td>\n",
       "      <td>0.696</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"2\" valign=\"top\">ZYDUSLIFE.BO</th>\n",
       "      <th>2025-01-22</th>\n",
       "      <td>foreign</td>\n",
       "      <td>ZYDUS LIFESCIENCES LIMITED</td>\n",
       "      <td>Zydus Lifesciences Limited</td>\n",
       "      <td>NCT06815835</td>\n",
       "      <td>A Prospective, Randomized, Parallel, Three-Arm...</td>\n",
       "      <td>PR-24098</td>\n",
       "      <td>Non-Interference Study Of Mr And Yellow Fever ...</td>\n",
       "      <td>International Centre for Diarrhoeal Disease Re...</td>\n",
       "      <td>International Centre For Diarrhoeal Disease Re...</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>1530</td>\n",
       "      <td>1</td>\n",
       "      <td>True</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Very Large</td>\n",
       "      <td>Safety; Non-interference; Measles and Rubella;...</td>\n",
       "      <td>Measles</td>\n",
       "      <td>BIOLOGICAL; BIOLOGICAL</td>\n",
       "      <td>Measles-Rubella vaccine (Live) I.P. (Freeze Dr...</td>\n",
       "      <td>Measles-Rubella vaccine (Live) I.P. (Freeze Dr...</td>\n",
       "      <td>Reference 1 (MR); Test (MR+YF); Reference 2 (Y...</td>\n",
       "      <td>Live Attenuated Vaccine; Live Attenuated Vaccine</td>\n",
       "      <td>True</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2025-02-07</td>\n",
       "      <td>2025-02-07</td>\n",
       "      <td>2025-04-01</td>\n",
       "      <td>2026-03-31</td>\n",
       "      <td>2026-03-31</td>\n",
       "      <td>Dhaka</td>\n",
       "      <td>Bangladesh</td>\n",
       "      <td>lat: 23.7104, lon: 90.40744</td>\n",
       "      <td>Icddr,B</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>ALL</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2025-02-01</td>\n",
       "      <td>Seropositivity</td>\n",
       "      <td>06 weeks</td>\n",
       "      <td>Equivalence for seropositivity rate for anti-m...</td>\n",
       "      <td>Immunogenicity; Safety reporting</td>\n",
       "      <td>06 months; 06 months</td>\n",
       "      <td>* Seropositivity rate for anti-measles (≥9 Nov...</td>\n",
       "      <td>False</td>\n",
       "      <td>Measles; Rubella; Yellow Fever</td>\n",
       "      <td>This Study Will Be Conducted Among 1530 Health...</td>\n",
       "      <td>This Is A Prospective, Randomized, Parallel, T...</td>\n",
       "      <td>NONE</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>PREVENTION</td>\n",
       "      <td>False</td>\n",
       "      <td>364</td>\n",
       "      <td>364.000</td>\n",
       "      <td>BACKGROUND; BACKGROUND; BACKGROUND; BACKGROUND...</td>\n",
       "      <td>Cracknell Daniels B, Gaythorpe K, Imai N, Dori...</td>\n",
       "      <td>33506250; 33258924; 18847312; 25453327; 337223...</td>\n",
       "      <td>Zydus Lifesciences Limited</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.910</td>\n",
       "      <td>0.510</td>\n",
       "      <td>1073.000</td>\n",
       "      <td>0.759</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2025-02-09</th>\n",
       "      <td>foreign</td>\n",
       "      <td>ZYDUS LIFESCIENCES LIMITED</td>\n",
       "      <td>Zydus Therapeutics Inc.</td>\n",
       "      <td>NCT06825559</td>\n",
       "      <td>A Phase 1, Open-Label, Single Arm Study To Eva...</td>\n",
       "      <td>SARO.24.003</td>\n",
       "      <td>Evaluating Pharmacokinetic And Safety Of Sarog...</td>\n",
       "      <td>Zydus Therapeutics Inc.</td>\n",
       "      <td>Zydus Therapeutics Inc.</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>phase_1</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>6</td>\n",
       "      <td>0</td>\n",
       "      <td>False</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Small</td>\n",
       "      <td>Saroglitazar Magnesium; Primary Biliary Cholan...</td>\n",
       "      <td>Cholestatic Liver Disease</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>Saroglitazar Magnesium 1 mg</td>\n",
       "      <td>Saroglitazar Magnesium 1 mg</td>\n",
       "      <td>Saroglitazar Magnesium 1 mg</td>\n",
       "      <td>Saroglitazar Magnesium 1 Mg Will Be Assigned T...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2025-02-13</td>\n",
       "      <td>2025-02-13</td>\n",
       "      <td>2025-03-31</td>\n",
       "      <td>2025-08-31</td>\n",
       "      <td>2025-08-31</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>80</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2025-02-01</td>\n",
       "      <td>Pharmacokinetics of Saroglitazar: Cmax; Pharma...</td>\n",
       "      <td>PK sampling timepoints: pre- dose, 20 min, 40 ...</td>\n",
       "      <td>Maximum plasma concentration (Cmax); Time to r...</td>\n",
       "      <td>Safety and Tolerability of Saroglitazar Magnes...</td>\n",
       "      <td>From baseline to End of study (35 days); PK sa...</td>\n",
       "      <td>Number of participants with adverse events; Ti...</td>\n",
       "      <td>False</td>\n",
       "      <td>Cholestatic Liver Disease</td>\n",
       "      <td>Evaluating Pharmacokinetic And Safety Of Sarog...</td>\n",
       "      <td>A Phase 1, Open-Label, Single Arm Study To Eva...</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>False</td>\n",
       "      <td>153</td>\n",
       "      <td>153.000</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Rodney P, Starzomski R. Constraints on the mor...</td>\n",
       "      <td>11652809</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>0.900</td>\n",
       "      <td>0.580</td>\n",
       "      <td>742.000</td>\n",
       "      <td>0.736</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"2\" valign=\"top\">ZYDUSLIFE.NS</th>\n",
       "      <th>2025-01-22</th>\n",
       "      <td>foreign</td>\n",
       "      <td>ZYDUS LIFESCIENCES LIMITED</td>\n",
       "      <td>Zydus Lifesciences Limited</td>\n",
       "      <td>NCT06815835</td>\n",
       "      <td>A Prospective, Randomized, Parallel, Three-Arm...</td>\n",
       "      <td>PR-24098</td>\n",
       "      <td>Non-Interference Study Of Mr And Yellow Fever ...</td>\n",
       "      <td>International Centre for Diarrhoeal Disease Re...</td>\n",
       "      <td>International Centre For Diarrhoeal Disease Re...</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>1530</td>\n",
       "      <td>1</td>\n",
       "      <td>True</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Very Large</td>\n",
       "      <td>Safety; Non-interference; Measles and Rubella;...</td>\n",
       "      <td>Measles</td>\n",
       "      <td>BIOLOGICAL; BIOLOGICAL</td>\n",
       "      <td>Measles-Rubella vaccine (Live) I.P. (Freeze Dr...</td>\n",
       "      <td>Measles-Rubella vaccine (Live) I.P. (Freeze Dr...</td>\n",
       "      <td>Reference 1 (MR); Test (MR+YF); Reference 2 (Y...</td>\n",
       "      <td>Live Attenuated Vaccine; Live Attenuated Vaccine</td>\n",
       "      <td>True</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2025-02-07</td>\n",
       "      <td>2025-02-07</td>\n",
       "      <td>2025-04-01</td>\n",
       "      <td>2026-03-31</td>\n",
       "      <td>2026-03-31</td>\n",
       "      <td>Dhaka</td>\n",
       "      <td>Bangladesh</td>\n",
       "      <td>lat: 23.7104, lon: 90.40744</td>\n",
       "      <td>Icddr,B</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>ALL</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2025-02-01</td>\n",
       "      <td>Seropositivity</td>\n",
       "      <td>06 weeks</td>\n",
       "      <td>Equivalence for seropositivity rate for anti-m...</td>\n",
       "      <td>Immunogenicity; Safety reporting</td>\n",
       "      <td>06 months; 06 months</td>\n",
       "      <td>* Seropositivity rate for anti-measles (≥9 Nov...</td>\n",
       "      <td>False</td>\n",
       "      <td>Measles; Rubella; Yellow Fever</td>\n",
       "      <td>This Study Will Be Conducted Among 1530 Health...</td>\n",
       "      <td>This Is A Prospective, Randomized, Parallel, T...</td>\n",
       "      <td>NONE</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>PREVENTION</td>\n",
       "      <td>False</td>\n",
       "      <td>364</td>\n",
       "      <td>364.000</td>\n",
       "      <td>BACKGROUND; BACKGROUND; BACKGROUND; BACKGROUND...</td>\n",
       "      <td>Cracknell Daniels B, Gaythorpe K, Imai N, Dori...</td>\n",
       "      <td>33506250; 33258924; 18847312; 25453327; 337223...</td>\n",
       "      <td>Zydus Lifesciences Limited</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.910</td>\n",
       "      <td>0.510</td>\n",
       "      <td>1073.000</td>\n",
       "      <td>0.759</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2025-02-09</th>\n",
       "      <td>foreign</td>\n",
       "      <td>ZYDUS LIFESCIENCES LIMITED</td>\n",
       "      <td>Zydus Therapeutics Inc.</td>\n",
       "      <td>NCT06825559</td>\n",
       "      <td>A Phase 1, Open-Label, Single Arm Study To Eva...</td>\n",
       "      <td>SARO.24.003</td>\n",
       "      <td>Evaluating Pharmacokinetic And Safety Of Sarog...</td>\n",
       "      <td>Zydus Therapeutics Inc.</td>\n",
       "      <td>Zydus Therapeutics Inc.</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>phase_1</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>6</td>\n",
       "      <td>0</td>\n",
       "      <td>False</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Small</td>\n",
       "      <td>Saroglitazar Magnesium; Primary Biliary Cholan...</td>\n",
       "      <td>Cholestatic Liver Disease</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>Saroglitazar Magnesium 1 mg</td>\n",
       "      <td>Saroglitazar Magnesium 1 mg</td>\n",
       "      <td>Saroglitazar Magnesium 1 mg</td>\n",
       "      <td>Saroglitazar Magnesium 1 Mg Will Be Assigned T...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2025-02-13</td>\n",
       "      <td>2025-02-13</td>\n",
       "      <td>2025-03-31</td>\n",
       "      <td>2025-08-31</td>\n",
       "      <td>2025-08-31</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>80</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2025-02-01</td>\n",
       "      <td>Pharmacokinetics of Saroglitazar: Cmax; Pharma...</td>\n",
       "      <td>PK sampling timepoints: pre- dose, 20 min, 40 ...</td>\n",
       "      <td>Maximum plasma concentration (Cmax); Time to r...</td>\n",
       "      <td>Safety and Tolerability of Saroglitazar Magnes...</td>\n",
       "      <td>From baseline to End of study (35 days); PK sa...</td>\n",
       "      <td>Number of participants with adverse events; Ti...</td>\n",
       "      <td>False</td>\n",
       "      <td>Cholestatic Liver Disease</td>\n",
       "      <td>Evaluating Pharmacokinetic And Safety Of Sarog...</td>\n",
       "      <td>A Phase 1, Open-Label, Single Arm Study To Eva...</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>False</td>\n",
       "      <td>153</td>\n",
       "      <td>153.000</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Rodney P, Starzomski R. Constraints on the mor...</td>\n",
       "      <td>11652809</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>0.900</td>\n",
       "      <td>0.580</td>\n",
       "      <td>742.000</td>\n",
       "      <td>0.736</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>10974 rows × 75 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                           source                  subsidiary  \\\n",
       "ticker       date                                               \n",
       "000020.KS    2025-02-24   foreign       Dongwha Pharm.Co.,Ltd   \n",
       "000100.KS    2025-03-08   foreign           Yuhan Corporation   \n",
       "             2025-03-27   foreign           Yuhan Corporation   \n",
       "000105.KS    2025-03-08   foreign           Yuhan Corporation   \n",
       "             2025-03-27   foreign           Yuhan Corporation   \n",
       "...                           ...                         ...   \n",
       "ZSPH         2025-04-02  delisted                 ASTRAZENECA   \n",
       "ZYDUSLIFE.BO 2025-01-22   foreign  ZYDUS LIFESCIENCES LIMITED   \n",
       "             2025-02-09   foreign  ZYDUS LIFESCIENCES LIMITED   \n",
       "ZYDUSLIFE.NS 2025-01-22   foreign  ZYDUS LIFESCIENCES LIMITED   \n",
       "             2025-02-09   foreign  ZYDUS LIFESCIENCES LIMITED   \n",
       "\n",
       "                                                  sponsor     trial_id  \\\n",
       "ticker       date                                                        \n",
       "000020.KS    2025-02-24  Dong Wha Pharmaceutical Co. Ltd.  NCT06875193   \n",
       "000100.KS    2025-03-08                 Yuhan Corporation  NCT06874894   \n",
       "             2025-03-27                 Yuhan Corporation  NCT06920719   \n",
       "000105.KS    2025-03-08                 Yuhan Corporation  NCT06874894   \n",
       "             2025-03-27                 Yuhan Corporation  NCT06920719   \n",
       "...                                                   ...          ...   \n",
       "ZSPH         2025-04-02                       AstraZeneca  NCT06908577   \n",
       "ZYDUSLIFE.BO 2025-01-22        Zydus Lifesciences Limited  NCT06815835   \n",
       "             2025-02-09           Zydus Therapeutics Inc.  NCT06825559   \n",
       "ZYDUSLIFE.NS 2025-01-22        Zydus Lifesciences Limited  NCT06815835   \n",
       "             2025-02-09           Zydus Therapeutics Inc.  NCT06825559   \n",
       "\n",
       "                                                            official_title  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24  Key Finding Of Dm Treatment With Combination, ...   \n",
       "000100.KS    2025-03-08  Thromboembolic And Bleeding Risk During Antico...   \n",
       "             2025-03-27  An Open-Label, Randomized, Fasting, Single-Dos...   \n",
       "000105.KS    2025-03-08  Thromboembolic And Bleeding Risk During Antico...   \n",
       "             2025-03-27  An Open-Label, Randomized, Fasting, Single-Dos...   \n",
       "...                                                                    ...   \n",
       "ZSPH         2025-04-02  A Multiple Centre, Randomised, Open-Label, Par...   \n",
       "ZYDUSLIFE.BO 2025-01-22  A Prospective, Randomized, Parallel, Three-Arm...   \n",
       "             2025-02-09  A Phase 1, Open-Label, Single Arm Study To Eva...   \n",
       "ZYDUSLIFE.NS 2025-01-22  A Prospective, Randomized, Parallel, Three-Arm...   \n",
       "             2025-02-09  A Phase 1, Open-Label, Single Arm Study To Eva...   \n",
       "\n",
       "                          sponsor_study_id  \\\n",
       "ticker       date                            \n",
       "000020.KS    2025-02-24        DW6012-IV-2   \n",
       "000100.KS    2025-03-08  CAUH 1992-002-387   \n",
       "             2025-03-27        YHP2406-101   \n",
       "000105.KS    2025-03-08  CAUH 1992-002-387   \n",
       "             2025-03-27        YHP2406-101   \n",
       "...                                    ...   \n",
       "ZSPH         2025-04-02        D9180C00006   \n",
       "ZYDUSLIFE.BO 2025-01-22           PR-24098   \n",
       "             2025-02-09        SARO.24.003   \n",
       "ZYDUSLIFE.NS 2025-01-22           PR-24098   \n",
       "             2025-02-09        SARO.24.003   \n",
       "\n",
       "                                                               brief_title  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24  Dm Treatment To Evaluate The Efficacy And Safe...   \n",
       "000100.KS    2025-03-08  Thromboembolic And Bleeding Risks During Antic...   \n",
       "             2025-03-27  Bioequivalence Study Betweenyhp2406 And Yhr250...   \n",
       "000105.KS    2025-03-08  Thromboembolic And Bleeding Risks During Antic...   \n",
       "             2025-03-27  Bioequivalence Study Betweenyhp2406 And Yhr250...   \n",
       "...                                                                    ...   \n",
       "ZSPH         2025-04-02  An Accessorised Prefilled Syringe To An Autoin...   \n",
       "ZYDUSLIFE.BO 2025-01-22  Non-Interference Study Of Mr And Yellow Fever ...   \n",
       "             2025-02-09  Evaluating Pharmacokinetic And Safety Of Sarog...   \n",
       "ZYDUSLIFE.NS 2025-01-22  Non-Interference Study Of Mr And Yellow Fever ...   \n",
       "             2025-02-09  Evaluating Pharmacokinetic And Safety Of Sarog...   \n",
       "\n",
       "                                                              lead_sponsor  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24                   Dong Wha Pharmaceutical Co. Ltd.   \n",
       "000100.KS    2025-03-08  Chung-Ang University Hosptial, Chung-Ang Unive...   \n",
       "             2025-03-27                                  Yuhan Corporation   \n",
       "000105.KS    2025-03-08  Chung-Ang University Hosptial, Chung-Ang Unive...   \n",
       "             2025-03-27                                  Yuhan Corporation   \n",
       "...                                                                    ...   \n",
       "ZSPH         2025-04-02                                        AstraZeneca   \n",
       "ZYDUSLIFE.BO 2025-01-22  International Centre for Diarrhoeal Disease Re...   \n",
       "             2025-02-09                            Zydus Therapeutics Inc.   \n",
       "ZYDUSLIFE.NS 2025-01-22  International Centre for Diarrhoeal Disease Re...   \n",
       "             2025-02-09                            Zydus Therapeutics Inc.   \n",
       "\n",
       "                                                         lead_sponsor_name  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24                   Dong Wha Pharmaceutical Co. Ltd.   \n",
       "000100.KS    2025-03-08  Chung-Ang University Hosptial, Chung-Ang Unive...   \n",
       "             2025-03-27                                  Yuhan Corporation   \n",
       "000105.KS    2025-03-08  Chung-Ang University Hosptial, Chung-Ang Unive...   \n",
       "             2025-03-27                                  Yuhan Corporation   \n",
       "...                                                                    ...   \n",
       "ZSPH         2025-04-02                                        Astrazeneca   \n",
       "ZYDUSLIFE.BO 2025-01-22  International Centre For Diarrhoeal Disease Re...   \n",
       "             2025-02-09                            Zydus Therapeutics Inc.   \n",
       "ZYDUSLIFE.NS 2025-01-22  International Centre For Diarrhoeal Disease Re...   \n",
       "             2025-02-09                            Zydus Therapeutics Inc.   \n",
       "\n",
       "                        sponsor_type lead_sponsor_type phase_category  \\\n",
       "ticker       date                                                       \n",
       "000020.KS    2025-02-24     INDUSTRY          INDUSTRY        phase_4   \n",
       "000100.KS    2025-03-08        OTHER             OTHER  not_specified   \n",
       "             2025-03-27     INDUSTRY          INDUSTRY        phase_1   \n",
       "000105.KS    2025-03-08        OTHER             OTHER  not_specified   \n",
       "             2025-03-27     INDUSTRY          INDUSTRY        phase_1   \n",
       "...                              ...               ...            ...   \n",
       "ZSPH         2025-04-02     INDUSTRY          INDUSTRY        phase_1   \n",
       "ZYDUSLIFE.BO 2025-01-22        OTHER             OTHER        phase_3   \n",
       "             2025-02-09     INDUSTRY          INDUSTRY        phase_1   \n",
       "ZYDUSLIFE.NS 2025-01-22        OTHER             OTHER        phase_3   \n",
       "             2025-02-09     INDUSTRY          INDUSTRY        phase_1   \n",
       "\n",
       "                             study_type  enrollment_count  \\\n",
       "ticker       date                                           \n",
       "000020.KS    2025-02-24  INTERVENTIONAL               196   \n",
       "000100.KS    2025-03-08   OBSERVATIONAL              1100   \n",
       "             2025-03-27  INTERVENTIONAL                62   \n",
       "000105.KS    2025-03-08   OBSERVATIONAL              1100   \n",
       "             2025-03-27  INTERVENTIONAL                62   \n",
       "...                                 ...               ...   \n",
       "ZSPH         2025-04-02  INTERVENTIONAL               252   \n",
       "ZYDUSLIFE.BO 2025-01-22  INTERVENTIONAL              1530   \n",
       "             2025-02-09  INTERVENTIONAL                 6   \n",
       "ZYDUSLIFE.NS 2025-01-22  INTERVENTIONAL              1530   \n",
       "             2025-02-09  INTERVENTIONAL                 6   \n",
       "\n",
       "                         number_of_locations healthy_volunteers  \\\n",
       "ticker       date                                                 \n",
       "000020.KS    2025-02-24                    1              False   \n",
       "000100.KS    2025-03-08                    1              False   \n",
       "             2025-03-27                    1               True   \n",
       "000105.KS    2025-03-08                    1              False   \n",
       "             2025-03-27                    1               True   \n",
       "...                                      ...                ...   \n",
       "ZSPH         2025-04-02                    0               True   \n",
       "ZYDUSLIFE.BO 2025-01-22                    1               True   \n",
       "             2025-02-09                    0              False   \n",
       "ZYDUSLIFE.NS 2025-01-22                    1               True   \n",
       "             2025-02-09                    0              False   \n",
       "\n",
       "                        enrollment_type study_size_category  \\\n",
       "ticker       date                                             \n",
       "000020.KS    2025-02-24       ESTIMATED              Medium   \n",
       "000100.KS    2025-03-08       ESTIMATED          Very Large   \n",
       "             2025-03-27       ESTIMATED               Small   \n",
       "000105.KS    2025-03-08       ESTIMATED          Very Large   \n",
       "             2025-03-27       ESTIMATED               Small   \n",
       "...                                 ...                 ...   \n",
       "ZSPH         2025-04-02       ESTIMATED              Medium   \n",
       "ZYDUSLIFE.BO 2025-01-22       ESTIMATED          Very Large   \n",
       "             2025-02-09       ESTIMATED               Small   \n",
       "ZYDUSLIFE.NS 2025-01-22       ESTIMATED          Very Large   \n",
       "             2025-02-09       ESTIMATED               Small   \n",
       "\n",
       "                                                        condition_keywords  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24       Dapagliflozin; Pioglitazone; DPP-4 inhibitor   \n",
       "000100.KS    2025-03-08              Atrial Fibrillation; Stroke; Bleeding   \n",
       "             2025-03-27                   Pharmacokinetics; Bioequivalence   \n",
       "000105.KS    2025-03-08              Atrial Fibrillation; Stroke; Bleeding   \n",
       "             2025-03-27                   Pharmacokinetics; Bioequivalence   \n",
       "...                                                                    ...   \n",
       "ZSPH         2025-04-02  Anti-Interleukin (IL)-33 antibody; Human immun...   \n",
       "ZYDUSLIFE.BO 2025-01-22  Safety; Non-interference; Measles and Rubella;...   \n",
       "             2025-02-09  Saroglitazar Magnesium; Primary Biliary Cholan...   \n",
       "ZYDUSLIFE.NS 2025-01-22  Safety; Non-interference; Measles and Rubella;...   \n",
       "             2025-02-09  Saroglitazar Magnesium; Primary Biliary Cholan...   \n",
       "\n",
       "                                 primary_condition       intervention_type  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24              Type2Diabetes                    DRUG   \n",
       "000100.KS    2025-03-08       Fibrillation, Atrial                     nan   \n",
       "             2025-03-27            Healthy Subject              DRUG; DRUG   \n",
       "000105.KS    2025-03-08       Fibrillation, Atrial                     nan   \n",
       "             2025-03-27            Healthy Subject              DRUG; DRUG   \n",
       "...                                            ...                     ...   \n",
       "ZSPH         2025-04-02       Healthy Participants    DRUG; DEVICE; DEVICE   \n",
       "ZYDUSLIFE.BO 2025-01-22                    Measles  BIOLOGICAL; BIOLOGICAL   \n",
       "             2025-02-09  Cholestatic Liver Disease                    DRUG   \n",
       "ZYDUSLIFE.NS 2025-01-22                    Measles  BIOLOGICAL; BIOLOGICAL   \n",
       "             2025-02-09  Cholestatic Liver Disease                    DRUG   \n",
       "\n",
       "                                                      primary_intervention  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24                     DW6012(Dasidiem tab. 10/100mg)   \n",
       "000100.KS    2025-03-08                                                nan   \n",
       "             2025-03-27                                            YHP2406   \n",
       "000105.KS    2025-03-08                                                nan   \n",
       "             2025-03-27                                            YHP2406   \n",
       "...                                                                    ...   \n",
       "ZSPH         2025-04-02                                        Tozorakimab   \n",
       "ZYDUSLIFE.BO 2025-01-22  Measles-Rubella vaccine (Live) I.P. (Freeze Dr...   \n",
       "             2025-02-09                        Saroglitazar Magnesium 1 mg   \n",
       "ZYDUSLIFE.NS 2025-01-22  Measles-Rubella vaccine (Live) I.P. (Freeze Dr...   \n",
       "             2025-02-09                        Saroglitazar Magnesium 1 mg   \n",
       "\n",
       "                                                         intervention_name  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24                     DW6012(Dasidiem tab. 10/100mg)   \n",
       "000100.KS    2025-03-08                                                nan   \n",
       "             2025-03-27                                   YHP2406; YHR2501   \n",
       "000105.KS    2025-03-08                                                nan   \n",
       "             2025-03-27                                   YHP2406; YHR2501   \n",
       "...                                                                    ...   \n",
       "ZSPH         2025-04-02  Tozorakimab; Autoinjector (AI) Device; Accesso...   \n",
       "ZYDUSLIFE.BO 2025-01-22  Measles-Rubella vaccine (Live) I.P. (Freeze Dr...   \n",
       "             2025-02-09                        Saroglitazar Magnesium 1 mg   \n",
       "ZYDUSLIFE.NS 2025-01-22  Measles-Rubella vaccine (Live) I.P. (Freeze Dr...   \n",
       "             2025-02-09                        Saroglitazar Magnesium 1 mg   \n",
       "\n",
       "                                             intervention_arm_group_labels  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24    Dasidiem 10/100mg; sitdiem 100mg, Piotazone15mg   \n",
       "000100.KS    2025-03-08                                               None   \n",
       "             2025-03-27                         A(RT); B(TR); A(RT); B(TR)   \n",
       "000105.KS    2025-03-08                                               None   \n",
       "             2025-03-27                         A(RT); B(TR); A(RT); B(TR)   \n",
       "...                                                                    ...   \n",
       "ZSPH         2025-04-02  Treatment A: Tozorakimab (Test); Treatment B: ...   \n",
       "ZYDUSLIFE.BO 2025-01-22  Reference 1 (MR); Test (MR+YF); Reference 2 (Y...   \n",
       "             2025-02-09                        Saroglitazar Magnesium 1 mg   \n",
       "ZYDUSLIFE.NS 2025-01-22  Reference 1 (MR); Test (MR+YF); Reference 2 (Y...   \n",
       "             2025-02-09                        Saroglitazar Magnesium 1 mg   \n",
       "\n",
       "                                                  intervention_description  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24                    Once A Day, Oral Administration   \n",
       "000100.KS    2025-03-08                                               None   \n",
       "             2025-03-27  Test Drug: Yhp2406, Comparator: Yhr2501; Test ...   \n",
       "000105.KS    2025-03-08                                               None   \n",
       "             2025-03-27  Test Drug: Yhp2406, Comparator: Yhr2501; Test ...   \n",
       "...                                                                    ...   \n",
       "ZSPH         2025-04-02  Tozorakimab Will Be Administered As A Single S...   \n",
       "ZYDUSLIFE.BO 2025-01-22   Live Attenuated Vaccine; Live Attenuated Vaccine   \n",
       "             2025-02-09  Saroglitazar Magnesium 1 Mg Will Be Assigned T...   \n",
       "ZYDUSLIFE.NS 2025-01-22   Live Attenuated Vaccine; Live Attenuated Vaccine   \n",
       "             2025-02-09  Saroglitazar Magnesium 1 Mg Will Be Assigned T...   \n",
       "\n",
       "                        has_data_monitoring_committee  \\\n",
       "ticker       date                                       \n",
       "000020.KS    2025-02-24                         False   \n",
       "000100.KS    2025-03-08                          True   \n",
       "             2025-03-27                         False   \n",
       "000105.KS    2025-03-08                          True   \n",
       "             2025-03-27                         False   \n",
       "...                                               ...   \n",
       "ZSPH         2025-04-02                         False   \n",
       "ZYDUSLIFE.BO 2025-01-22                          True   \n",
       "             2025-02-09                         False   \n",
       "ZYDUSLIFE.NS 2025-01-22                          True   \n",
       "             2025-02-09                         False   \n",
       "\n",
       "                                responsible_party_investigator_affiliation  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24                                               None   \n",
       "000100.KS    2025-03-08  Chung-Ang University Hosptial, Chung-Ang Unive...   \n",
       "             2025-03-27                                               None   \n",
       "000105.KS    2025-03-08  Chung-Ang University Hosptial, Chung-Ang Unive...   \n",
       "             2025-03-27                                               None   \n",
       "...                                                                    ...   \n",
       "ZSPH         2025-04-02                                               None   \n",
       "ZYDUSLIFE.BO 2025-01-22                                               None   \n",
       "             2025-02-09                                               None   \n",
       "ZYDUSLIFE.NS 2025-01-22                                               None   \n",
       "             2025-02-09                                               None   \n",
       "\n",
       "                        responsible_party_investigator_title  \\\n",
       "ticker       date                                              \n",
       "000020.KS    2025-02-24                                 None   \n",
       "000100.KS    2025-03-08                  Associate Professor   \n",
       "             2025-03-27                                 None   \n",
       "000105.KS    2025-03-08                  Associate Professor   \n",
       "             2025-03-27                                 None   \n",
       "...                                                      ...   \n",
       "ZSPH         2025-04-02                                 None   \n",
       "ZYDUSLIFE.BO 2025-01-22                                 None   \n",
       "             2025-02-09                                 None   \n",
       "ZYDUSLIFE.NS 2025-01-22                                 None   \n",
       "             2025-02-09                                 None   \n",
       "\n",
       "                        responsible_party_investigator_name first_posted_date  \\\n",
       "ticker       date                                                               \n",
       "000020.KS    2025-02-24                                None        2025-03-13   \n",
       "000100.KS    2025-03-08                        Ki-Woon Kang        2025-03-13   \n",
       "             2025-03-27                                None        2025-04-10   \n",
       "000105.KS    2025-03-08                        Ki-Woon Kang        2025-03-13   \n",
       "             2025-03-27                                None        2025-04-10   \n",
       "...                                                     ...               ...   \n",
       "ZSPH         2025-04-02                                None        2025-04-03   \n",
       "ZYDUSLIFE.BO 2025-01-22                                None        2025-02-07   \n",
       "             2025-02-09                                None        2025-02-13   \n",
       "ZYDUSLIFE.NS 2025-01-22                                None        2025-02-07   \n",
       "             2025-02-09                                None        2025-02-13   \n",
       "\n",
       "                        last_update_posted_date start_date  \\\n",
       "ticker       date                                            \n",
       "000020.KS    2025-02-24              2025-03-17 2024-05-28   \n",
       "000100.KS    2025-03-08              2025-03-13 2022-05-25   \n",
       "             2025-03-27              2025-04-10        NaT   \n",
       "000105.KS    2025-03-08              2025-03-13 2022-05-25   \n",
       "             2025-03-27              2025-04-10        NaT   \n",
       "...                                         ...        ...   \n",
       "ZSPH         2025-04-02              2025-04-03        NaT   \n",
       "ZYDUSLIFE.BO 2025-01-22              2025-02-07 2025-04-01   \n",
       "             2025-02-09              2025-02-13 2025-03-31   \n",
       "ZYDUSLIFE.NS 2025-01-22              2025-02-07 2025-04-01   \n",
       "             2025-02-09              2025-02-13 2025-03-31   \n",
       "\n",
       "                        study_completion_date primary_completion_date  \\\n",
       "ticker       date                                                       \n",
       "000020.KS    2025-02-24            2025-12-31              2025-12-31   \n",
       "000100.KS    2025-03-08            2026-08-30              2025-08-30   \n",
       "             2025-03-27                   NaT                     NaT   \n",
       "000105.KS    2025-03-08            2026-08-30              2025-08-30   \n",
       "             2025-03-27                   NaT                     NaT   \n",
       "...                                       ...                     ...   \n",
       "ZSPH         2025-04-02                   NaT                     NaT   \n",
       "ZYDUSLIFE.BO 2025-01-22            2026-03-31              2026-03-31   \n",
       "             2025-02-09            2025-08-31              2025-08-31   \n",
       "ZYDUSLIFE.NS 2025-01-22            2026-03-31              2026-03-31   \n",
       "             2025-02-09            2025-08-31              2025-08-31   \n",
       "\n",
       "                        study_locations_city study_locations_country  \\\n",
       "ticker       date                                                      \n",
       "000020.KS    2025-02-24                Seoul      Korea, Republic of   \n",
       "000100.KS    2025-03-08                Seoul      Korea, Republic of   \n",
       "             2025-03-27                Seoul      Korea, Republic of   \n",
       "000105.KS    2025-03-08                Seoul      Korea, Republic of   \n",
       "             2025-03-27                Seoul      Korea, Republic of   \n",
       "...                                      ...                     ...   \n",
       "ZSPH         2025-04-02                 None                    None   \n",
       "ZYDUSLIFE.BO 2025-01-22                Dhaka              Bangladesh   \n",
       "             2025-02-09                 None                    None   \n",
       "ZYDUSLIFE.NS 2025-01-22                Dhaka              Bangladesh   \n",
       "             2025-02-09                 None                    None   \n",
       "\n",
       "                            study_locations_geopoint  \\\n",
       "ticker       date                                      \n",
       "000020.KS    2025-02-24   lat: 37.566, lon: 126.9784   \n",
       "000100.KS    2025-03-08   lat: 37.566, lon: 126.9784   \n",
       "             2025-03-27   lat: 37.566, lon: 126.9784   \n",
       "000105.KS    2025-03-08   lat: 37.566, lon: 126.9784   \n",
       "             2025-03-27   lat: 37.566, lon: 126.9784   \n",
       "...                                              ...   \n",
       "ZSPH         2025-04-02                         None   \n",
       "ZYDUSLIFE.BO 2025-01-22  lat: 23.7104, lon: 90.40744   \n",
       "             2025-02-09                         None   \n",
       "ZYDUSLIFE.NS 2025-01-22  lat: 23.7104, lon: 90.40744   \n",
       "             2025-02-09                         None   \n",
       "\n",
       "                                          study_locations_facility  \\\n",
       "ticker       date                                                    \n",
       "000020.KS    2025-02-24  Kyung Hee University Hospital at Gangdong   \n",
       "000100.KS    2025-03-08              Chung-Ang University Hospital   \n",
       "             2025-03-27                     H Plus Yangji Hospital   \n",
       "000105.KS    2025-03-08              Chung-Ang University Hospital   \n",
       "             2025-03-27                     H Plus Yangji Hospital   \n",
       "...                                                            ...   \n",
       "ZSPH         2025-04-02                                       None   \n",
       "ZYDUSLIFE.BO 2025-01-22                                    Icddr,B   \n",
       "             2025-02-09                                       None   \n",
       "ZYDUSLIFE.NS 2025-01-22                                    Icddr,B   \n",
       "             2025-02-09                                       None   \n",
       "\n",
       "                        study_locations_zip study_locations_state  \\\n",
       "ticker       date                                                   \n",
       "000020.KS    2025-02-24                None                  None   \n",
       "000100.KS    2025-03-08               06973                  None   \n",
       "             2025-03-27               08779                  None   \n",
       "000105.KS    2025-03-08               06973                  None   \n",
       "             2025-03-27               08779                  None   \n",
       "...                                     ...                   ...   \n",
       "ZSPH         2025-04-02                None                  None   \n",
       "ZYDUSLIFE.BO 2025-01-22                None                  None   \n",
       "             2025-02-09                None                  None   \n",
       "ZYDUSLIFE.NS 2025-01-22                None                  None   \n",
       "             2025-02-09                None                  None   \n",
       "\n",
       "                               standard_age_groups  sex  minimum_age  \\\n",
       "ticker       date                                                      \n",
       "000020.KS    2025-02-24         ADULT; OLDER_ADULT  ALL           19   \n",
       "000100.KS    2025-03-08  CHILD; ADULT; OLDER_ADULT  ALL            2   \n",
       "             2025-03-27         ADULT; OLDER_ADULT  ALL           19   \n",
       "000105.KS    2025-03-08  CHILD; ADULT; OLDER_ADULT  ALL            2   \n",
       "             2025-03-27         ADULT; OLDER_ADULT  ALL           19   \n",
       "...                                            ...  ...          ...   \n",
       "ZSPH         2025-04-02                      ADULT  ALL           18   \n",
       "ZYDUSLIFE.BO 2025-01-22                      CHILD  ALL            1   \n",
       "             2025-02-09         ADULT; OLDER_ADULT  ALL           18   \n",
       "ZYDUSLIFE.NS 2025-01-22                      CHILD  ALL            1   \n",
       "             2025-02-09         ADULT; OLDER_ADULT  ALL           18   \n",
       "\n",
       "                         maximum_age           overall_status status_category  \\\n",
       "ticker       date                                                               \n",
       "000020.KS    2025-02-24         <NA>               RECRUITING          active   \n",
       "000100.KS    2025-03-08         <NA>  ENROLLING_BY_INVITATION          active   \n",
       "             2025-03-27         <NA>       NOT_YET_RECRUITING          active   \n",
       "000105.KS    2025-03-08         <NA>  ENROLLING_BY_INVITATION          active   \n",
       "             2025-03-27         <NA>       NOT_YET_RECRUITING          active   \n",
       "...                              ...                      ...             ...   \n",
       "ZSPH         2025-04-02           55       NOT_YET_RECRUITING          active   \n",
       "ZYDUSLIFE.BO 2025-01-22            1       NOT_YET_RECRUITING          active   \n",
       "             2025-02-09           80       NOT_YET_RECRUITING          active   \n",
       "ZYDUSLIFE.NS 2025-01-22            1       NOT_YET_RECRUITING          active   \n",
       "             2025-02-09           80       NOT_YET_RECRUITING          active   \n",
       "\n",
       "                        status_verified_date  \\\n",
       "ticker       date                              \n",
       "000020.KS    2025-02-24           2025-03-01   \n",
       "000100.KS    2025-03-08           2025-03-01   \n",
       "             2025-03-27           2025-04-01   \n",
       "000105.KS    2025-03-08           2025-03-01   \n",
       "             2025-03-27           2025-04-01   \n",
       "...                                      ...   \n",
       "ZSPH         2025-04-02           2025-03-01   \n",
       "ZYDUSLIFE.BO 2025-01-22           2025-02-01   \n",
       "             2025-02-09           2025-02-01   \n",
       "ZYDUSLIFE.NS 2025-01-22           2025-02-01   \n",
       "             2025-02-09           2025-02-01   \n",
       "\n",
       "                                                 primary_outcomes_measures  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24  Variance in HbA1c from baseline to 24 weeks on...   \n",
       "000100.KS    2025-03-08           Clinical ischemic and hemorrhagic events   \n",
       "             2025-03-27  Area under the plasma drug concentration-time ...   \n",
       "000105.KS    2025-03-08           Clinical ischemic and hemorrhagic events   \n",
       "             2025-03-27  Area under the plasma drug concentration-time ...   \n",
       "...                                                                    ...   \n",
       "ZSPH         2025-04-02  Area under concentration-time curve from time ...   \n",
       "ZYDUSLIFE.BO 2025-01-22                                     Seropositivity   \n",
       "             2025-02-09  Pharmacokinetics of Saroglitazar: Cmax; Pharma...   \n",
       "ZYDUSLIFE.NS 2025-01-22                                     Seropositivity   \n",
       "             2025-02-09  Pharmacokinetics of Saroglitazar: Cmax; Pharma...   \n",
       "\n",
       "                                               primary_outcomes_timeframes  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24                                           24 weeks   \n",
       "000100.KS    2025-03-08                                          12 months   \n",
       "             2025-03-27                               0-8 hours; 0-8 hours   \n",
       "000105.KS    2025-03-08                                          12 months   \n",
       "             2025-03-27                               0-8 hours; 0-8 hours   \n",
       "...                                                                    ...   \n",
       "ZSPH         2025-04-02  From Day 1 to Day 113; From Day 1 to Day 113; ...   \n",
       "ZYDUSLIFE.BO 2025-01-22                                           06 weeks   \n",
       "             2025-02-09  PK sampling timepoints: pre- dose, 20 min, 40 ...   \n",
       "ZYDUSLIFE.NS 2025-01-22                                           06 weeks   \n",
       "             2025-02-09  PK sampling timepoints: pre- dose, 20 min, 40 ...   \n",
       "\n",
       "                                             primary_outcomes_descriptions  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24                                    Change in HbA1c   \n",
       "000100.KS    2025-03-08  Ischemic stroke, systemic embolism, or myocard...   \n",
       "             2025-03-27  Area under the plasma drug concentration-time ...   \n",
       "000105.KS    2025-03-08  Ischemic stroke, systemic embolism, or myocard...   \n",
       "             2025-03-27  Area under the plasma drug concentration-time ...   \n",
       "...                                                                    ...   \n",
       "ZSPH         2025-04-02  To compare the PK exposure following single SC...   \n",
       "ZYDUSLIFE.BO 2025-01-22  Equivalence for seropositivity rate for anti-m...   \n",
       "             2025-02-09  Maximum plasma concentration (Cmax); Time to r...   \n",
       "ZYDUSLIFE.NS 2025-01-22  Equivalence for seropositivity rate for anti-m...   \n",
       "             2025-02-09  Maximum plasma concentration (Cmax); Time to r...   \n",
       "\n",
       "                                               secondary_outcomes_measures  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24  Variance in HbA1c from baseline to 12 weeks on...   \n",
       "000100.KS    2025-03-08                              Clinical other events   \n",
       "             2025-03-27  Area under the plasma drug concentration-time ...   \n",
       "000105.KS    2025-03-08                              Clinical other events   \n",
       "             2025-03-27  Area under the plasma drug concentration-time ...   \n",
       "...                                                                    ...   \n",
       "ZSPH         2025-04-02  Time to reach maximum observed concentration (...   \n",
       "ZYDUSLIFE.BO 2025-01-22                   Immunogenicity; Safety reporting   \n",
       "             2025-02-09  Safety and Tolerability of Saroglitazar Magnes...   \n",
       "ZYDUSLIFE.NS 2025-01-22                   Immunogenicity; Safety reporting   \n",
       "             2025-02-09  Safety and Tolerability of Saroglitazar Magnes...   \n",
       "\n",
       "                                             secondary_outcomes_timeframes  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24  12 weeks; 12, 24 weeks; 12, 24 weeks; 12, 24 w...   \n",
       "000100.KS    2025-03-08                                          12 months   \n",
       "             2025-03-27         0-8 Hours; 0-8 Hours; 0-8 Hours; 0-8 Hours   \n",
       "000105.KS    2025-03-08                                          12 months   \n",
       "             2025-03-27         0-8 Hours; 0-8 Hours; 0-8 Hours; 0-8 Hours   \n",
       "...                                                                    ...   \n",
       "ZSPH         2025-04-02  From Day 1 to Day 113; From Day 1 to Day 113; ...   \n",
       "ZYDUSLIFE.BO 2025-01-22                               06 months; 06 months   \n",
       "             2025-02-09  From baseline to End of study (35 days); PK sa...   \n",
       "ZYDUSLIFE.NS 2025-01-22                               06 months; 06 months   \n",
       "             2025-02-09  From baseline to End of study (35 days); PK sa...   \n",
       "\n",
       "                                           secondary_outcomes_descriptions  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24  Change in HbA1c; Change in Fasting Plasma Gluc...   \n",
       "000100.KS    2025-03-08  Major Adverse Cardiovascular Events: Myocardia...   \n",
       "             2025-03-27  Area under the plasma drug concentration-time ...   \n",
       "000105.KS    2025-03-08  Major Adverse Cardiovascular Events: Myocardia...   \n",
       "             2025-03-27  Area under the plasma drug concentration-time ...   \n",
       "...                                                                    ...   \n",
       "ZSPH         2025-04-02  To assess additional PK parameters following s...   \n",
       "ZYDUSLIFE.BO 2025-01-22  * Seropositivity rate for anti-measles (≥9 Nov...   \n",
       "             2025-02-09  Number of participants with adverse events; Ti...   \n",
       "ZYDUSLIFE.NS 2025-01-22  * Seropositivity rate for anti-measles (≥9 Nov...   \n",
       "             2025-02-09  Number of participants with adverse events; Ti...   \n",
       "\n",
       "                         has_results                      conditions  \\\n",
       "ticker       date                                                      \n",
       "000020.KS    2025-02-24        False                   Type2Diabetes   \n",
       "000100.KS    2025-03-08        False            Fibrillation, Atrial   \n",
       "             2025-03-27        False                 Healthy Subject   \n",
       "000105.KS    2025-03-08        False            Fibrillation, Atrial   \n",
       "             2025-03-27        False                 Healthy Subject   \n",
       "...                              ...                             ...   \n",
       "ZSPH         2025-04-02        False            Healthy Participants   \n",
       "ZYDUSLIFE.BO 2025-01-22        False  Measles; Rubella; Yellow Fever   \n",
       "             2025-02-09        False       Cholestatic Liver Disease   \n",
       "ZYDUSLIFE.NS 2025-01-22        False  Measles; Rubella; Yellow Fever   \n",
       "             2025-02-09        False       Cholestatic Liver Disease   \n",
       "\n",
       "                                                             brief_summary  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24  Key Finding Of Dm Treatment With Combination, ...   \n",
       "000100.KS    2025-03-08  This Study Was Design To Investigate The Effic...   \n",
       "             2025-03-27  A Randomized, Open-Label, Single-Dose, 2-Seque...   \n",
       "000105.KS    2025-03-08  This Study Was Design To Investigate The Effic...   \n",
       "             2025-03-27  A Randomized, Open-Label, Single-Dose, 2-Seque...   \n",
       "...                                                                    ...   \n",
       "ZSPH         2025-04-02  The Purpose Of This Study Is To Compare The Ph...   \n",
       "ZYDUSLIFE.BO 2025-01-22  This Study Will Be Conducted Among 1530 Health...   \n",
       "             2025-02-09  Evaluating Pharmacokinetic And Safety Of Sarog...   \n",
       "ZYDUSLIFE.NS 2025-01-22  This Study Will Be Conducted Among 1530 Health...   \n",
       "             2025-02-09  Evaluating Pharmacokinetic And Safety Of Sarog...   \n",
       "\n",
       "                                                      detailed_description  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24  This Is A Phase 4, Multicenter, Randomized, Op...   \n",
       "000100.KS    2025-03-08  East Asians Have Demonstrated A Higher Bleedin...   \n",
       "             2025-03-27  62 Healthy Subjects Will Be Randomized To One ...   \n",
       "000105.KS    2025-03-08  East Asians Have Demonstrated A Higher Bleedin...   \n",
       "             2025-03-27  62 Healthy Subjects Will Be Randomized To One ...   \n",
       "...                                                                    ...   \n",
       "ZSPH         2025-04-02  This Is A Multiple Center, Randomized, Open-La...   \n",
       "ZYDUSLIFE.BO 2025-01-22  This Is A Prospective, Randomized, Parallel, T...   \n",
       "             2025-02-09  A Phase 1, Open-Label, Single Arm Study To Eva...   \n",
       "ZYDUSLIFE.NS 2025-01-22  This Is A Prospective, Randomized, Parallel, T...   \n",
       "             2025-02-09  A Phase 1, Open-Label, Single Arm Study To Eva...   \n",
       "\n",
       "                        masking  allocation intervention_model  \\\n",
       "ticker       date                                                \n",
       "000020.KS    2025-02-24    NONE  RANDOMIZED           PARALLEL   \n",
       "000100.KS    2025-03-08    None        None               None   \n",
       "             2025-03-27    NONE  RANDOMIZED          CROSSOVER   \n",
       "000105.KS    2025-03-08    None        None               None   \n",
       "             2025-03-27    NONE  RANDOMIZED          CROSSOVER   \n",
       "...                         ...         ...                ...   \n",
       "ZSPH         2025-04-02    NONE  RANDOMIZED           PARALLEL   \n",
       "ZYDUSLIFE.BO 2025-01-22    NONE  RANDOMIZED           PARALLEL   \n",
       "             2025-02-09    NONE          NA       SINGLE_GROUP   \n",
       "ZYDUSLIFE.NS 2025-01-22    NONE  RANDOMIZED           PARALLEL   \n",
       "             2025-02-09    NONE          NA       SINGLE_GROUP   \n",
       "\n",
       "                         primary_purpose  has_expanded_access  \\\n",
       "ticker       date                                               \n",
       "000020.KS    2025-02-24  SUPPORTIVE_CARE                False   \n",
       "000100.KS    2025-03-08             None                False   \n",
       "             2025-03-27        TREATMENT                False   \n",
       "000105.KS    2025-03-08             None                False   \n",
       "             2025-03-27        TREATMENT                False   \n",
       "...                                  ...                  ...   \n",
       "ZSPH         2025-04-02        TREATMENT                False   \n",
       "ZYDUSLIFE.BO 2025-01-22       PREVENTION                False   \n",
       "             2025-02-09        TREATMENT                False   \n",
       "ZYDUSLIFE.NS 2025-01-22       PREVENTION                False   \n",
       "             2025-02-09        TREATMENT                False   \n",
       "\n",
       "                         study_duration_days  trial_duration  \\\n",
       "ticker       date                                              \n",
       "000020.KS    2025-02-24                  582         582.000   \n",
       "000100.KS    2025-03-08                 1558        1558.000   \n",
       "             2025-03-27                 <NA>             NaN   \n",
       "000105.KS    2025-03-08                 1558        1558.000   \n",
       "             2025-03-27                 <NA>             NaN   \n",
       "...                                      ...             ...   \n",
       "ZSPH         2025-04-02                 <NA>             NaN   \n",
       "ZYDUSLIFE.BO 2025-01-22                  364         364.000   \n",
       "             2025-02-09                  153         153.000   \n",
       "ZYDUSLIFE.NS 2025-01-22                  364         364.000   \n",
       "             2025-02-09                  153         153.000   \n",
       "\n",
       "                                                           references_type  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24                                               None   \n",
       "000100.KS    2025-03-08                                             RESULT   \n",
       "             2025-03-27                                               None   \n",
       "000105.KS    2025-03-08                                             RESULT   \n",
       "             2025-03-27                                               None   \n",
       "...                                                                    ...   \n",
       "ZSPH         2025-04-02                                               None   \n",
       "ZYDUSLIFE.BO 2025-01-22  BACKGROUND; BACKGROUND; BACKGROUND; BACKGROUND...   \n",
       "             2025-02-09                                         BACKGROUND   \n",
       "ZYDUSLIFE.NS 2025-01-22  BACKGROUND; BACKGROUND; BACKGROUND; BACKGROUND...   \n",
       "             2025-02-09                                         BACKGROUND   \n",
       "\n",
       "                                                       references_citation  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24                                               None   \n",
       "000100.KS    2025-03-08  Lee SH, Kim HK, Ahn JH, Kang MG, Kim KH, Bae J...   \n",
       "             2025-03-27                                               None   \n",
       "000105.KS    2025-03-08  Lee SH, Kim HK, Ahn JH, Kang MG, Kim KH, Bae J...   \n",
       "             2025-03-27                                               None   \n",
       "...                                                                    ...   \n",
       "ZSPH         2025-04-02                                               None   \n",
       "ZYDUSLIFE.BO 2025-01-22  Cracknell Daniels B, Gaythorpe K, Imai N, Dori...   \n",
       "             2025-02-09  Rodney P, Starzomski R. Constraints on the mor...   \n",
       "ZYDUSLIFE.NS 2025-01-22  Cracknell Daniels B, Gaythorpe K, Imai N, Dori...   \n",
       "             2025-02-09  Rodney P, Starzomski R. Constraints on the mor...   \n",
       "\n",
       "                                                           references_pmid  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24                                               None   \n",
       "000100.KS    2025-03-08                                           36857519   \n",
       "             2025-03-27                                               None   \n",
       "000105.KS    2025-03-08                                           36857519   \n",
       "             2025-03-27                                               None   \n",
       "...                                                                    ...   \n",
       "ZSPH         2025-04-02                                               None   \n",
       "ZYDUSLIFE.BO 2025-01-22  33506250; 33258924; 18847312; 25453327; 337223...   \n",
       "             2025-02-09                                           11652809   \n",
       "ZYDUSLIFE.NS 2025-01-22  33506250; 33258924; 18847312; 25453327; 337223...   \n",
       "             2025-02-09                                           11652809   \n",
       "\n",
       "                                                        collaborators_name  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24                                               None   \n",
       "000100.KS    2025-03-08  Chung-Ang University Gwangmyeong Hospital; Sam...   \n",
       "             2025-03-27                                               None   \n",
       "000105.KS    2025-03-08  Chung-Ang University Gwangmyeong Hospital; Sam...   \n",
       "             2025-03-27                                               None   \n",
       "...                                                                    ...   \n",
       "ZSPH         2025-04-02                                            Parexel   \n",
       "ZYDUSLIFE.BO 2025-01-22                         Zydus Lifesciences Limited   \n",
       "             2025-02-09                                               None   \n",
       "ZYDUSLIFE.NS 2025-01-22                         Zydus Lifesciences Limited   \n",
       "             2025-02-09                                               None   \n",
       "\n",
       "                                                 collaborators_class  \\\n",
       "ticker       date                                                      \n",
       "000020.KS    2025-02-24                                         None   \n",
       "000100.KS    2025-03-08  OTHER; OTHER; OTHER; OTHER; OTHER; INDUSTRY   \n",
       "             2025-03-27                                         None   \n",
       "000105.KS    2025-03-08  OTHER; OTHER; OTHER; OTHER; OTHER; INDUSTRY   \n",
       "             2025-03-27                                         None   \n",
       "...                                                              ...   \n",
       "ZSPH         2025-04-02                                     INDUSTRY   \n",
       "ZYDUSLIFE.BO 2025-01-22                                     INDUSTRY   \n",
       "             2025-02-09                                         None   \n",
       "ZYDUSLIFE.NS 2025-01-22                                     INDUSTRY   \n",
       "             2025-02-09                                         None   \n",
       "\n",
       "                        ipd_sharing  success_prediction  economic_effect  \\\n",
       "ticker       date                                                          \n",
       "000020.KS    2025-02-24          NO               0.250            0.060   \n",
       "000100.KS    2025-03-08          NO               0.400            0.150   \n",
       "             2025-03-27          NO               0.890            0.500   \n",
       "000105.KS    2025-03-08          NO               0.400            0.150   \n",
       "             2025-03-27          NO               0.890            0.500   \n",
       "...                             ...                 ...              ...   \n",
       "ZSPH         2025-04-02         YES               0.870            0.510   \n",
       "ZYDUSLIFE.BO 2025-01-22          NO               0.910            0.510   \n",
       "             2025-02-09        None               0.900            0.580   \n",
       "ZYDUSLIFE.NS 2025-01-22          NO               0.910            0.510   \n",
       "             2025-02-09        None               0.900            0.580   \n",
       "\n",
       "                         duration_prediction  success_composite     class  \n",
       "ticker       date                                                          \n",
       "000020.KS    2025-02-24              293.000              0.293  INDUSTRY  \n",
       "000100.KS    2025-03-08             1023.000              0.287  INDUSTRY  \n",
       "             2025-03-27              742.000              0.704  INDUSTRY  \n",
       "000105.KS    2025-03-08             1023.000              0.287  INDUSTRY  \n",
       "             2025-03-27              742.000              0.704  INDUSTRY  \n",
       "...                                      ...                ...       ...  \n",
       "ZSPH         2025-04-02              742.000              0.696  INDUSTRY  \n",
       "ZYDUSLIFE.BO 2025-01-22             1073.000              0.759  INDUSTRY  \n",
       "             2025-02-09              742.000              0.736  INDUSTRY  \n",
       "ZYDUSLIFE.NS 2025-01-22             1073.000              0.759  INDUSTRY  \n",
       "             2025-02-09              742.000              0.736  INDUSTRY  \n",
       "\n",
       "[10974 rows x 75 columns]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_apps"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Starting data request for endpoint: clinical/trials\n",
      "Prepared endpoint: /clinical/trials\n",
      "Full URL: https://data.sov.ai/clinical/trials with params: {'parquet': 'True', 'full_history': 'False', 'source': 'listed'}\n",
      "Cache key: e00935e8507f4b8f6c1406e157122e212426758b415740bd3ec308a4fed986b8\n",
      "Sending API request\n",
      "Response received - Status: 200, Content-Type: application/json\n",
      "Using tickers: \n",
      "Processing 'all tickers' response\n",
      "Attempting URL 1/2: https://s3.wasabisys.com/sovai-clinical-trials-export/output/df_listed_latest_week.parquet?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=KI07G4DK9XP5EC0NH1VU%2F20250407%2Fus-east-1%2Fs3%2Faws4_request&X-Amz-Date=20250407T161157Z&X-Amz-Expires=3600&X-Amz-SignedHeaders=host&X-Amz-Signature=e701ccf61d8b22f814e8e40a45bd3c99e3ba36f5868e3f0f43758b51c7624daf\n",
      "Successfully downloaded data from URL 1\n",
      "Applying filters to data\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th>source</th>\n",
       "      <th>subsidiary</th>\n",
       "      <th>sponsor</th>\n",
       "      <th>trial_id</th>\n",
       "      <th>official_title</th>\n",
       "      <th>sponsor_study_id</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>lead_sponsor</th>\n",
       "      <th>lead_sponsor_name</th>\n",
       "      <th>sponsor_type</th>\n",
       "      <th>lead_sponsor_type</th>\n",
       "      <th>phase_category</th>\n",
       "      <th>study_type</th>\n",
       "      <th>enrollment_count</th>\n",
       "      <th>number_of_locations</th>\n",
       "      <th>healthy_volunteers</th>\n",
       "      <th>enrollment_type</th>\n",
       "      <th>study_size_category</th>\n",
       "      <th>condition_keywords</th>\n",
       "      <th>primary_condition</th>\n",
       "      <th>intervention_type</th>\n",
       "      <th>primary_intervention</th>\n",
       "      <th>intervention_name</th>\n",
       "      <th>intervention_arm_group_labels</th>\n",
       "      <th>intervention_description</th>\n",
       "      <th>has_data_monitoring_committee</th>\n",
       "      <th>responsible_party_investigator_affiliation</th>\n",
       "      <th>responsible_party_investigator_title</th>\n",
       "      <th>responsible_party_investigator_name</th>\n",
       "      <th>first_posted_date</th>\n",
       "      <th>last_update_posted_date</th>\n",
       "      <th>start_date</th>\n",
       "      <th>study_completion_date</th>\n",
       "      <th>primary_completion_date</th>\n",
       "      <th>study_locations_city</th>\n",
       "      <th>study_locations_country</th>\n",
       "      <th>study_locations_geopoint</th>\n",
       "      <th>study_locations_facility</th>\n",
       "      <th>study_locations_zip</th>\n",
       "      <th>study_locations_state</th>\n",
       "      <th>standard_age_groups</th>\n",
       "      <th>sex</th>\n",
       "      <th>minimum_age</th>\n",
       "      <th>maximum_age</th>\n",
       "      <th>overall_status</th>\n",
       "      <th>status_category</th>\n",
       "      <th>status_verified_date</th>\n",
       "      <th>primary_outcomes_measures</th>\n",
       "      <th>primary_outcomes_timeframes</th>\n",
       "      <th>primary_outcomes_descriptions</th>\n",
       "      <th>secondary_outcomes_measures</th>\n",
       "      <th>secondary_outcomes_timeframes</th>\n",
       "      <th>secondary_outcomes_descriptions</th>\n",
       "      <th>has_results</th>\n",
       "      <th>conditions</th>\n",
       "      <th>brief_summary</th>\n",
       "      <th>detailed_description</th>\n",
       "      <th>masking</th>\n",
       "      <th>allocation</th>\n",
       "      <th>intervention_model</th>\n",
       "      <th>primary_purpose</th>\n",
       "      <th>has_expanded_access</th>\n",
       "      <th>study_duration_days</th>\n",
       "      <th>trial_duration</th>\n",
       "      <th>references_type</th>\n",
       "      <th>references_citation</th>\n",
       "      <th>references_pmid</th>\n",
       "      <th>collaborators_name</th>\n",
       "      <th>collaborators_class</th>\n",
       "      <th>ipd_sharing</th>\n",
       "      <th>success_prediction</th>\n",
       "      <th>economic_effect</th>\n",
       "      <th>duration_prediction</th>\n",
       "      <th>success_composite</th>\n",
       "      <th>class</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ticker</th>\n",
       "      <th>date</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>REPL</th>\n",
       "      <th>2025-03-20</th>\n",
       "      <td>listed</td>\n",
       "      <td>Replimune, Inc</td>\n",
       "      <td>Replimune Inc.</td>\n",
       "      <td>NCT06898970</td>\n",
       "      <td>An Open-Label, Multicenter, Phase 2 Study With...</td>\n",
       "      <td>25871</td>\n",
       "      <td>Intratumoral Vusolimogene Oderparepvec (Vo) In...</td>\n",
       "      <td>University of California, San Francisco</td>\n",
       "      <td>Varun Monga, Mbbs</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>phase_2</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>18</td>\n",
       "      <td>1</td>\n",
       "      <td>False</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Small</td>\n",
       "      <td>Immunotherapy</td>\n",
       "      <td>Angiosarcoma</td>\n",
       "      <td>BIOLOGICAL; DRUG</td>\n",
       "      <td>Vusolimogene Oderparepvec (VO)</td>\n",
       "      <td>Vusolimogene Oderparepvec (VO); Pembrolizumab</td>\n",
       "      <td>Treatment (Vusolimogene Oderparepvec (VO), Pem...</td>\n",
       "      <td>Given Intratumorally; Given Iv</td>\n",
       "      <td>True</td>\n",
       "      <td>University of California, San Francisco</td>\n",
       "      <td>Principal Investigator</td>\n",
       "      <td>Varun Monga, Mbbs</td>\n",
       "      <td>2025-03-27</td>\n",
       "      <td>2025-03-27</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>San Francisco</td>\n",
       "      <td>United States</td>\n",
       "      <td>lat: 37.77493, lon: -122.41942</td>\n",
       "      <td>University of California, San Francisco</td>\n",
       "      <td>94143</td>\n",
       "      <td>California</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2025-03-01</td>\n",
       "      <td>Percentage of participants with reported treat...</td>\n",
       "      <td>Up to 1 year; Up to 1 year; Up to 1 year</td>\n",
       "      <td>Safety and tolerability will be reported as th...</td>\n",
       "      <td>Median Duration of Response (DOR); Percentage ...</td>\n",
       "      <td>Up to 1 year; Up to 1 year; Up to 1 year; Up t...</td>\n",
       "      <td>The DOR is the time from the first day of docu...</td>\n",
       "      <td>False</td>\n",
       "      <td>Angiosarcoma; Angiosarcoma, Adult</td>\n",
       "      <td>This Is A Multicenter, Open-Label Study Of Int...</td>\n",
       "      <td>Primary Objectives:\\n\\nSafety Lead-In:\\n\\nI. T...</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Replimune Inc.</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>YES</td>\n",
       "      <td>0.860</td>\n",
       "      <td>0.510</td>\n",
       "      <td>1087.000</td>\n",
       "      <td>0.720</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SEM</th>\n",
       "      <th>2025-03-19</th>\n",
       "      <td>listed</td>\n",
       "      <td>Rush Specialty Hospital, LLC</td>\n",
       "      <td>Rush University Medical Center</td>\n",
       "      <td>NCT06895785</td>\n",
       "      <td>Exalt Single-Use Duodenoscope Vs Reusable Scop...</td>\n",
       "      <td>RUMC-ORA-24022203</td>\n",
       "      <td>Exalt Single-Use Duodenoscope Vs Reusable Scop...</td>\n",
       "      <td>Rush University Medical Center</td>\n",
       "      <td>Rush University Medical Center</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>other</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>100</td>\n",
       "      <td>1</td>\n",
       "      <td>False</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Small</td>\n",
       "      <td>endoscopic retrograde cholangiopancreatography...</td>\n",
       "      <td>Biliary Diseases</td>\n",
       "      <td>DEVICE; DEVICE</td>\n",
       "      <td>Exalt Model D</td>\n",
       "      <td>Exalt Model D; Reusable</td>\n",
       "      <td>Exalt Model D; Standard Reusable</td>\n",
       "      <td>Exalt Model D Single-Use Duodenoscope Will Be ...</td>\n",
       "      <td>False</td>\n",
       "      <td>Rush University Medical Center</td>\n",
       "      <td>Assistant Professor</td>\n",
       "      <td>Neal Ambrish Mehta</td>\n",
       "      <td>2025-03-26</td>\n",
       "      <td>2025-03-26</td>\n",
       "      <td>2025-02-21</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>Chicago</td>\n",
       "      <td>United States</td>\n",
       "      <td>lat: 41.85003, lon: -87.65005</td>\n",
       "      <td>Rush University Medical Center</td>\n",
       "      <td>60607</td>\n",
       "      <td>Illinois</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>19</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2025-03-01</td>\n",
       "      <td>Number of attempts required to achieve success...</td>\n",
       "      <td>From the time of the ERCP to 7 days post-ERCP ...</td>\n",
       "      <td>Measure and compare the total number of attemp...</td>\n",
       "      <td>Crossover single to reusable; Use of advanced ...</td>\n",
       "      <td>From the start of the ERCP to the end of proce...</td>\n",
       "      <td>The incidence of crossovers from single-use du...</td>\n",
       "      <td>False</td>\n",
       "      <td>Biliary Diseases; Pancreatic Duct Disorder</td>\n",
       "      <td>This Randomized Controlled Trial (Rct) Is Desi...</td>\n",
       "      <td>To Ensure A Safe And High-Quality Endoscopy, T...</td>\n",
       "      <td>SINGLE</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>UNDECIDED</td>\n",
       "      <td>0.270</td>\n",
       "      <td>0.030</td>\n",
       "      <td>33.000</td>\n",
       "      <td>0.194</td>\n",
       "      <td>OTHER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>TAK</th>\n",
       "      <th>2025-03-20</th>\n",
       "      <td>listed</td>\n",
       "      <td>TAKEDA PHARMACEUTICAL CO LTD</td>\n",
       "      <td>Takeda</td>\n",
       "      <td>NCT06895967</td>\n",
       "      <td>A Phase 1, Randomized, Open-Label, Pharmacokin...</td>\n",
       "      <td>TAK-881-1002</td>\n",
       "      <td>A Study Of Tak-881 And Hyqvia In Healthy Adults</td>\n",
       "      <td>Takeda</td>\n",
       "      <td>Takeda</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>phase_1</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>30</td>\n",
       "      <td>1</td>\n",
       "      <td>True</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Small</td>\n",
       "      <td>Drug Therapy</td>\n",
       "      <td>Healthy Volunteers</td>\n",
       "      <td>BIOLOGICAL; BIOLOGICAL; DEVICE; DEVICE</td>\n",
       "      <td>TAK-881</td>\n",
       "      <td>TAK-881; HyQvia; SC Investigational Needle Set...</td>\n",
       "      <td>TAK-881 1.0 g/kg; HyQvia 1g/kg; TAK-881 1.0 g/...</td>\n",
       "      <td>Participants Will Receive Sc Infusion Of Tak-8...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2025-03-26</td>\n",
       "      <td>2025-03-26</td>\n",
       "      <td>2025-03-24</td>\n",
       "      <td>2025-07-16</td>\n",
       "      <td>2025-07-16</td>\n",
       "      <td>Tempe</td>\n",
       "      <td>United States</td>\n",
       "      <td>lat: 33.41477, lon: -111.90931</td>\n",
       "      <td>Celerion</td>\n",
       "      <td>85283</td>\n",
       "      <td>Arizona</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>50</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2025-03-01</td>\n",
       "      <td>Baseline-corrected Area Under the Concentratio...</td>\n",
       "      <td>Day 1 up to Day 29</td>\n",
       "      <td>None</td>\n",
       "      <td>Baseline-Uncorrected Maximum Observed Concentr...</td>\n",
       "      <td>From Screening up to Day 85; From Screening up...</td>\n",
       "      <td>TEAEs are defined as AEs that started at or af...</td>\n",
       "      <td>False</td>\n",
       "      <td>Healthy Volunteers</td>\n",
       "      <td>The Main Aim Of This Study Is To Understand Ho...</td>\n",
       "      <td>None</td>\n",
       "      <td>NONE</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>False</td>\n",
       "      <td>114</td>\n",
       "      <td>114.000</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>YES</td>\n",
       "      <td>0.860</td>\n",
       "      <td>0.500</td>\n",
       "      <td>732.000</td>\n",
       "      <td>0.694</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"2\" valign=\"top\">VRTX</th>\n",
       "      <th>2025-03-19</th>\n",
       "      <td>listed</td>\n",
       "      <td>VERTEX PHARMACEUTICALS INCORPORATED</td>\n",
       "      <td>Vertex Pharmaceuticals Incorporated</td>\n",
       "      <td>NCT06887959</td>\n",
       "      <td>A Phase 4, Open-Label, Single-Arm Study Evalua...</td>\n",
       "      <td>VX24-548-108</td>\n",
       "      <td>A Single-Arm Study Evaluating The Effectivenes...</td>\n",
       "      <td>Vertex Pharmaceuticals Incorporated</td>\n",
       "      <td>Vertex Pharmaceuticals Incorporated</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>phase_4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>200</td>\n",
       "      <td>0</td>\n",
       "      <td>False</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Medium</td>\n",
       "      <td>nan</td>\n",
       "      <td>Acute Pain</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>Suzetrigine</td>\n",
       "      <td>Suzetrigine</td>\n",
       "      <td>Suzetrigine (SUZ)</td>\n",
       "      <td>Tablets For Oral Administration.</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2025-03-25</td>\n",
       "      <td>2025-03-25</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2025-03-01</td>\n",
       "      <td>Proportion of Participants Reporting Good, Ver...</td>\n",
       "      <td>From Day 3 up to Day 14</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>Acute Pain</td>\n",
       "      <td>The Purpose Of This Study Is To Evaluate The E...</td>\n",
       "      <td>None</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.280</td>\n",
       "      <td>0.040</td>\n",
       "      <td>828.000</td>\n",
       "      <td>0.303</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2025-03-19</th>\n",
       "      <td>listed</td>\n",
       "      <td>VERTEX PHARMACEUTICALS INCORPORATED</td>\n",
       "      <td>Vertex Pharmaceuticals Incorporated</td>\n",
       "      <td>NCT06887972</td>\n",
       "      <td>A Phase 4, Open-Label, Single-Arm Study Evalua...</td>\n",
       "      <td>VX24-548-113</td>\n",
       "      <td>A Single-Arm Study Evaluating The Effectivenes...</td>\n",
       "      <td>Vertex Pharmaceuticals Incorporated</td>\n",
       "      <td>Vertex Pharmaceuticals Incorporated</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>phase_4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>100</td>\n",
       "      <td>0</td>\n",
       "      <td>False</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Small</td>\n",
       "      <td>nan</td>\n",
       "      <td>Acute Pain</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>Suzetrigine</td>\n",
       "      <td>Suzetrigine</td>\n",
       "      <td>Suzetrigine (SUZ)</td>\n",
       "      <td>Tablets For Oral Administration.</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2025-03-25</td>\n",
       "      <td>2025-03-25</td>\n",
       "      <td>2025-03-28</td>\n",
       "      <td>2026-01-01</td>\n",
       "      <td>2025-12-18</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2025-02-01</td>\n",
       "      <td>Proportion of Participants Reporting Good, Ver...</td>\n",
       "      <td>From Day 3 up to Day 14</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>Acute Pain</td>\n",
       "      <td>The Purpose Of This Study To Evaluate The Effe...</td>\n",
       "      <td>None</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>False</td>\n",
       "      <td>279</td>\n",
       "      <td>279.000</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.300</td>\n",
       "      <td>0.050</td>\n",
       "      <td>828.000</td>\n",
       "      <td>0.318</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                   source                           subsidiary  \\\n",
       "ticker date                                                      \n",
       "REPL   2025-03-20  listed                       Replimune, Inc   \n",
       "SEM    2025-03-19  listed         Rush Specialty Hospital, LLC   \n",
       "TAK    2025-03-20  listed         TAKEDA PHARMACEUTICAL CO LTD   \n",
       "VRTX   2025-03-19  listed  VERTEX PHARMACEUTICALS INCORPORATED   \n",
       "       2025-03-19  listed  VERTEX PHARMACEUTICALS INCORPORATED   \n",
       "\n",
       "                                               sponsor     trial_id  \\\n",
       "ticker date                                                           \n",
       "REPL   2025-03-20                       Replimune Inc.  NCT06898970   \n",
       "SEM    2025-03-19       Rush University Medical Center  NCT06895785   \n",
       "TAK    2025-03-20                               Takeda  NCT06895967   \n",
       "VRTX   2025-03-19  Vertex Pharmaceuticals Incorporated  NCT06887959   \n",
       "       2025-03-19  Vertex Pharmaceuticals Incorporated  NCT06887972   \n",
       "\n",
       "                                                      official_title  \\\n",
       "ticker date                                                            \n",
       "REPL   2025-03-20  An Open-Label, Multicenter, Phase 2 Study With...   \n",
       "SEM    2025-03-19  Exalt Single-Use Duodenoscope Vs Reusable Scop...   \n",
       "TAK    2025-03-20  A Phase 1, Randomized, Open-Label, Pharmacokin...   \n",
       "VRTX   2025-03-19  A Phase 4, Open-Label, Single-Arm Study Evalua...   \n",
       "       2025-03-19  A Phase 4, Open-Label, Single-Arm Study Evalua...   \n",
       "\n",
       "                    sponsor_study_id  \\\n",
       "ticker date                            \n",
       "REPL   2025-03-20              25871   \n",
       "SEM    2025-03-19  RUMC-ORA-24022203   \n",
       "TAK    2025-03-20       TAK-881-1002   \n",
       "VRTX   2025-03-19       VX24-548-108   \n",
       "       2025-03-19       VX24-548-113   \n",
       "\n",
       "                                                         brief_title  \\\n",
       "ticker date                                                            \n",
       "REPL   2025-03-20  Intratumoral Vusolimogene Oderparepvec (Vo) In...   \n",
       "SEM    2025-03-19  Exalt Single-Use Duodenoscope Vs Reusable Scop...   \n",
       "TAK    2025-03-20    A Study Of Tak-881 And Hyqvia In Healthy Adults   \n",
       "VRTX   2025-03-19  A Single-Arm Study Evaluating The Effectivenes...   \n",
       "       2025-03-19  A Single-Arm Study Evaluating The Effectivenes...   \n",
       "\n",
       "                                              lead_sponsor  \\\n",
       "ticker date                                                  \n",
       "REPL   2025-03-20  University of California, San Francisco   \n",
       "SEM    2025-03-19           Rush University Medical Center   \n",
       "TAK    2025-03-20                                   Takeda   \n",
       "VRTX   2025-03-19      Vertex Pharmaceuticals Incorporated   \n",
       "       2025-03-19      Vertex Pharmaceuticals Incorporated   \n",
       "\n",
       "                                     lead_sponsor_name sponsor_type  \\\n",
       "ticker date                                                           \n",
       "REPL   2025-03-20                    Varun Monga, Mbbs        OTHER   \n",
       "SEM    2025-03-19       Rush University Medical Center        OTHER   \n",
       "TAK    2025-03-20                               Takeda     INDUSTRY   \n",
       "VRTX   2025-03-19  Vertex Pharmaceuticals Incorporated     INDUSTRY   \n",
       "       2025-03-19  Vertex Pharmaceuticals Incorporated     INDUSTRY   \n",
       "\n",
       "                  lead_sponsor_type phase_category      study_type  \\\n",
       "ticker date                                                          \n",
       "REPL   2025-03-20             OTHER        phase_2  INTERVENTIONAL   \n",
       "SEM    2025-03-19             OTHER          other  INTERVENTIONAL   \n",
       "TAK    2025-03-20          INDUSTRY        phase_1  INTERVENTIONAL   \n",
       "VRTX   2025-03-19          INDUSTRY        phase_4  INTERVENTIONAL   \n",
       "       2025-03-19          INDUSTRY        phase_4  INTERVENTIONAL   \n",
       "\n",
       "                   enrollment_count  number_of_locations  healthy_volunteers  \\\n",
       "ticker date                                                                    \n",
       "REPL   2025-03-20                18                    1               False   \n",
       "SEM    2025-03-19               100                    1               False   \n",
       "TAK    2025-03-20                30                    1                True   \n",
       "VRTX   2025-03-19               200                    0               False   \n",
       "       2025-03-19               100                    0               False   \n",
       "\n",
       "                  enrollment_type study_size_category  \\\n",
       "ticker date                                             \n",
       "REPL   2025-03-20       ESTIMATED               Small   \n",
       "SEM    2025-03-19       ESTIMATED               Small   \n",
       "TAK    2025-03-20       ESTIMATED               Small   \n",
       "VRTX   2025-03-19       ESTIMATED              Medium   \n",
       "       2025-03-19       ESTIMATED               Small   \n",
       "\n",
       "                                                  condition_keywords  \\\n",
       "ticker date                                                            \n",
       "REPL   2025-03-20                                      Immunotherapy   \n",
       "SEM    2025-03-19  endoscopic retrograde cholangiopancreatography...   \n",
       "TAK    2025-03-20                                       Drug Therapy   \n",
       "VRTX   2025-03-19                                                nan   \n",
       "       2025-03-19                                                nan   \n",
       "\n",
       "                    primary_condition                       intervention_type  \\\n",
       "ticker date                                                                     \n",
       "REPL   2025-03-20        Angiosarcoma                        BIOLOGICAL; DRUG   \n",
       "SEM    2025-03-19    Biliary Diseases                          DEVICE; DEVICE   \n",
       "TAK    2025-03-20  Healthy Volunteers  BIOLOGICAL; BIOLOGICAL; DEVICE; DEVICE   \n",
       "VRTX   2025-03-19          Acute Pain                                    DRUG   \n",
       "       2025-03-19          Acute Pain                                    DRUG   \n",
       "\n",
       "                             primary_intervention  \\\n",
       "ticker date                                         \n",
       "REPL   2025-03-20  Vusolimogene Oderparepvec (VO)   \n",
       "SEM    2025-03-19                   Exalt Model D   \n",
       "TAK    2025-03-20                         TAK-881   \n",
       "VRTX   2025-03-19                     Suzetrigine   \n",
       "       2025-03-19                     Suzetrigine   \n",
       "\n",
       "                                                   intervention_name  \\\n",
       "ticker date                                                            \n",
       "REPL   2025-03-20      Vusolimogene Oderparepvec (VO); Pembrolizumab   \n",
       "SEM    2025-03-19                            Exalt Model D; Reusable   \n",
       "TAK    2025-03-20  TAK-881; HyQvia; SC Investigational Needle Set...   \n",
       "VRTX   2025-03-19                                        Suzetrigine   \n",
       "       2025-03-19                                        Suzetrigine   \n",
       "\n",
       "                                       intervention_arm_group_labels  \\\n",
       "ticker date                                                            \n",
       "REPL   2025-03-20  Treatment (Vusolimogene Oderparepvec (VO), Pem...   \n",
       "SEM    2025-03-19                   Exalt Model D; Standard Reusable   \n",
       "TAK    2025-03-20  TAK-881 1.0 g/kg; HyQvia 1g/kg; TAK-881 1.0 g/...   \n",
       "VRTX   2025-03-19                                  Suzetrigine (SUZ)   \n",
       "       2025-03-19                                  Suzetrigine (SUZ)   \n",
       "\n",
       "                                            intervention_description  \\\n",
       "ticker date                                                            \n",
       "REPL   2025-03-20                     Given Intratumorally; Given Iv   \n",
       "SEM    2025-03-19  Exalt Model D Single-Use Duodenoscope Will Be ...   \n",
       "TAK    2025-03-20  Participants Will Receive Sc Infusion Of Tak-8...   \n",
       "VRTX   2025-03-19                   Tablets For Oral Administration.   \n",
       "       2025-03-19                   Tablets For Oral Administration.   \n",
       "\n",
       "                  has_data_monitoring_committee  \\\n",
       "ticker date                                       \n",
       "REPL   2025-03-20                          True   \n",
       "SEM    2025-03-19                         False   \n",
       "TAK    2025-03-20                         False   \n",
       "VRTX   2025-03-19                          None   \n",
       "       2025-03-19                          None   \n",
       "\n",
       "                  responsible_party_investigator_affiliation  \\\n",
       "ticker date                                                    \n",
       "REPL   2025-03-20    University of California, San Francisco   \n",
       "SEM    2025-03-19             Rush University Medical Center   \n",
       "TAK    2025-03-20                                       None   \n",
       "VRTX   2025-03-19                                       None   \n",
       "       2025-03-19                                       None   \n",
       "\n",
       "                  responsible_party_investigator_title  \\\n",
       "ticker date                                              \n",
       "REPL   2025-03-20               Principal Investigator   \n",
       "SEM    2025-03-19                  Assistant Professor   \n",
       "TAK    2025-03-20                                 None   \n",
       "VRTX   2025-03-19                                 None   \n",
       "       2025-03-19                                 None   \n",
       "\n",
       "                  responsible_party_investigator_name first_posted_date  \\\n",
       "ticker date                                                               \n",
       "REPL   2025-03-20                   Varun Monga, Mbbs        2025-03-27   \n",
       "SEM    2025-03-19                  Neal Ambrish Mehta        2025-03-26   \n",
       "TAK    2025-03-20                                None        2025-03-26   \n",
       "VRTX   2025-03-19                                None        2025-03-25   \n",
       "       2025-03-19                                None        2025-03-25   \n",
       "\n",
       "                  last_update_posted_date start_date study_completion_date  \\\n",
       "ticker date                                                                  \n",
       "REPL   2025-03-20              2025-03-27        NaT                   NaT   \n",
       "SEM    2025-03-19              2025-03-26 2025-02-21                   NaT   \n",
       "TAK    2025-03-20              2025-03-26 2025-03-24            2025-07-16   \n",
       "VRTX   2025-03-19              2025-03-25        NaT                   NaT   \n",
       "       2025-03-19              2025-03-25 2025-03-28            2026-01-01   \n",
       "\n",
       "                  primary_completion_date study_locations_city  \\\n",
       "ticker date                                                      \n",
       "REPL   2025-03-20                     NaT        San Francisco   \n",
       "SEM    2025-03-19                     NaT              Chicago   \n",
       "TAK    2025-03-20              2025-07-16                Tempe   \n",
       "VRTX   2025-03-19                     NaT                 None   \n",
       "       2025-03-19              2025-12-18                 None   \n",
       "\n",
       "                  study_locations_country        study_locations_geopoint  \\\n",
       "ticker date                                                                 \n",
       "REPL   2025-03-20           United States  lat: 37.77493, lon: -122.41942   \n",
       "SEM    2025-03-19           United States   lat: 41.85003, lon: -87.65005   \n",
       "TAK    2025-03-20           United States  lat: 33.41477, lon: -111.90931   \n",
       "VRTX   2025-03-19                    None                            None   \n",
       "       2025-03-19                    None                            None   \n",
       "\n",
       "                                  study_locations_facility  \\\n",
       "ticker date                                                  \n",
       "REPL   2025-03-20  University of California, San Francisco   \n",
       "SEM    2025-03-19           Rush University Medical Center   \n",
       "TAK    2025-03-20                                 Celerion   \n",
       "VRTX   2025-03-19                                     None   \n",
       "       2025-03-19                                     None   \n",
       "\n",
       "                  study_locations_zip study_locations_state  \\\n",
       "ticker date                                                   \n",
       "REPL   2025-03-20               94143            California   \n",
       "SEM    2025-03-19               60607              Illinois   \n",
       "TAK    2025-03-20               85283               Arizona   \n",
       "VRTX   2025-03-19                None                  None   \n",
       "       2025-03-19                None                  None   \n",
       "\n",
       "                  standard_age_groups  sex  minimum_age  maximum_age  \\\n",
       "ticker date                                                            \n",
       "REPL   2025-03-20  ADULT; OLDER_ADULT  ALL           18         <NA>   \n",
       "SEM    2025-03-19  ADULT; OLDER_ADULT  ALL           19         <NA>   \n",
       "TAK    2025-03-20               ADULT  ALL           18           50   \n",
       "VRTX   2025-03-19  ADULT; OLDER_ADULT  ALL           18         <NA>   \n",
       "       2025-03-19  ADULT; OLDER_ADULT  ALL           18         <NA>   \n",
       "\n",
       "                       overall_status status_category status_verified_date  \\\n",
       "ticker date                                                                  \n",
       "REPL   2025-03-20  NOT_YET_RECRUITING          active           2025-03-01   \n",
       "SEM    2025-03-19          RECRUITING          active           2025-03-01   \n",
       "TAK    2025-03-20  NOT_YET_RECRUITING          active           2025-03-01   \n",
       "VRTX   2025-03-19  NOT_YET_RECRUITING          active           2025-03-01   \n",
       "       2025-03-19  NOT_YET_RECRUITING          active           2025-02-01   \n",
       "\n",
       "                                           primary_outcomes_measures  \\\n",
       "ticker date                                                            \n",
       "REPL   2025-03-20  Percentage of participants with reported treat...   \n",
       "SEM    2025-03-19  Number of attempts required to achieve success...   \n",
       "TAK    2025-03-20  Baseline-corrected Area Under the Concentratio...   \n",
       "VRTX   2025-03-19  Proportion of Participants Reporting Good, Ver...   \n",
       "       2025-03-19  Proportion of Participants Reporting Good, Ver...   \n",
       "\n",
       "                                         primary_outcomes_timeframes  \\\n",
       "ticker date                                                            \n",
       "REPL   2025-03-20           Up to 1 year; Up to 1 year; Up to 1 year   \n",
       "SEM    2025-03-19  From the time of the ERCP to 7 days post-ERCP ...   \n",
       "TAK    2025-03-20                                 Day 1 up to Day 29   \n",
       "VRTX   2025-03-19                            From Day 3 up to Day 14   \n",
       "       2025-03-19                            From Day 3 up to Day 14   \n",
       "\n",
       "                                       primary_outcomes_descriptions  \\\n",
       "ticker date                                                            \n",
       "REPL   2025-03-20  Safety and tolerability will be reported as th...   \n",
       "SEM    2025-03-19  Measure and compare the total number of attemp...   \n",
       "TAK    2025-03-20                                               None   \n",
       "VRTX   2025-03-19                                               None   \n",
       "       2025-03-19                                               None   \n",
       "\n",
       "                                         secondary_outcomes_measures  \\\n",
       "ticker date                                                            \n",
       "REPL   2025-03-20  Median Duration of Response (DOR); Percentage ...   \n",
       "SEM    2025-03-19  Crossover single to reusable; Use of advanced ...   \n",
       "TAK    2025-03-20  Baseline-Uncorrected Maximum Observed Concentr...   \n",
       "VRTX   2025-03-19                                               None   \n",
       "       2025-03-19                                               None   \n",
       "\n",
       "                                       secondary_outcomes_timeframes  \\\n",
       "ticker date                                                            \n",
       "REPL   2025-03-20  Up to 1 year; Up to 1 year; Up to 1 year; Up t...   \n",
       "SEM    2025-03-19  From the start of the ERCP to the end of proce...   \n",
       "TAK    2025-03-20  From Screening up to Day 85; From Screening up...   \n",
       "VRTX   2025-03-19                                               None   \n",
       "       2025-03-19                                               None   \n",
       "\n",
       "                                     secondary_outcomes_descriptions  \\\n",
       "ticker date                                                            \n",
       "REPL   2025-03-20  The DOR is the time from the first day of docu...   \n",
       "SEM    2025-03-19  The incidence of crossovers from single-use du...   \n",
       "TAK    2025-03-20  TEAEs are defined as AEs that started at or af...   \n",
       "VRTX   2025-03-19                                               None   \n",
       "       2025-03-19                                               None   \n",
       "\n",
       "                   has_results                                  conditions  \\\n",
       "ticker date                                                                  \n",
       "REPL   2025-03-20        False           Angiosarcoma; Angiosarcoma, Adult   \n",
       "SEM    2025-03-19        False  Biliary Diseases; Pancreatic Duct Disorder   \n",
       "TAK    2025-03-20        False                          Healthy Volunteers   \n",
       "VRTX   2025-03-19        False                                  Acute Pain   \n",
       "       2025-03-19        False                                  Acute Pain   \n",
       "\n",
       "                                                       brief_summary  \\\n",
       "ticker date                                                            \n",
       "REPL   2025-03-20  This Is A Multicenter, Open-Label Study Of Int...   \n",
       "SEM    2025-03-19  This Randomized Controlled Trial (Rct) Is Desi...   \n",
       "TAK    2025-03-20  The Main Aim Of This Study Is To Understand Ho...   \n",
       "VRTX   2025-03-19  The Purpose Of This Study Is To Evaluate The E...   \n",
       "       2025-03-19  The Purpose Of This Study To Evaluate The Effe...   \n",
       "\n",
       "                                                detailed_description masking  \\\n",
       "ticker date                                                                    \n",
       "REPL   2025-03-20  Primary Objectives:\\n\\nSafety Lead-In:\\n\\nI. T...    NONE   \n",
       "SEM    2025-03-19  To Ensure A Safe And High-Quality Endoscopy, T...  SINGLE   \n",
       "TAK    2025-03-20                                               None    NONE   \n",
       "VRTX   2025-03-19                                               None    NONE   \n",
       "       2025-03-19                                               None    NONE   \n",
       "\n",
       "                   allocation intervention_model primary_purpose  \\\n",
       "ticker date                                                        \n",
       "REPL   2025-03-20          NA       SINGLE_GROUP       TREATMENT   \n",
       "SEM    2025-03-19  RANDOMIZED           PARALLEL           OTHER   \n",
       "TAK    2025-03-20  RANDOMIZED           PARALLEL           OTHER   \n",
       "VRTX   2025-03-19          NA       SINGLE_GROUP       TREATMENT   \n",
       "       2025-03-19          NA       SINGLE_GROUP       TREATMENT   \n",
       "\n",
       "                   has_expanded_access  study_duration_days  trial_duration  \\\n",
       "ticker date                                                                   \n",
       "REPL   2025-03-20                False                 <NA>             NaN   \n",
       "SEM    2025-03-19                False                 <NA>             NaN   \n",
       "TAK    2025-03-20                False                  114         114.000   \n",
       "VRTX   2025-03-19                False                 <NA>             NaN   \n",
       "       2025-03-19                False                  279         279.000   \n",
       "\n",
       "                  references_type references_citation references_pmid  \\\n",
       "ticker date                                                             \n",
       "REPL   2025-03-20            None                None            None   \n",
       "SEM    2025-03-19            None                None            None   \n",
       "TAK    2025-03-20            None                None            None   \n",
       "VRTX   2025-03-19            None                None            None   \n",
       "       2025-03-19            None                None            None   \n",
       "\n",
       "                  collaborators_name collaborators_class ipd_sharing  \\\n",
       "ticker date                                                            \n",
       "REPL   2025-03-20     Replimune Inc.            INDUSTRY         YES   \n",
       "SEM    2025-03-19               None                None   UNDECIDED   \n",
       "TAK    2025-03-20               None                None         YES   \n",
       "VRTX   2025-03-19               None                None          NO   \n",
       "       2025-03-19               None                None          NO   \n",
       "\n",
       "                   success_prediction  economic_effect  duration_prediction  \\\n",
       "ticker date                                                                   \n",
       "REPL   2025-03-20               0.860            0.510             1087.000   \n",
       "SEM    2025-03-19               0.270            0.030               33.000   \n",
       "TAK    2025-03-20               0.860            0.500              732.000   \n",
       "VRTX   2025-03-19               0.280            0.040              828.000   \n",
       "       2025-03-19               0.300            0.050              828.000   \n",
       "\n",
       "                   success_composite     class  \n",
       "ticker date                                     \n",
       "REPL   2025-03-20              0.720  INDUSTRY  \n",
       "SEM    2025-03-19              0.194     OTHER  \n",
       "TAK    2025-03-20              0.694  INDUSTRY  \n",
       "VRTX   2025-03-19              0.303  INDUSTRY  \n",
       "       2025-03-19              0.318  INDUSTRY  "
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_clinical = sov.data(\"clinical/trials\", verbose=True, source=\"listed\"); df_clinical.tail()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th>source</th>\n",
       "      <th>subsidiary</th>\n",
       "      <th>sponsor</th>\n",
       "      <th>trial_id</th>\n",
       "      <th>official_title</th>\n",
       "      <th>sponsor_study_id</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>lead_sponsor</th>\n",
       "      <th>lead_sponsor_name</th>\n",
       "      <th>sponsor_type</th>\n",
       "      <th>lead_sponsor_type</th>\n",
       "      <th>phase_category</th>\n",
       "      <th>study_type</th>\n",
       "      <th>enrollment_count</th>\n",
       "      <th>number_of_locations</th>\n",
       "      <th>healthy_volunteers</th>\n",
       "      <th>enrollment_type</th>\n",
       "      <th>study_size_category</th>\n",
       "      <th>condition_keywords</th>\n",
       "      <th>primary_condition</th>\n",
       "      <th>intervention_type</th>\n",
       "      <th>primary_intervention</th>\n",
       "      <th>intervention_name</th>\n",
       "      <th>intervention_arm_group_labels</th>\n",
       "      <th>intervention_description</th>\n",
       "      <th>has_data_monitoring_committee</th>\n",
       "      <th>responsible_party_investigator_affiliation</th>\n",
       "      <th>responsible_party_investigator_title</th>\n",
       "      <th>responsible_party_investigator_name</th>\n",
       "      <th>first_posted_date</th>\n",
       "      <th>last_update_posted_date</th>\n",
       "      <th>start_date</th>\n",
       "      <th>study_completion_date</th>\n",
       "      <th>primary_completion_date</th>\n",
       "      <th>study_locations_city</th>\n",
       "      <th>study_locations_country</th>\n",
       "      <th>study_locations_geopoint</th>\n",
       "      <th>study_locations_facility</th>\n",
       "      <th>study_locations_zip</th>\n",
       "      <th>study_locations_state</th>\n",
       "      <th>standard_age_groups</th>\n",
       "      <th>sex</th>\n",
       "      <th>minimum_age</th>\n",
       "      <th>maximum_age</th>\n",
       "      <th>overall_status</th>\n",
       "      <th>status_category</th>\n",
       "      <th>status_verified_date</th>\n",
       "      <th>primary_outcomes_measures</th>\n",
       "      <th>primary_outcomes_timeframes</th>\n",
       "      <th>primary_outcomes_descriptions</th>\n",
       "      <th>secondary_outcomes_measures</th>\n",
       "      <th>secondary_outcomes_timeframes</th>\n",
       "      <th>secondary_outcomes_descriptions</th>\n",
       "      <th>has_results</th>\n",
       "      <th>conditions</th>\n",
       "      <th>brief_summary</th>\n",
       "      <th>detailed_description</th>\n",
       "      <th>masking</th>\n",
       "      <th>allocation</th>\n",
       "      <th>intervention_model</th>\n",
       "      <th>primary_purpose</th>\n",
       "      <th>has_expanded_access</th>\n",
       "      <th>study_duration_days</th>\n",
       "      <th>trial_duration</th>\n",
       "      <th>references_type</th>\n",
       "      <th>references_citation</th>\n",
       "      <th>references_pmid</th>\n",
       "      <th>collaborators_name</th>\n",
       "      <th>collaborators_class</th>\n",
       "      <th>ipd_sharing</th>\n",
       "      <th>success_prediction</th>\n",
       "      <th>economic_effect</th>\n",
       "      <th>duration_prediction</th>\n",
       "      <th>success_composite</th>\n",
       "      <th>class</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ticker</th>\n",
       "      <th>date</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>000020.KS</th>\n",
       "      <th>2025-02-24</th>\n",
       "      <td>foreign</td>\n",
       "      <td>Dongwha Pharm.Co.,Ltd</td>\n",
       "      <td>Dong Wha Pharmaceutical Co. Ltd.</td>\n",
       "      <td>NCT06875193</td>\n",
       "      <td>Key Finding Of Dm Treatment With Combination, ...</td>\n",
       "      <td>DW6012-IV-2</td>\n",
       "      <td>Dm Treatment To Evaluate The Efficacy And Safe...</td>\n",
       "      <td>Dong Wha Pharmaceutical Co. Ltd.</td>\n",
       "      <td>Dong Wha Pharmaceutical Co. Ltd.</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>phase_4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>196</td>\n",
       "      <td>1</td>\n",
       "      <td>False</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Medium</td>\n",
       "      <td>Dapagliflozin; Pioglitazone; DPP-4 inhibitor</td>\n",
       "      <td>Type2Diabetes</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>DW6012(Dasidiem tab. 10/100mg)</td>\n",
       "      <td>DW6012(Dasidiem tab. 10/100mg)</td>\n",
       "      <td>Dasidiem 10/100mg; sitdiem 100mg, Piotazone15mg</td>\n",
       "      <td>Once A Day, Oral Administration</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2025-03-25</td>\n",
       "      <td>2025-03-25</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>2025-12-31</td>\n",
       "      <td>Seoul</td>\n",
       "      <td>Korea, Republic of</td>\n",
       "      <td>lat: 37.566, lon: 126.9784</td>\n",
       "      <td>Kyung Hee University Hospital at Gangdong</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>19</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2025-03-01</td>\n",
       "      <td>Variance in HbA1c from baseline to 24 weeks on...</td>\n",
       "      <td>24 weeks</td>\n",
       "      <td>Change in HbA1c</td>\n",
       "      <td>Variance in HbA1c from baseline to 12 weeks on...</td>\n",
       "      <td>12 weeks; 12, 24 weeks; 12, 24 weeks; 12, 24 w...</td>\n",
       "      <td>Change in HbA1c; Change in Fasting Plasma Gluc...</td>\n",
       "      <td>False</td>\n",
       "      <td>Type2Diabetes</td>\n",
       "      <td>Key Finding Of Dm Treatment With Combination, ...</td>\n",
       "      <td>This Is A Phase 4, Multicenter, Randomized, Op...</td>\n",
       "      <td>NONE</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>SUPPORTIVE_CARE</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.280</td>\n",
       "      <td>0.040</td>\n",
       "      <td>828.000</td>\n",
       "      <td>0.303</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"3\" valign=\"top\">000100.KS</th>\n",
       "      <th>2025-01-03</th>\n",
       "      <td>foreign</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>NCT06767345</td>\n",
       "      <td>Comparing The Moderate Intensity Statin With E...</td>\n",
       "      <td>STOP-PLAQUE</td>\n",
       "      <td>Comparison Of Moderate-Intensity Statin Plus E...</td>\n",
       "      <td>Korea University Anam Hospital</td>\n",
       "      <td>Korea University Anam Hospital</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>phase_4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>330</td>\n",
       "      <td>0</td>\n",
       "      <td>False</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Medium</td>\n",
       "      <td>nan</td>\n",
       "      <td>Coronary Artery Disease</td>\n",
       "      <td>DRUG; DRUG</td>\n",
       "      <td>statins, ezetimibe</td>\n",
       "      <td>statins, ezetimibe; Combination therapy</td>\n",
       "      <td>High Intensity Statin monotherapy; Combination...</td>\n",
       "      <td>Rosuvastatin 20Mg Once Daily; Rosuvastatin 10M...</td>\n",
       "      <td>True</td>\n",
       "      <td>Korea University Anam Hospital</td>\n",
       "      <td>Professor</td>\n",
       "      <td>Soon Jun Hong</td>\n",
       "      <td>2025-03-25</td>\n",
       "      <td>2025-03-25</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2024-12-01</td>\n",
       "      <td>percentage change in coronary atheroma volume ...</td>\n",
       "      <td>52 weeks</td>\n",
       "      <td>None</td>\n",
       "      <td>Change from baseline to week 52 in total lipid...</td>\n",
       "      <td>52 weeks; 52 weeks; 52 weeks</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>Coronary Artery Disease; Atherosclerosis Of Co...</td>\n",
       "      <td>This Study Is A Prospective, Multicenter, Rand...</td>\n",
       "      <td>None</td>\n",
       "      <td>NONE</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BACKGROUND; BACKGROUND; BACKGROUND; BACKGROUND...</td>\n",
       "      <td>Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho ...</td>\n",
       "      <td>21693744; 20167359; 34130955; 32227755; 386042...</td>\n",
       "      <td>Yuhan Corporation; Hanmi Pharmaceutical co., ltd.</td>\n",
       "      <td>INDUSTRY; OTHER</td>\n",
       "      <td>UNDECIDED</td>\n",
       "      <td>0.390</td>\n",
       "      <td>0.040</td>\n",
       "      <td>81.000</td>\n",
       "      <td>0.377</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2025-01-07</th>\n",
       "      <td>foreign</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>NCT06775522</td>\n",
       "      <td>An Open-Label, Randomized, Single-Dose, Oral A...</td>\n",
       "      <td>YHP2205-102</td>\n",
       "      <td>Bioequivalence (Be) Study Between Yhp2205 And ...</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>phase_1</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>60</td>\n",
       "      <td>1</td>\n",
       "      <td>True</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Small</td>\n",
       "      <td>Pharmacokinetics; Bioequivalence</td>\n",
       "      <td>Healthy Volunteers</td>\n",
       "      <td>DRUG; DRUG</td>\n",
       "      <td>YHP2205</td>\n",
       "      <td>YHP2205; YHR2401</td>\n",
       "      <td>Sequence Group A; Sequence Group B; Sequence G...</td>\n",
       "      <td>Test Drug: Yhp2205 Comparator: Yhr2401; Test D...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2025-03-25</td>\n",
       "      <td>2025-03-25</td>\n",
       "      <td>2025-01-11</td>\n",
       "      <td>2025-01-21</td>\n",
       "      <td>2025-01-20</td>\n",
       "      <td>Seoul</td>\n",
       "      <td>Korea, Republic of</td>\n",
       "      <td>lat: 37.566, lon: 126.9784</td>\n",
       "      <td>Bumin Hospital</td>\n",
       "      <td>07590</td>\n",
       "      <td>Gangseo-gu</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>19</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>completed</td>\n",
       "      <td>2025-01-01</td>\n",
       "      <td>Area under the plasma drug concentration-time ...</td>\n",
       "      <td>0-36 hours; 0-36 hours</td>\n",
       "      <td>Area under the plasma drug concentration-time ...</td>\n",
       "      <td>Area under the plasma drug concentration-time ...</td>\n",
       "      <td>0-36 hours; 0-36 hours; 0-36 hours; 0-36 hours</td>\n",
       "      <td>Area under the plasma drug concentration-time ...</td>\n",
       "      <td>False</td>\n",
       "      <td>Healthy Volunteers</td>\n",
       "      <td>A Randomized, Open-Label, Single-Dose, 2-Seque...</td>\n",
       "      <td>60 Healthy Subjects Will Be Randomized To One ...</td>\n",
       "      <td>NONE</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>CROSSOVER</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>False</td>\n",
       "      <td>10</td>\n",
       "      <td>10.000</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.900</td>\n",
       "      <td>0.490</td>\n",
       "      <td>732.000</td>\n",
       "      <td>0.713</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2025-03-08</th>\n",
       "      <td>foreign</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>NCT06874894</td>\n",
       "      <td>Thromboembolic And Bleeding Risk During Antico...</td>\n",
       "      <td>CAUH 1992-002-387</td>\n",
       "      <td>Thromboembolic And Bleeding Risks During Antic...</td>\n",
       "      <td>Chung-Ang University Hosptial, Chung-Ang Unive...</td>\n",
       "      <td>Chung-Ang University Hosptial, Chung-Ang Unive...</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>not_specified</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>1100</td>\n",
       "      <td>1</td>\n",
       "      <td>False</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Very Large</td>\n",
       "      <td>Atrial Fibrillation; Stroke; Bleeding</td>\n",
       "      <td>Fibrillation, Atrial</td>\n",
       "      <td>nan</td>\n",
       "      <td>nan</td>\n",
       "      <td>nan</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>True</td>\n",
       "      <td>Chung-Ang University Hosptial, Chung-Ang Unive...</td>\n",
       "      <td>Associate Professor</td>\n",
       "      <td>Ki-Woon Kang</td>\n",
       "      <td>2025-03-25</td>\n",
       "      <td>2025-03-25</td>\n",
       "      <td>NaT</td>\n",
       "      <td>2026-08-30</td>\n",
       "      <td>2025-08-30</td>\n",
       "      <td>Seoul</td>\n",
       "      <td>Korea, Republic of</td>\n",
       "      <td>lat: 37.566, lon: 126.9784</td>\n",
       "      <td>Chung-Ang University Hospital</td>\n",
       "      <td>06973</td>\n",
       "      <td>None</td>\n",
       "      <td>CHILD; ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>2</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>ENROLLING_BY_INVITATION</td>\n",
       "      <td>active</td>\n",
       "      <td>2025-03-01</td>\n",
       "      <td>Clinical ischemic and hemorrhagic events</td>\n",
       "      <td>12 months</td>\n",
       "      <td>Ischemic stroke, systemic embolism, or myocard...</td>\n",
       "      <td>Clinical other events</td>\n",
       "      <td>12 months</td>\n",
       "      <td>Major Adverse Cardiovascular Events: Myocardia...</td>\n",
       "      <td>False</td>\n",
       "      <td>Fibrillation, Atrial</td>\n",
       "      <td>This Study Was Design To Investigate The Effic...</td>\n",
       "      <td>East Asians Have Demonstrated A Higher Bleedin...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>RESULT</td>\n",
       "      <td>Lee SH, Kim HK, Ahn JH, Kang MG, Kim KH, Bae J...</td>\n",
       "      <td>36857519</td>\n",
       "      <td>Chung-Ang University Gwangmyeong Hospital; Sam...</td>\n",
       "      <td>OTHER; OTHER; OTHER; OTHER; OTHER; INDUSTRY</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.390</td>\n",
       "      <td>0.080</td>\n",
       "      <td>721.000</td>\n",
       "      <td>0.267</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>000105.KS</th>\n",
       "      <th>2025-01-03</th>\n",
       "      <td>foreign</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>Yuhan Corporation</td>\n",
       "      <td>NCT06767345</td>\n",
       "      <td>Comparing The Moderate Intensity Statin With E...</td>\n",
       "      <td>STOP-PLAQUE</td>\n",
       "      <td>Comparison Of Moderate-Intensity Statin Plus E...</td>\n",
       "      <td>Korea University Anam Hospital</td>\n",
       "      <td>Korea University Anam Hospital</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>phase_4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>330</td>\n",
       "      <td>0</td>\n",
       "      <td>False</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Medium</td>\n",
       "      <td>nan</td>\n",
       "      <td>Coronary Artery Disease</td>\n",
       "      <td>DRUG; DRUG</td>\n",
       "      <td>statins, ezetimibe</td>\n",
       "      <td>statins, ezetimibe; Combination therapy</td>\n",
       "      <td>High Intensity Statin monotherapy; Combination...</td>\n",
       "      <td>Rosuvastatin 20Mg Once Daily; Rosuvastatin 10M...</td>\n",
       "      <td>True</td>\n",
       "      <td>Korea University Anam Hospital</td>\n",
       "      <td>Professor</td>\n",
       "      <td>Soon Jun Hong</td>\n",
       "      <td>2025-03-25</td>\n",
       "      <td>2025-03-25</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2024-12-01</td>\n",
       "      <td>percentage change in coronary atheroma volume ...</td>\n",
       "      <td>52 weeks</td>\n",
       "      <td>None</td>\n",
       "      <td>Change from baseline to week 52 in total lipid...</td>\n",
       "      <td>52 weeks; 52 weeks; 52 weeks</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>Coronary Artery Disease; Atherosclerosis Of Co...</td>\n",
       "      <td>This Study Is A Prospective, Multicenter, Rand...</td>\n",
       "      <td>None</td>\n",
       "      <td>NONE</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BACKGROUND; BACKGROUND; BACKGROUND; BACKGROUND...</td>\n",
       "      <td>Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho ...</td>\n",
       "      <td>21693744; 20167359; 34130955; 32227755; 386042...</td>\n",
       "      <td>Yuhan Corporation; Hanmi Pharmaceutical co., ltd.</td>\n",
       "      <td>INDUSTRY; OTHER</td>\n",
       "      <td>UNDECIDED</td>\n",
       "      <td>0.390</td>\n",
       "      <td>0.040</td>\n",
       "      <td>81.000</td>\n",
       "      <td>0.377</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ZYDUSLIFE.BO</th>\n",
       "      <th>2025-02-09</th>\n",
       "      <td>foreign</td>\n",
       "      <td>ZYDUS LIFESCIENCES LIMITED</td>\n",
       "      <td>Zydus Therapeutics Inc.</td>\n",
       "      <td>NCT06825559</td>\n",
       "      <td>A Phase 1, Open-Label, Single Arm Study To Eva...</td>\n",
       "      <td>SARO.24.003</td>\n",
       "      <td>Evaluating Pharmacokinetic And Safety Of Sarog...</td>\n",
       "      <td>Zydus Therapeutics Inc.</td>\n",
       "      <td>Zydus Therapeutics Inc.</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>phase_1</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>6</td>\n",
       "      <td>0</td>\n",
       "      <td>False</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Small</td>\n",
       "      <td>Saroglitazar Magnesium; Primary Biliary Cholan...</td>\n",
       "      <td>Cholestatic Liver Disease</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>Saroglitazar Magnesium 1 mg</td>\n",
       "      <td>Saroglitazar Magnesium 1 mg</td>\n",
       "      <td>Saroglitazar Magnesium 1 mg</td>\n",
       "      <td>Saroglitazar Magnesium 1 Mg Will Be Assigned T...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2025-03-25</td>\n",
       "      <td>2025-03-25</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>80</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2025-02-01</td>\n",
       "      <td>Pharmacokinetics of Saroglitazar: Cmax; Pharma...</td>\n",
       "      <td>PK sampling timepoints: pre- dose, 20 min, 40 ...</td>\n",
       "      <td>Maximum plasma concentration (Cmax); Time to r...</td>\n",
       "      <td>Safety and Tolerability of Saroglitazar Magnes...</td>\n",
       "      <td>From baseline to End of study (35 days); PK sa...</td>\n",
       "      <td>Number of participants with adverse events; Ti...</td>\n",
       "      <td>False</td>\n",
       "      <td>Cholestatic Liver Disease</td>\n",
       "      <td>Evaluating Pharmacokinetic And Safety Of Sarog...</td>\n",
       "      <td>A Phase 1, Open-Label, Single Arm Study To Eva...</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Rodney P, Starzomski R. Constraints on the mor...</td>\n",
       "      <td>11652809</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>0.920</td>\n",
       "      <td>0.500</td>\n",
       "      <td>44.000</td>\n",
       "      <td>0.740</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"4\" valign=\"top\">ZYDUSLIFE.NS</th>\n",
       "      <th>2024-12-20</th>\n",
       "      <td>foreign</td>\n",
       "      <td>ZYDUS LIFESCIENCES LIMITED</td>\n",
       "      <td>Zydus Lifesciences Limited</td>\n",
       "      <td>NCT06757283</td>\n",
       "      <td>Evaluation Of Typhoid Conjugate Vaccine (Tcv) ...</td>\n",
       "      <td>PR-24059</td>\n",
       "      <td>Zyvac-Tcv Bangladesh Study</td>\n",
       "      <td>International Centre for Diarrhoeal Disease Re...</td>\n",
       "      <td>International Centre For Diarrhoeal Disease Re...</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>4000</td>\n",
       "      <td>1</td>\n",
       "      <td>True</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Very Large</td>\n",
       "      <td>Conjugate vaccine; Immunogenicity; Safety; Typ...</td>\n",
       "      <td>Typhoid Vaccination</td>\n",
       "      <td>BIOLOGICAL</td>\n",
       "      <td>Purified Vi capsular polysaccharide of Salmone...</td>\n",
       "      <td>Purified Vi capsular polysaccharide of Salmone...</td>\n",
       "      <td>Culture-negative control; Culture-positive case</td>\n",
       "      <td>Purified Vi Capsular Polysaccharide Of Salmone...</td>\n",
       "      <td>True</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2025-03-25</td>\n",
       "      <td>2025-03-25</td>\n",
       "      <td>2025-04-01</td>\n",
       "      <td>2026-05-30</td>\n",
       "      <td>2026-03-31</td>\n",
       "      <td>Dhaka</td>\n",
       "      <td>Bangladesh</td>\n",
       "      <td>lat: 23.7104, lon: 90.40744</td>\n",
       "      <td>International Centre for Diarrhoeal Disease Re...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>ALL</td>\n",
       "      <td>0</td>\n",
       "      <td>15</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2024-12-01</td>\n",
       "      <td>Primary outcome</td>\n",
       "      <td>12 months</td>\n",
       "      <td>Blood culture-confirmed typhoid fever</td>\n",
       "      <td>Secondary outcome; Secondary outcome</td>\n",
       "      <td>12 months; 12 months</td>\n",
       "      <td>Anti-Vi-IgG antibody concentration Blood cultu...</td>\n",
       "      <td>False</td>\n",
       "      <td>Typhoid Vaccination; Typhoid; Typhoid Fever</td>\n",
       "      <td>This Is A Prospective Closed Cohort, Open-Labe...</td>\n",
       "      <td>This Will Be A Phase Iii Effectiveness Study O...</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NON_RANDOMIZED</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>PREVENTION</td>\n",
       "      <td>False</td>\n",
       "      <td>424</td>\n",
       "      <td>424.000</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Zydus Lifesciences Limited</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.840</td>\n",
       "      <td>0.430</td>\n",
       "      <td>95.000</td>\n",
       "      <td>0.712</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2024-12-20</th>\n",
       "      <td>foreign</td>\n",
       "      <td>ZYDUS LIFESCIENCES LIMITED</td>\n",
       "      <td>Zydus Lifesciences Limited</td>\n",
       "      <td>NCT06757283</td>\n",
       "      <td>Evaluation Of Typhoid Conjugate Vaccine (Tcv) ...</td>\n",
       "      <td>PR-24059</td>\n",
       "      <td>Zyvac-Tcv Bangladesh Study</td>\n",
       "      <td>International Centre for Diarrhoeal Disease Re...</td>\n",
       "      <td>International Centre For Diarrhoeal Disease Re...</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>4000</td>\n",
       "      <td>1</td>\n",
       "      <td>True</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Very Large</td>\n",
       "      <td>Conjugate vaccine; Immunogenicity; Safety; Typ...</td>\n",
       "      <td>Typhoid Vaccination</td>\n",
       "      <td>BIOLOGICAL</td>\n",
       "      <td>Purified Vi capsular polysaccharide of Salmone...</td>\n",
       "      <td>Purified Vi capsular polysaccharide of Salmone...</td>\n",
       "      <td>Culture-negative control; Culture-positive case</td>\n",
       "      <td>Purified Vi Capsular Polysaccharide Of Salmone...</td>\n",
       "      <td>True</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2025-01-03</td>\n",
       "      <td>2025-01-03</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>Dhaka</td>\n",
       "      <td>Bangladesh</td>\n",
       "      <td>lat: 23.7104, lon: 90.40744</td>\n",
       "      <td>International Centre for Diarrhoeal Disease Re...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>ALL</td>\n",
       "      <td>0</td>\n",
       "      <td>15</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2024-12-01</td>\n",
       "      <td>Primary outcome</td>\n",
       "      <td>12 months</td>\n",
       "      <td>Blood culture-confirmed typhoid fever</td>\n",
       "      <td>Secondary outcome; Secondary outcome</td>\n",
       "      <td>12 months; 12 months</td>\n",
       "      <td>Anti-Vi-IgG antibody concentration Blood cultu...</td>\n",
       "      <td>False</td>\n",
       "      <td>Typhoid Vaccination; Typhoid; Typhoid Fever</td>\n",
       "      <td>This Is A Prospective Closed Cohort, Open-Labe...</td>\n",
       "      <td>This Will Be A Phase Iii Effectiveness Study O...</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NON_RANDOMIZED</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>PREVENTION</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Zydus Lifesciences Limited</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.830</td>\n",
       "      <td>0.390</td>\n",
       "      <td>1053.000</td>\n",
       "      <td>0.669</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2025-01-22</th>\n",
       "      <td>foreign</td>\n",
       "      <td>ZYDUS LIFESCIENCES LIMITED</td>\n",
       "      <td>Zydus Lifesciences Limited</td>\n",
       "      <td>NCT06815835</td>\n",
       "      <td>A Prospective, Randomized, Parallel, Three-Arm...</td>\n",
       "      <td>PR-24098</td>\n",
       "      <td>Non-Interference Study Of Mr And Yellow Fever ...</td>\n",
       "      <td>International Centre for Diarrhoeal Disease Re...</td>\n",
       "      <td>International Centre For Diarrhoeal Disease Re...</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>1530</td>\n",
       "      <td>1</td>\n",
       "      <td>True</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Very Large</td>\n",
       "      <td>Safety; Non-interference; Measles and Rubella;...</td>\n",
       "      <td>Measles</td>\n",
       "      <td>BIOLOGICAL; BIOLOGICAL</td>\n",
       "      <td>Measles-Rubella vaccine (Live) I.P. (Freeze Dr...</td>\n",
       "      <td>Measles-Rubella vaccine (Live) I.P. (Freeze Dr...</td>\n",
       "      <td>Reference 1 (MR); Test (MR+YF); Reference 2 (Y...</td>\n",
       "      <td>Live Attenuated Vaccine; Live Attenuated Vaccine</td>\n",
       "      <td>True</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2025-03-25</td>\n",
       "      <td>2025-03-25</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>Dhaka</td>\n",
       "      <td>Bangladesh</td>\n",
       "      <td>lat: 23.7104, lon: 90.40744</td>\n",
       "      <td>Icddr,B</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>ALL</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2025-02-01</td>\n",
       "      <td>Seropositivity</td>\n",
       "      <td>06 weeks</td>\n",
       "      <td>Equivalence for seropositivity rate for anti-m...</td>\n",
       "      <td>Immunogenicity; Safety reporting</td>\n",
       "      <td>06 months; 06 months</td>\n",
       "      <td>* Seropositivity rate for anti-measles (≥9 Nov...</td>\n",
       "      <td>False</td>\n",
       "      <td>Measles; Rubella; Yellow Fever</td>\n",
       "      <td>This Study Will Be Conducted Among 1530 Health...</td>\n",
       "      <td>This Is A Prospective, Randomized, Parallel, T...</td>\n",
       "      <td>NONE</td>\n",
       "      <td>RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>PREVENTION</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BACKGROUND; BACKGROUND; BACKGROUND; BACKGROUND...</td>\n",
       "      <td>Cracknell Daniels B, Gaythorpe K, Imai N, Dori...</td>\n",
       "      <td>33506250; 33258924; 18847312; 25453327; 337223...</td>\n",
       "      <td>Zydus Lifesciences Limited</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.910</td>\n",
       "      <td>0.500</td>\n",
       "      <td>62.000</td>\n",
       "      <td>0.777</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2025-02-09</th>\n",
       "      <td>foreign</td>\n",
       "      <td>ZYDUS LIFESCIENCES LIMITED</td>\n",
       "      <td>Zydus Therapeutics Inc.</td>\n",
       "      <td>NCT06825559</td>\n",
       "      <td>A Phase 1, Open-Label, Single Arm Study To Eva...</td>\n",
       "      <td>SARO.24.003</td>\n",
       "      <td>Evaluating Pharmacokinetic And Safety Of Sarog...</td>\n",
       "      <td>Zydus Therapeutics Inc.</td>\n",
       "      <td>Zydus Therapeutics Inc.</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>phase_1</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>6</td>\n",
       "      <td>0</td>\n",
       "      <td>False</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>Small</td>\n",
       "      <td>Saroglitazar Magnesium; Primary Biliary Cholan...</td>\n",
       "      <td>Cholestatic Liver Disease</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>Saroglitazar Magnesium 1 mg</td>\n",
       "      <td>Saroglitazar Magnesium 1 mg</td>\n",
       "      <td>Saroglitazar Magnesium 1 mg</td>\n",
       "      <td>Saroglitazar Magnesium 1 Mg Will Be Assigned T...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2025-03-25</td>\n",
       "      <td>2025-03-25</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>80</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>active</td>\n",
       "      <td>2025-02-01</td>\n",
       "      <td>Pharmacokinetics of Saroglitazar: Cmax; Pharma...</td>\n",
       "      <td>PK sampling timepoints: pre- dose, 20 min, 40 ...</td>\n",
       "      <td>Maximum plasma concentration (Cmax); Time to r...</td>\n",
       "      <td>Safety and Tolerability of Saroglitazar Magnes...</td>\n",
       "      <td>From baseline to End of study (35 days); PK sa...</td>\n",
       "      <td>Number of participants with adverse events; Ti...</td>\n",
       "      <td>False</td>\n",
       "      <td>Cholestatic Liver Disease</td>\n",
       "      <td>Evaluating Pharmacokinetic And Safety Of Sarog...</td>\n",
       "      <td>A Phase 1, Open-Label, Single Arm Study To Eva...</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>Rodney P, Starzomski R. Constraints on the mor...</td>\n",
       "      <td>11652809</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>0.920</td>\n",
       "      <td>0.500</td>\n",
       "      <td>44.000</td>\n",
       "      <td>0.740</td>\n",
       "      <td>INDUSTRY</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>19117 rows × 75 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                          source                  subsidiary  \\\n",
       "ticker       date                                              \n",
       "000020.KS    2025-02-24  foreign       Dongwha Pharm.Co.,Ltd   \n",
       "000100.KS    2025-01-03  foreign           Yuhan Corporation   \n",
       "             2025-01-07  foreign           Yuhan Corporation   \n",
       "             2025-03-08  foreign           Yuhan Corporation   \n",
       "000105.KS    2025-01-03  foreign           Yuhan Corporation   \n",
       "...                          ...                         ...   \n",
       "ZYDUSLIFE.BO 2025-02-09  foreign  ZYDUS LIFESCIENCES LIMITED   \n",
       "ZYDUSLIFE.NS 2024-12-20  foreign  ZYDUS LIFESCIENCES LIMITED   \n",
       "             2024-12-20  foreign  ZYDUS LIFESCIENCES LIMITED   \n",
       "             2025-01-22  foreign  ZYDUS LIFESCIENCES LIMITED   \n",
       "             2025-02-09  foreign  ZYDUS LIFESCIENCES LIMITED   \n",
       "\n",
       "                                                  sponsor     trial_id  \\\n",
       "ticker       date                                                        \n",
       "000020.KS    2025-02-24  Dong Wha Pharmaceutical Co. Ltd.  NCT06875193   \n",
       "000100.KS    2025-01-03                 Yuhan Corporation  NCT06767345   \n",
       "             2025-01-07                 Yuhan Corporation  NCT06775522   \n",
       "             2025-03-08                 Yuhan Corporation  NCT06874894   \n",
       "000105.KS    2025-01-03                 Yuhan Corporation  NCT06767345   \n",
       "...                                                   ...          ...   \n",
       "ZYDUSLIFE.BO 2025-02-09           Zydus Therapeutics Inc.  NCT06825559   \n",
       "ZYDUSLIFE.NS 2024-12-20        Zydus Lifesciences Limited  NCT06757283   \n",
       "             2024-12-20        Zydus Lifesciences Limited  NCT06757283   \n",
       "             2025-01-22        Zydus Lifesciences Limited  NCT06815835   \n",
       "             2025-02-09           Zydus Therapeutics Inc.  NCT06825559   \n",
       "\n",
       "                                                            official_title  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24  Key Finding Of Dm Treatment With Combination, ...   \n",
       "000100.KS    2025-01-03  Comparing The Moderate Intensity Statin With E...   \n",
       "             2025-01-07  An Open-Label, Randomized, Single-Dose, Oral A...   \n",
       "             2025-03-08  Thromboembolic And Bleeding Risk During Antico...   \n",
       "000105.KS    2025-01-03  Comparing The Moderate Intensity Statin With E...   \n",
       "...                                                                    ...   \n",
       "ZYDUSLIFE.BO 2025-02-09  A Phase 1, Open-Label, Single Arm Study To Eva...   \n",
       "ZYDUSLIFE.NS 2024-12-20  Evaluation Of Typhoid Conjugate Vaccine (Tcv) ...   \n",
       "             2024-12-20  Evaluation Of Typhoid Conjugate Vaccine (Tcv) ...   \n",
       "             2025-01-22  A Prospective, Randomized, Parallel, Three-Arm...   \n",
       "             2025-02-09  A Phase 1, Open-Label, Single Arm Study To Eva...   \n",
       "\n",
       "                          sponsor_study_id  \\\n",
       "ticker       date                            \n",
       "000020.KS    2025-02-24        DW6012-IV-2   \n",
       "000100.KS    2025-01-03        STOP-PLAQUE   \n",
       "             2025-01-07        YHP2205-102   \n",
       "             2025-03-08  CAUH 1992-002-387   \n",
       "000105.KS    2025-01-03        STOP-PLAQUE   \n",
       "...                                    ...   \n",
       "ZYDUSLIFE.BO 2025-02-09        SARO.24.003   \n",
       "ZYDUSLIFE.NS 2024-12-20           PR-24059   \n",
       "             2024-12-20           PR-24059   \n",
       "             2025-01-22           PR-24098   \n",
       "             2025-02-09        SARO.24.003   \n",
       "\n",
       "                                                               brief_title  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24  Dm Treatment To Evaluate The Efficacy And Safe...   \n",
       "000100.KS    2025-01-03  Comparison Of Moderate-Intensity Statin Plus E...   \n",
       "             2025-01-07  Bioequivalence (Be) Study Between Yhp2205 And ...   \n",
       "             2025-03-08  Thromboembolic And Bleeding Risks During Antic...   \n",
       "000105.KS    2025-01-03  Comparison Of Moderate-Intensity Statin Plus E...   \n",
       "...                                                                    ...   \n",
       "ZYDUSLIFE.BO 2025-02-09  Evaluating Pharmacokinetic And Safety Of Sarog...   \n",
       "ZYDUSLIFE.NS 2024-12-20                         Zyvac-Tcv Bangladesh Study   \n",
       "             2024-12-20                         Zyvac-Tcv Bangladesh Study   \n",
       "             2025-01-22  Non-Interference Study Of Mr And Yellow Fever ...   \n",
       "             2025-02-09  Evaluating Pharmacokinetic And Safety Of Sarog...   \n",
       "\n",
       "                                                              lead_sponsor  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24                   Dong Wha Pharmaceutical Co. Ltd.   \n",
       "000100.KS    2025-01-03                     Korea University Anam Hospital   \n",
       "             2025-01-07                                  Yuhan Corporation   \n",
       "             2025-03-08  Chung-Ang University Hosptial, Chung-Ang Unive...   \n",
       "000105.KS    2025-01-03                     Korea University Anam Hospital   \n",
       "...                                                                    ...   \n",
       "ZYDUSLIFE.BO 2025-02-09                            Zydus Therapeutics Inc.   \n",
       "ZYDUSLIFE.NS 2024-12-20  International Centre for Diarrhoeal Disease Re...   \n",
       "             2024-12-20  International Centre for Diarrhoeal Disease Re...   \n",
       "             2025-01-22  International Centre for Diarrhoeal Disease Re...   \n",
       "             2025-02-09                            Zydus Therapeutics Inc.   \n",
       "\n",
       "                                                         lead_sponsor_name  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24                   Dong Wha Pharmaceutical Co. Ltd.   \n",
       "000100.KS    2025-01-03                     Korea University Anam Hospital   \n",
       "             2025-01-07                                  Yuhan Corporation   \n",
       "             2025-03-08  Chung-Ang University Hosptial, Chung-Ang Unive...   \n",
       "000105.KS    2025-01-03                     Korea University Anam Hospital   \n",
       "...                                                                    ...   \n",
       "ZYDUSLIFE.BO 2025-02-09                            Zydus Therapeutics Inc.   \n",
       "ZYDUSLIFE.NS 2024-12-20  International Centre For Diarrhoeal Disease Re...   \n",
       "             2024-12-20  International Centre For Diarrhoeal Disease Re...   \n",
       "             2025-01-22  International Centre For Diarrhoeal Disease Re...   \n",
       "             2025-02-09                            Zydus Therapeutics Inc.   \n",
       "\n",
       "                        sponsor_type lead_sponsor_type phase_category  \\\n",
       "ticker       date                                                       \n",
       "000020.KS    2025-02-24     INDUSTRY          INDUSTRY        phase_4   \n",
       "000100.KS    2025-01-03        OTHER             OTHER        phase_4   \n",
       "             2025-01-07     INDUSTRY          INDUSTRY        phase_1   \n",
       "             2025-03-08        OTHER             OTHER  not_specified   \n",
       "000105.KS    2025-01-03        OTHER             OTHER        phase_4   \n",
       "...                              ...               ...            ...   \n",
       "ZYDUSLIFE.BO 2025-02-09     INDUSTRY          INDUSTRY        phase_1   \n",
       "ZYDUSLIFE.NS 2024-12-20        OTHER             OTHER        phase_3   \n",
       "             2024-12-20        OTHER             OTHER        phase_3   \n",
       "             2025-01-22        OTHER             OTHER        phase_3   \n",
       "             2025-02-09     INDUSTRY          INDUSTRY        phase_1   \n",
       "\n",
       "                             study_type  enrollment_count  \\\n",
       "ticker       date                                           \n",
       "000020.KS    2025-02-24  INTERVENTIONAL               196   \n",
       "000100.KS    2025-01-03  INTERVENTIONAL               330   \n",
       "             2025-01-07  INTERVENTIONAL                60   \n",
       "             2025-03-08   OBSERVATIONAL              1100   \n",
       "000105.KS    2025-01-03  INTERVENTIONAL               330   \n",
       "...                                 ...               ...   \n",
       "ZYDUSLIFE.BO 2025-02-09  INTERVENTIONAL                 6   \n",
       "ZYDUSLIFE.NS 2024-12-20  INTERVENTIONAL              4000   \n",
       "             2024-12-20  INTERVENTIONAL              4000   \n",
       "             2025-01-22  INTERVENTIONAL              1530   \n",
       "             2025-02-09  INTERVENTIONAL                 6   \n",
       "\n",
       "                         number_of_locations healthy_volunteers  \\\n",
       "ticker       date                                                 \n",
       "000020.KS    2025-02-24                    1              False   \n",
       "000100.KS    2025-01-03                    0              False   \n",
       "             2025-01-07                    1               True   \n",
       "             2025-03-08                    1              False   \n",
       "000105.KS    2025-01-03                    0              False   \n",
       "...                                      ...                ...   \n",
       "ZYDUSLIFE.BO 2025-02-09                    0              False   \n",
       "ZYDUSLIFE.NS 2024-12-20                    1               True   \n",
       "             2024-12-20                    1               True   \n",
       "             2025-01-22                    1               True   \n",
       "             2025-02-09                    0              False   \n",
       "\n",
       "                        enrollment_type study_size_category  \\\n",
       "ticker       date                                             \n",
       "000020.KS    2025-02-24       ESTIMATED              Medium   \n",
       "000100.KS    2025-01-03       ESTIMATED              Medium   \n",
       "             2025-01-07          ACTUAL               Small   \n",
       "             2025-03-08       ESTIMATED          Very Large   \n",
       "000105.KS    2025-01-03       ESTIMATED              Medium   \n",
       "...                                 ...                 ...   \n",
       "ZYDUSLIFE.BO 2025-02-09       ESTIMATED               Small   \n",
       "ZYDUSLIFE.NS 2024-12-20       ESTIMATED          Very Large   \n",
       "             2024-12-20       ESTIMATED          Very Large   \n",
       "             2025-01-22       ESTIMATED          Very Large   \n",
       "             2025-02-09       ESTIMATED               Small   \n",
       "\n",
       "                                                        condition_keywords  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24       Dapagliflozin; Pioglitazone; DPP-4 inhibitor   \n",
       "000100.KS    2025-01-03                                                nan   \n",
       "             2025-01-07                   Pharmacokinetics; Bioequivalence   \n",
       "             2025-03-08              Atrial Fibrillation; Stroke; Bleeding   \n",
       "000105.KS    2025-01-03                                                nan   \n",
       "...                                                                    ...   \n",
       "ZYDUSLIFE.BO 2025-02-09  Saroglitazar Magnesium; Primary Biliary Cholan...   \n",
       "ZYDUSLIFE.NS 2024-12-20  Conjugate vaccine; Immunogenicity; Safety; Typ...   \n",
       "             2024-12-20  Conjugate vaccine; Immunogenicity; Safety; Typ...   \n",
       "             2025-01-22  Safety; Non-interference; Measles and Rubella;...   \n",
       "             2025-02-09  Saroglitazar Magnesium; Primary Biliary Cholan...   \n",
       "\n",
       "                                 primary_condition       intervention_type  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24              Type2Diabetes                    DRUG   \n",
       "000100.KS    2025-01-03    Coronary Artery Disease              DRUG; DRUG   \n",
       "             2025-01-07         Healthy Volunteers              DRUG; DRUG   \n",
       "             2025-03-08       Fibrillation, Atrial                     nan   \n",
       "000105.KS    2025-01-03    Coronary Artery Disease              DRUG; DRUG   \n",
       "...                                            ...                     ...   \n",
       "ZYDUSLIFE.BO 2025-02-09  Cholestatic Liver Disease                    DRUG   \n",
       "ZYDUSLIFE.NS 2024-12-20        Typhoid Vaccination              BIOLOGICAL   \n",
       "             2024-12-20        Typhoid Vaccination              BIOLOGICAL   \n",
       "             2025-01-22                    Measles  BIOLOGICAL; BIOLOGICAL   \n",
       "             2025-02-09  Cholestatic Liver Disease                    DRUG   \n",
       "\n",
       "                                                      primary_intervention  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24                     DW6012(Dasidiem tab. 10/100mg)   \n",
       "000100.KS    2025-01-03                                 statins, ezetimibe   \n",
       "             2025-01-07                                            YHP2205   \n",
       "             2025-03-08                                                nan   \n",
       "000105.KS    2025-01-03                                 statins, ezetimibe   \n",
       "...                                                                    ...   \n",
       "ZYDUSLIFE.BO 2025-02-09                        Saroglitazar Magnesium 1 mg   \n",
       "ZYDUSLIFE.NS 2024-12-20  Purified Vi capsular polysaccharide of Salmone...   \n",
       "             2024-12-20  Purified Vi capsular polysaccharide of Salmone...   \n",
       "             2025-01-22  Measles-Rubella vaccine (Live) I.P. (Freeze Dr...   \n",
       "             2025-02-09                        Saroglitazar Magnesium 1 mg   \n",
       "\n",
       "                                                         intervention_name  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24                     DW6012(Dasidiem tab. 10/100mg)   \n",
       "000100.KS    2025-01-03            statins, ezetimibe; Combination therapy   \n",
       "             2025-01-07                                   YHP2205; YHR2401   \n",
       "             2025-03-08                                                nan   \n",
       "000105.KS    2025-01-03            statins, ezetimibe; Combination therapy   \n",
       "...                                                                    ...   \n",
       "ZYDUSLIFE.BO 2025-02-09                        Saroglitazar Magnesium 1 mg   \n",
       "ZYDUSLIFE.NS 2024-12-20  Purified Vi capsular polysaccharide of Salmone...   \n",
       "             2024-12-20  Purified Vi capsular polysaccharide of Salmone...   \n",
       "             2025-01-22  Measles-Rubella vaccine (Live) I.P. (Freeze Dr...   \n",
       "             2025-02-09                        Saroglitazar Magnesium 1 mg   \n",
       "\n",
       "                                             intervention_arm_group_labels  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24    Dasidiem 10/100mg; sitdiem 100mg, Piotazone15mg   \n",
       "000100.KS    2025-01-03  High Intensity Statin monotherapy; Combination...   \n",
       "             2025-01-07  Sequence Group A; Sequence Group B; Sequence G...   \n",
       "             2025-03-08                                               None   \n",
       "000105.KS    2025-01-03  High Intensity Statin monotherapy; Combination...   \n",
       "...                                                                    ...   \n",
       "ZYDUSLIFE.BO 2025-02-09                        Saroglitazar Magnesium 1 mg   \n",
       "ZYDUSLIFE.NS 2024-12-20    Culture-negative control; Culture-positive case   \n",
       "             2024-12-20    Culture-negative control; Culture-positive case   \n",
       "             2025-01-22  Reference 1 (MR); Test (MR+YF); Reference 2 (Y...   \n",
       "             2025-02-09                        Saroglitazar Magnesium 1 mg   \n",
       "\n",
       "                                                  intervention_description  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24                    Once A Day, Oral Administration   \n",
       "000100.KS    2025-01-03  Rosuvastatin 20Mg Once Daily; Rosuvastatin 10M...   \n",
       "             2025-01-07  Test Drug: Yhp2205 Comparator: Yhr2401; Test D...   \n",
       "             2025-03-08                                               None   \n",
       "000105.KS    2025-01-03  Rosuvastatin 20Mg Once Daily; Rosuvastatin 10M...   \n",
       "...                                                                    ...   \n",
       "ZYDUSLIFE.BO 2025-02-09  Saroglitazar Magnesium 1 Mg Will Be Assigned T...   \n",
       "ZYDUSLIFE.NS 2024-12-20  Purified Vi Capsular Polysaccharide Of Salmone...   \n",
       "             2024-12-20  Purified Vi Capsular Polysaccharide Of Salmone...   \n",
       "             2025-01-22   Live Attenuated Vaccine; Live Attenuated Vaccine   \n",
       "             2025-02-09  Saroglitazar Magnesium 1 Mg Will Be Assigned T...   \n",
       "\n",
       "                        has_data_monitoring_committee  \\\n",
       "ticker       date                                       \n",
       "000020.KS    2025-02-24                         False   \n",
       "000100.KS    2025-01-03                          True   \n",
       "             2025-01-07                          None   \n",
       "             2025-03-08                          True   \n",
       "000105.KS    2025-01-03                          True   \n",
       "...                                               ...   \n",
       "ZYDUSLIFE.BO 2025-02-09                         False   \n",
       "ZYDUSLIFE.NS 2024-12-20                          True   \n",
       "             2024-12-20                          True   \n",
       "             2025-01-22                          True   \n",
       "             2025-02-09                         False   \n",
       "\n",
       "                                responsible_party_investigator_affiliation  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24                                               None   \n",
       "000100.KS    2025-01-03                     Korea University Anam Hospital   \n",
       "             2025-01-07                                               None   \n",
       "             2025-03-08  Chung-Ang University Hosptial, Chung-Ang Unive...   \n",
       "000105.KS    2025-01-03                     Korea University Anam Hospital   \n",
       "...                                                                    ...   \n",
       "ZYDUSLIFE.BO 2025-02-09                                               None   \n",
       "ZYDUSLIFE.NS 2024-12-20                                               None   \n",
       "             2024-12-20                                               None   \n",
       "             2025-01-22                                               None   \n",
       "             2025-02-09                                               None   \n",
       "\n",
       "                        responsible_party_investigator_title  \\\n",
       "ticker       date                                              \n",
       "000020.KS    2025-02-24                                 None   \n",
       "000100.KS    2025-01-03                            Professor   \n",
       "             2025-01-07                                 None   \n",
       "             2025-03-08                  Associate Professor   \n",
       "000105.KS    2025-01-03                            Professor   \n",
       "...                                                      ...   \n",
       "ZYDUSLIFE.BO 2025-02-09                                 None   \n",
       "ZYDUSLIFE.NS 2024-12-20                                 None   \n",
       "             2024-12-20                                 None   \n",
       "             2025-01-22                                 None   \n",
       "             2025-02-09                                 None   \n",
       "\n",
       "                        responsible_party_investigator_name first_posted_date  \\\n",
       "ticker       date                                                               \n",
       "000020.KS    2025-02-24                                None        2025-03-25   \n",
       "000100.KS    2025-01-03                       Soon Jun Hong        2025-03-25   \n",
       "             2025-01-07                                None        2025-03-25   \n",
       "             2025-03-08                        Ki-Woon Kang        2025-03-25   \n",
       "000105.KS    2025-01-03                       Soon Jun Hong        2025-03-25   \n",
       "...                                                     ...               ...   \n",
       "ZYDUSLIFE.BO 2025-02-09                                None        2025-03-25   \n",
       "ZYDUSLIFE.NS 2024-12-20                                None        2025-03-25   \n",
       "             2024-12-20                                None        2025-01-03   \n",
       "             2025-01-22                                None        2025-03-25   \n",
       "             2025-02-09                                None        2025-03-25   \n",
       "\n",
       "                        last_update_posted_date start_date  \\\n",
       "ticker       date                                            \n",
       "000020.KS    2025-02-24              2025-03-25        NaT   \n",
       "000100.KS    2025-01-03              2025-03-25        NaT   \n",
       "             2025-01-07              2025-03-25 2025-01-11   \n",
       "             2025-03-08              2025-03-25        NaT   \n",
       "000105.KS    2025-01-03              2025-03-25        NaT   \n",
       "...                                         ...        ...   \n",
       "ZYDUSLIFE.BO 2025-02-09              2025-03-25        NaT   \n",
       "ZYDUSLIFE.NS 2024-12-20              2025-03-25 2025-04-01   \n",
       "             2024-12-20              2025-01-03        NaT   \n",
       "             2025-01-22              2025-03-25        NaT   \n",
       "             2025-02-09              2025-03-25        NaT   \n",
       "\n",
       "                        study_completion_date primary_completion_date  \\\n",
       "ticker       date                                                       \n",
       "000020.KS    2025-02-24                   NaT              2025-12-31   \n",
       "000100.KS    2025-01-03                   NaT                     NaT   \n",
       "             2025-01-07            2025-01-21              2025-01-20   \n",
       "             2025-03-08            2026-08-30              2025-08-30   \n",
       "000105.KS    2025-01-03                   NaT                     NaT   \n",
       "...                                       ...                     ...   \n",
       "ZYDUSLIFE.BO 2025-02-09                   NaT                     NaT   \n",
       "ZYDUSLIFE.NS 2024-12-20            2026-05-30              2026-03-31   \n",
       "             2024-12-20                   NaT                     NaT   \n",
       "             2025-01-22                   NaT                     NaT   \n",
       "             2025-02-09                   NaT                     NaT   \n",
       "\n",
       "                        study_locations_city study_locations_country  \\\n",
       "ticker       date                                                      \n",
       "000020.KS    2025-02-24                Seoul      Korea, Republic of   \n",
       "000100.KS    2025-01-03                 None                    None   \n",
       "             2025-01-07                Seoul      Korea, Republic of   \n",
       "             2025-03-08                Seoul      Korea, Republic of   \n",
       "000105.KS    2025-01-03                 None                    None   \n",
       "...                                      ...                     ...   \n",
       "ZYDUSLIFE.BO 2025-02-09                 None                    None   \n",
       "ZYDUSLIFE.NS 2024-12-20                Dhaka              Bangladesh   \n",
       "             2024-12-20                Dhaka              Bangladesh   \n",
       "             2025-01-22                Dhaka              Bangladesh   \n",
       "             2025-02-09                 None                    None   \n",
       "\n",
       "                            study_locations_geopoint  \\\n",
       "ticker       date                                      \n",
       "000020.KS    2025-02-24   lat: 37.566, lon: 126.9784   \n",
       "000100.KS    2025-01-03                         None   \n",
       "             2025-01-07   lat: 37.566, lon: 126.9784   \n",
       "             2025-03-08   lat: 37.566, lon: 126.9784   \n",
       "000105.KS    2025-01-03                         None   \n",
       "...                                              ...   \n",
       "ZYDUSLIFE.BO 2025-02-09                         None   \n",
       "ZYDUSLIFE.NS 2024-12-20  lat: 23.7104, lon: 90.40744   \n",
       "             2024-12-20  lat: 23.7104, lon: 90.40744   \n",
       "             2025-01-22  lat: 23.7104, lon: 90.40744   \n",
       "             2025-02-09                         None   \n",
       "\n",
       "                                                  study_locations_facility  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24          Kyung Hee University Hospital at Gangdong   \n",
       "000100.KS    2025-01-03                                               None   \n",
       "             2025-01-07                                     Bumin Hospital   \n",
       "             2025-03-08                      Chung-Ang University Hospital   \n",
       "000105.KS    2025-01-03                                               None   \n",
       "...                                                                    ...   \n",
       "ZYDUSLIFE.BO 2025-02-09                                               None   \n",
       "ZYDUSLIFE.NS 2024-12-20  International Centre for Diarrhoeal Disease Re...   \n",
       "             2024-12-20  International Centre for Diarrhoeal Disease Re...   \n",
       "             2025-01-22                                            Icddr,B   \n",
       "             2025-02-09                                               None   \n",
       "\n",
       "                        study_locations_zip study_locations_state  \\\n",
       "ticker       date                                                   \n",
       "000020.KS    2025-02-24                None                  None   \n",
       "000100.KS    2025-01-03                None                  None   \n",
       "             2025-01-07               07590            Gangseo-gu   \n",
       "             2025-03-08               06973                  None   \n",
       "000105.KS    2025-01-03                None                  None   \n",
       "...                                     ...                   ...   \n",
       "ZYDUSLIFE.BO 2025-02-09                None                  None   \n",
       "ZYDUSLIFE.NS 2024-12-20                None                  None   \n",
       "             2024-12-20                None                  None   \n",
       "             2025-01-22                None                  None   \n",
       "             2025-02-09                None                  None   \n",
       "\n",
       "                               standard_age_groups  sex  minimum_age  \\\n",
       "ticker       date                                                      \n",
       "000020.KS    2025-02-24         ADULT; OLDER_ADULT  ALL           19   \n",
       "000100.KS    2025-01-03         ADULT; OLDER_ADULT  ALL           18   \n",
       "             2025-01-07         ADULT; OLDER_ADULT  ALL           19   \n",
       "             2025-03-08  CHILD; ADULT; OLDER_ADULT  ALL            2   \n",
       "000105.KS    2025-01-03         ADULT; OLDER_ADULT  ALL           18   \n",
       "...                                            ...  ...          ...   \n",
       "ZYDUSLIFE.BO 2025-02-09         ADULT; OLDER_ADULT  ALL           18   \n",
       "ZYDUSLIFE.NS 2024-12-20                      CHILD  ALL            0   \n",
       "             2024-12-20                      CHILD  ALL            0   \n",
       "             2025-01-22                      CHILD  ALL            1   \n",
       "             2025-02-09         ADULT; OLDER_ADULT  ALL           18   \n",
       "\n",
       "                         maximum_age           overall_status status_category  \\\n",
       "ticker       date                                                               \n",
       "000020.KS    2025-02-24         <NA>               RECRUITING          active   \n",
       "000100.KS    2025-01-03         <NA>       NOT_YET_RECRUITING          active   \n",
       "             2025-01-07         <NA>                COMPLETED       completed   \n",
       "             2025-03-08         <NA>  ENROLLING_BY_INVITATION          active   \n",
       "000105.KS    2025-01-03         <NA>       NOT_YET_RECRUITING          active   \n",
       "...                              ...                      ...             ...   \n",
       "ZYDUSLIFE.BO 2025-02-09           80       NOT_YET_RECRUITING          active   \n",
       "ZYDUSLIFE.NS 2024-12-20           15       NOT_YET_RECRUITING          active   \n",
       "             2024-12-20           15       NOT_YET_RECRUITING          active   \n",
       "             2025-01-22            1       NOT_YET_RECRUITING          active   \n",
       "             2025-02-09           80       NOT_YET_RECRUITING          active   \n",
       "\n",
       "                        status_verified_date  \\\n",
       "ticker       date                              \n",
       "000020.KS    2025-02-24           2025-03-01   \n",
       "000100.KS    2025-01-03           2024-12-01   \n",
       "             2025-01-07           2025-01-01   \n",
       "             2025-03-08           2025-03-01   \n",
       "000105.KS    2025-01-03           2024-12-01   \n",
       "...                                      ...   \n",
       "ZYDUSLIFE.BO 2025-02-09           2025-02-01   \n",
       "ZYDUSLIFE.NS 2024-12-20           2024-12-01   \n",
       "             2024-12-20           2024-12-01   \n",
       "             2025-01-22           2025-02-01   \n",
       "             2025-02-09           2025-02-01   \n",
       "\n",
       "                                                 primary_outcomes_measures  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24  Variance in HbA1c from baseline to 24 weeks on...   \n",
       "000100.KS    2025-01-03  percentage change in coronary atheroma volume ...   \n",
       "             2025-01-07  Area under the plasma drug concentration-time ...   \n",
       "             2025-03-08           Clinical ischemic and hemorrhagic events   \n",
       "000105.KS    2025-01-03  percentage change in coronary atheroma volume ...   \n",
       "...                                                                    ...   \n",
       "ZYDUSLIFE.BO 2025-02-09  Pharmacokinetics of Saroglitazar: Cmax; Pharma...   \n",
       "ZYDUSLIFE.NS 2024-12-20                                    Primary outcome   \n",
       "             2024-12-20                                    Primary outcome   \n",
       "             2025-01-22                                     Seropositivity   \n",
       "             2025-02-09  Pharmacokinetics of Saroglitazar: Cmax; Pharma...   \n",
       "\n",
       "                                               primary_outcomes_timeframes  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24                                           24 weeks   \n",
       "000100.KS    2025-01-03                                           52 weeks   \n",
       "             2025-01-07                             0-36 hours; 0-36 hours   \n",
       "             2025-03-08                                          12 months   \n",
       "000105.KS    2025-01-03                                           52 weeks   \n",
       "...                                                                    ...   \n",
       "ZYDUSLIFE.BO 2025-02-09  PK sampling timepoints: pre- dose, 20 min, 40 ...   \n",
       "ZYDUSLIFE.NS 2024-12-20                                          12 months   \n",
       "             2024-12-20                                          12 months   \n",
       "             2025-01-22                                           06 weeks   \n",
       "             2025-02-09  PK sampling timepoints: pre- dose, 20 min, 40 ...   \n",
       "\n",
       "                                             primary_outcomes_descriptions  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24                                    Change in HbA1c   \n",
       "000100.KS    2025-01-03                                               None   \n",
       "             2025-01-07  Area under the plasma drug concentration-time ...   \n",
       "             2025-03-08  Ischemic stroke, systemic embolism, or myocard...   \n",
       "000105.KS    2025-01-03                                               None   \n",
       "...                                                                    ...   \n",
       "ZYDUSLIFE.BO 2025-02-09  Maximum plasma concentration (Cmax); Time to r...   \n",
       "ZYDUSLIFE.NS 2024-12-20              Blood culture-confirmed typhoid fever   \n",
       "             2024-12-20              Blood culture-confirmed typhoid fever   \n",
       "             2025-01-22  Equivalence for seropositivity rate for anti-m...   \n",
       "             2025-02-09  Maximum plasma concentration (Cmax); Time to r...   \n",
       "\n",
       "                                               secondary_outcomes_measures  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24  Variance in HbA1c from baseline to 12 weeks on...   \n",
       "000100.KS    2025-01-03  Change from baseline to week 52 in total lipid...   \n",
       "             2025-01-07  Area under the plasma drug concentration-time ...   \n",
       "             2025-03-08                              Clinical other events   \n",
       "000105.KS    2025-01-03  Change from baseline to week 52 in total lipid...   \n",
       "...                                                                    ...   \n",
       "ZYDUSLIFE.BO 2025-02-09  Safety and Tolerability of Saroglitazar Magnes...   \n",
       "ZYDUSLIFE.NS 2024-12-20               Secondary outcome; Secondary outcome   \n",
       "             2024-12-20               Secondary outcome; Secondary outcome   \n",
       "             2025-01-22                   Immunogenicity; Safety reporting   \n",
       "             2025-02-09  Safety and Tolerability of Saroglitazar Magnes...   \n",
       "\n",
       "                                             secondary_outcomes_timeframes  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24  12 weeks; 12, 24 weeks; 12, 24 weeks; 12, 24 w...   \n",
       "000100.KS    2025-01-03                       52 weeks; 52 weeks; 52 weeks   \n",
       "             2025-01-07     0-36 hours; 0-36 hours; 0-36 hours; 0-36 hours   \n",
       "             2025-03-08                                          12 months   \n",
       "000105.KS    2025-01-03                       52 weeks; 52 weeks; 52 weeks   \n",
       "...                                                                    ...   \n",
       "ZYDUSLIFE.BO 2025-02-09  From baseline to End of study (35 days); PK sa...   \n",
       "ZYDUSLIFE.NS 2024-12-20                               12 months; 12 months   \n",
       "             2024-12-20                               12 months; 12 months   \n",
       "             2025-01-22                               06 months; 06 months   \n",
       "             2025-02-09  From baseline to End of study (35 days); PK sa...   \n",
       "\n",
       "                                           secondary_outcomes_descriptions  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24  Change in HbA1c; Change in Fasting Plasma Gluc...   \n",
       "000100.KS    2025-01-03                                               None   \n",
       "             2025-01-07  Area under the plasma drug concentration-time ...   \n",
       "             2025-03-08  Major Adverse Cardiovascular Events: Myocardia...   \n",
       "000105.KS    2025-01-03                                               None   \n",
       "...                                                                    ...   \n",
       "ZYDUSLIFE.BO 2025-02-09  Number of participants with adverse events; Ti...   \n",
       "ZYDUSLIFE.NS 2024-12-20  Anti-Vi-IgG antibody concentration Blood cultu...   \n",
       "             2024-12-20  Anti-Vi-IgG antibody concentration Blood cultu...   \n",
       "             2025-01-22  * Seropositivity rate for anti-measles (≥9 Nov...   \n",
       "             2025-02-09  Number of participants with adverse events; Ti...   \n",
       "\n",
       "                         has_results  \\\n",
       "ticker       date                      \n",
       "000020.KS    2025-02-24        False   \n",
       "000100.KS    2025-01-03        False   \n",
       "             2025-01-07        False   \n",
       "             2025-03-08        False   \n",
       "000105.KS    2025-01-03        False   \n",
       "...                              ...   \n",
       "ZYDUSLIFE.BO 2025-02-09        False   \n",
       "ZYDUSLIFE.NS 2024-12-20        False   \n",
       "             2024-12-20        False   \n",
       "             2025-01-22        False   \n",
       "             2025-02-09        False   \n",
       "\n",
       "                                                                conditions  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24                                      Type2Diabetes   \n",
       "000100.KS    2025-01-03  Coronary Artery Disease; Atherosclerosis Of Co...   \n",
       "             2025-01-07                                 Healthy Volunteers   \n",
       "             2025-03-08                               Fibrillation, Atrial   \n",
       "000105.KS    2025-01-03  Coronary Artery Disease; Atherosclerosis Of Co...   \n",
       "...                                                                    ...   \n",
       "ZYDUSLIFE.BO 2025-02-09                          Cholestatic Liver Disease   \n",
       "ZYDUSLIFE.NS 2024-12-20        Typhoid Vaccination; Typhoid; Typhoid Fever   \n",
       "             2024-12-20        Typhoid Vaccination; Typhoid; Typhoid Fever   \n",
       "             2025-01-22                     Measles; Rubella; Yellow Fever   \n",
       "             2025-02-09                          Cholestatic Liver Disease   \n",
       "\n",
       "                                                             brief_summary  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24  Key Finding Of Dm Treatment With Combination, ...   \n",
       "000100.KS    2025-01-03  This Study Is A Prospective, Multicenter, Rand...   \n",
       "             2025-01-07  A Randomized, Open-Label, Single-Dose, 2-Seque...   \n",
       "             2025-03-08  This Study Was Design To Investigate The Effic...   \n",
       "000105.KS    2025-01-03  This Study Is A Prospective, Multicenter, Rand...   \n",
       "...                                                                    ...   \n",
       "ZYDUSLIFE.BO 2025-02-09  Evaluating Pharmacokinetic And Safety Of Sarog...   \n",
       "ZYDUSLIFE.NS 2024-12-20  This Is A Prospective Closed Cohort, Open-Labe...   \n",
       "             2024-12-20  This Is A Prospective Closed Cohort, Open-Labe...   \n",
       "             2025-01-22  This Study Will Be Conducted Among 1530 Health...   \n",
       "             2025-02-09  Evaluating Pharmacokinetic And Safety Of Sarog...   \n",
       "\n",
       "                                                      detailed_description  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24  This Is A Phase 4, Multicenter, Randomized, Op...   \n",
       "000100.KS    2025-01-03                                               None   \n",
       "             2025-01-07  60 Healthy Subjects Will Be Randomized To One ...   \n",
       "             2025-03-08  East Asians Have Demonstrated A Higher Bleedin...   \n",
       "000105.KS    2025-01-03                                               None   \n",
       "...                                                                    ...   \n",
       "ZYDUSLIFE.BO 2025-02-09  A Phase 1, Open-Label, Single Arm Study To Eva...   \n",
       "ZYDUSLIFE.NS 2024-12-20  This Will Be A Phase Iii Effectiveness Study O...   \n",
       "             2024-12-20  This Will Be A Phase Iii Effectiveness Study O...   \n",
       "             2025-01-22  This Is A Prospective, Randomized, Parallel, T...   \n",
       "             2025-02-09  A Phase 1, Open-Label, Single Arm Study To Eva...   \n",
       "\n",
       "                        masking      allocation intervention_model  \\\n",
       "ticker       date                                                    \n",
       "000020.KS    2025-02-24    NONE      RANDOMIZED           PARALLEL   \n",
       "000100.KS    2025-01-03    NONE      RANDOMIZED           PARALLEL   \n",
       "             2025-01-07    NONE      RANDOMIZED          CROSSOVER   \n",
       "             2025-03-08    None            None               None   \n",
       "000105.KS    2025-01-03    NONE      RANDOMIZED           PARALLEL   \n",
       "...                         ...             ...                ...   \n",
       "ZYDUSLIFE.BO 2025-02-09    NONE              NA       SINGLE_GROUP   \n",
       "ZYDUSLIFE.NS 2024-12-20    NONE  NON_RANDOMIZED       SINGLE_GROUP   \n",
       "             2024-12-20    NONE  NON_RANDOMIZED       SINGLE_GROUP   \n",
       "             2025-01-22    NONE      RANDOMIZED           PARALLEL   \n",
       "             2025-02-09    NONE              NA       SINGLE_GROUP   \n",
       "\n",
       "                         primary_purpose  has_expanded_access  \\\n",
       "ticker       date                                               \n",
       "000020.KS    2025-02-24  SUPPORTIVE_CARE                False   \n",
       "000100.KS    2025-01-03        TREATMENT                False   \n",
       "             2025-01-07        TREATMENT                False   \n",
       "             2025-03-08             None                False   \n",
       "000105.KS    2025-01-03        TREATMENT                False   \n",
       "...                                  ...                  ...   \n",
       "ZYDUSLIFE.BO 2025-02-09        TREATMENT                False   \n",
       "ZYDUSLIFE.NS 2024-12-20       PREVENTION                False   \n",
       "             2024-12-20       PREVENTION                False   \n",
       "             2025-01-22       PREVENTION                False   \n",
       "             2025-02-09        TREATMENT                False   \n",
       "\n",
       "                         study_duration_days  trial_duration  \\\n",
       "ticker       date                                              \n",
       "000020.KS    2025-02-24                 <NA>             NaN   \n",
       "000100.KS    2025-01-03                 <NA>             NaN   \n",
       "             2025-01-07                   10          10.000   \n",
       "             2025-03-08                 <NA>             NaN   \n",
       "000105.KS    2025-01-03                 <NA>             NaN   \n",
       "...                                      ...             ...   \n",
       "ZYDUSLIFE.BO 2025-02-09                 <NA>             NaN   \n",
       "ZYDUSLIFE.NS 2024-12-20                  424         424.000   \n",
       "             2024-12-20                 <NA>             NaN   \n",
       "             2025-01-22                 <NA>             NaN   \n",
       "             2025-02-09                 <NA>             NaN   \n",
       "\n",
       "                                                           references_type  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24                                               None   \n",
       "000100.KS    2025-01-03  BACKGROUND; BACKGROUND; BACKGROUND; BACKGROUND...   \n",
       "             2025-01-07                                               None   \n",
       "             2025-03-08                                             RESULT   \n",
       "000105.KS    2025-01-03  BACKGROUND; BACKGROUND; BACKGROUND; BACKGROUND...   \n",
       "...                                                                    ...   \n",
       "ZYDUSLIFE.BO 2025-02-09                                         BACKGROUND   \n",
       "ZYDUSLIFE.NS 2024-12-20                                               None   \n",
       "             2024-12-20                                               None   \n",
       "             2025-01-22  BACKGROUND; BACKGROUND; BACKGROUND; BACKGROUND...   \n",
       "             2025-02-09                                         BACKGROUND   \n",
       "\n",
       "                                                       references_citation  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24                                               None   \n",
       "000100.KS    2025-01-03  Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho ...   \n",
       "             2025-01-07                                               None   \n",
       "             2025-03-08  Lee SH, Kim HK, Ahn JH, Kang MG, Kim KH, Bae J...   \n",
       "000105.KS    2025-01-03  Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho ...   \n",
       "...                                                                    ...   \n",
       "ZYDUSLIFE.BO 2025-02-09  Rodney P, Starzomski R. Constraints on the mor...   \n",
       "ZYDUSLIFE.NS 2024-12-20                                               None   \n",
       "             2024-12-20                                               None   \n",
       "             2025-01-22  Cracknell Daniels B, Gaythorpe K, Imai N, Dori...   \n",
       "             2025-02-09  Rodney P, Starzomski R. Constraints on the mor...   \n",
       "\n",
       "                                                           references_pmid  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24                                               None   \n",
       "000100.KS    2025-01-03  21693744; 20167359; 34130955; 32227755; 386042...   \n",
       "             2025-01-07                                               None   \n",
       "             2025-03-08                                           36857519   \n",
       "000105.KS    2025-01-03  21693744; 20167359; 34130955; 32227755; 386042...   \n",
       "...                                                                    ...   \n",
       "ZYDUSLIFE.BO 2025-02-09                                           11652809   \n",
       "ZYDUSLIFE.NS 2024-12-20                                               None   \n",
       "             2024-12-20                                               None   \n",
       "             2025-01-22  33506250; 33258924; 18847312; 25453327; 337223...   \n",
       "             2025-02-09                                           11652809   \n",
       "\n",
       "                                                        collaborators_name  \\\n",
       "ticker       date                                                            \n",
       "000020.KS    2025-02-24                                               None   \n",
       "000100.KS    2025-01-03  Yuhan Corporation; Hanmi Pharmaceutical co., ltd.   \n",
       "             2025-01-07                                               None   \n",
       "             2025-03-08  Chung-Ang University Gwangmyeong Hospital; Sam...   \n",
       "000105.KS    2025-01-03  Yuhan Corporation; Hanmi Pharmaceutical co., ltd.   \n",
       "...                                                                    ...   \n",
       "ZYDUSLIFE.BO 2025-02-09                                               None   \n",
       "ZYDUSLIFE.NS 2024-12-20                         Zydus Lifesciences Limited   \n",
       "             2024-12-20                         Zydus Lifesciences Limited   \n",
       "             2025-01-22                         Zydus Lifesciences Limited   \n",
       "             2025-02-09                                               None   \n",
       "\n",
       "                                                 collaborators_class  \\\n",
       "ticker       date                                                      \n",
       "000020.KS    2025-02-24                                         None   \n",
       "000100.KS    2025-01-03                              INDUSTRY; OTHER   \n",
       "             2025-01-07                                         None   \n",
       "             2025-03-08  OTHER; OTHER; OTHER; OTHER; OTHER; INDUSTRY   \n",
       "000105.KS    2025-01-03                              INDUSTRY; OTHER   \n",
       "...                                                              ...   \n",
       "ZYDUSLIFE.BO 2025-02-09                                         None   \n",
       "ZYDUSLIFE.NS 2024-12-20                                     INDUSTRY   \n",
       "             2024-12-20                                     INDUSTRY   \n",
       "             2025-01-22                                     INDUSTRY   \n",
       "             2025-02-09                                         None   \n",
       "\n",
       "                        ipd_sharing  success_prediction  economic_effect  \\\n",
       "ticker       date                                                          \n",
       "000020.KS    2025-02-24          NO               0.280            0.040   \n",
       "000100.KS    2025-01-03   UNDECIDED               0.390            0.040   \n",
       "             2025-01-07          NO               0.900            0.490   \n",
       "             2025-03-08          NO               0.390            0.080   \n",
       "000105.KS    2025-01-03   UNDECIDED               0.390            0.040   \n",
       "...                             ...                 ...              ...   \n",
       "ZYDUSLIFE.BO 2025-02-09        None               0.920            0.500   \n",
       "ZYDUSLIFE.NS 2024-12-20          NO               0.840            0.430   \n",
       "             2024-12-20          NO               0.830            0.390   \n",
       "             2025-01-22          NO               0.910            0.500   \n",
       "             2025-02-09        None               0.920            0.500   \n",
       "\n",
       "                         duration_prediction  success_composite     class  \n",
       "ticker       date                                                          \n",
       "000020.KS    2025-02-24              828.000              0.303  INDUSTRY  \n",
       "000100.KS    2025-01-03               81.000              0.377  INDUSTRY  \n",
       "             2025-01-07              732.000              0.713  INDUSTRY  \n",
       "             2025-03-08              721.000              0.267  INDUSTRY  \n",
       "000105.KS    2025-01-03               81.000              0.377  INDUSTRY  \n",
       "...                                      ...                ...       ...  \n",
       "ZYDUSLIFE.BO 2025-02-09               44.000              0.740  INDUSTRY  \n",
       "ZYDUSLIFE.NS 2024-12-20               95.000              0.712  INDUSTRY  \n",
       "             2024-12-20             1053.000              0.669  INDUSTRY  \n",
       "             2025-01-22               62.000              0.777  INDUSTRY  \n",
       "             2025-02-09               44.000              0.740  INDUSTRY  \n",
       "\n",
       "[19117 rows x 75 columns]"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_apps"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th>match</th>\n",
       "      <th>trial_id</th>\n",
       "      <th>lead_sponsor_name</th>\n",
       "      <th>official_title</th>\n",
       "      <th>phase_category</th>\n",
       "      <th>success_prediction</th>\n",
       "      <th>economic_effect</th>\n",
       "      <th>duration_prediction</th>\n",
       "      <th>success_composite</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ticker</th>\n",
       "      <th>date</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th rowspan=\"3\" valign=\"top\">SNY</th>\n",
       "      <th>2024-11-27</th>\n",
       "      <td>SANOFI</td>\n",
       "      <td>NCT06714448</td>\n",
       "      <td>Sanofi</td>\n",
       "      <td>Post Authorization Safety Study Assessing The ...</td>\n",
       "      <td>not_specified</td>\n",
       "      <td>0.260</td>\n",
       "      <td>0.050</td>\n",
       "      <td>731.000</td>\n",
       "      <td>0.153</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2024-11-27</th>\n",
       "      <td>SANOFI</td>\n",
       "      <td>NCT06714461</td>\n",
       "      <td>Sanofi</td>\n",
       "      <td>Post Authorization Safety Study On Assessment ...</td>\n",
       "      <td>not_specified</td>\n",
       "      <td>0.270</td>\n",
       "      <td>0.040</td>\n",
       "      <td>731.000</td>\n",
       "      <td>0.156</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2024-11-29</th>\n",
       "      <td>SANOFI</td>\n",
       "      <td>NCT06716424</td>\n",
       "      <td>Sanofi</td>\n",
       "      <td>Multicentre Phase Iv Single Arm Clinical Trial...</td>\n",
       "      <td>phase_4</td>\n",
       "      <td>0.790</td>\n",
       "      <td>0.310</td>\n",
       "      <td>841.000</td>\n",
       "      <td>0.672</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>TNDM</th>\n",
       "      <th>2024-12-02</th>\n",
       "      <td>TANDEM DIABETES CARE INC</td>\n",
       "      <td>NCT06717451</td>\n",
       "      <td>Tandem Diabetes Care, Inc.</td>\n",
       "      <td>Ps230005 Control-Iq 1.5 Post-Approval Study</td>\n",
       "      <td>not_specified</td>\n",
       "      <td>0.270</td>\n",
       "      <td>0.040</td>\n",
       "      <td>731.000</td>\n",
       "      <td>0.156</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>XRAY</th>\n",
       "      <th>2024-11-27</th>\n",
       "      <td>DENTSPLY SIRONA DEUTSCHLAND GMBH</td>\n",
       "      <td>NCT06713577</td>\n",
       "      <td>Dentsply Sirona Implants And Consumables</td>\n",
       "      <td>Clinical Study Of A 3D Shaded Zirconia For Cha...</td>\n",
       "      <td>not_specified</td>\n",
       "      <td>0.260</td>\n",
       "      <td>0.040</td>\n",
       "      <td>731.000</td>\n",
       "      <td>0.150</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              match     trial_id  \\\n",
       "ticker date                                                        \n",
       "SNY    2024-11-27                            SANOFI  NCT06714448   \n",
       "       2024-11-27                            SANOFI  NCT06714461   \n",
       "       2024-11-29                            SANOFI  NCT06716424   \n",
       "TNDM   2024-12-02          TANDEM DIABETES CARE INC  NCT06717451   \n",
       "XRAY   2024-11-27  DENTSPLY SIRONA DEUTSCHLAND GMBH  NCT06713577   \n",
       "\n",
       "                                          lead_sponsor_name  \\\n",
       "ticker date                                                   \n",
       "SNY    2024-11-27                                    Sanofi   \n",
       "       2024-11-27                                    Sanofi   \n",
       "       2024-11-29                                    Sanofi   \n",
       "TNDM   2024-12-02                Tandem Diabetes Care, Inc.   \n",
       "XRAY   2024-11-27  Dentsply Sirona Implants And Consumables   \n",
       "\n",
       "                                                      official_title  \\\n",
       "ticker date                                                            \n",
       "SNY    2024-11-27  Post Authorization Safety Study Assessing The ...   \n",
       "       2024-11-27  Post Authorization Safety Study On Assessment ...   \n",
       "       2024-11-29  Multicentre Phase Iv Single Arm Clinical Trial...   \n",
       "TNDM   2024-12-02        Ps230005 Control-Iq 1.5 Post-Approval Study   \n",
       "XRAY   2024-11-27  Clinical Study Of A 3D Shaded Zirconia For Cha...   \n",
       "\n",
       "                  phase_category  success_prediction  economic_effect  \\\n",
       "ticker date                                                             \n",
       "SNY    2024-11-27  not_specified               0.260            0.050   \n",
       "       2024-11-27  not_specified               0.270            0.040   \n",
       "       2024-11-29        phase_4               0.790            0.310   \n",
       "TNDM   2024-12-02  not_specified               0.270            0.040   \n",
       "XRAY   2024-11-27  not_specified               0.260            0.040   \n",
       "\n",
       "                   duration_prediction  success_composite  \n",
       "ticker date                                                \n",
       "SNY    2024-11-27              731.000              0.153  \n",
       "       2024-11-27              731.000              0.156  \n",
       "       2024-11-29              841.000              0.672  \n",
       "TNDM   2024-12-02              731.000              0.156  \n",
       "XRAY   2024-11-27              731.000              0.150  "
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_clinical = sov.data(\"trials/predict\"); df_clinical.tail()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_clinical[\"links\"] = \"https://clinicaltrials.gov/study/\" + df_clinical[\"trial_id\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th>match</th>\n",
       "      <th>trial_id</th>\n",
       "      <th>lead_sponsor_name</th>\n",
       "      <th>official_title</th>\n",
       "      <th>phase_category</th>\n",
       "      <th>success_prediction</th>\n",
       "      <th>economic_effect</th>\n",
       "      <th>duration_prediction</th>\n",
       "      <th>success_composite</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ticker</th>\n",
       "      <th>date</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th rowspan=\"5\" valign=\"top\">A</th>\n",
       "      <th>2005-07-22</th>\n",
       "      <td>VARIAN A.G.</td>\n",
       "      <td>NCT00123838</td>\n",
       "      <td>Varian, A Siemens Healthineers Company</td>\n",
       "      <td>Beacon® Transponder Implantation And Localizat...</td>\n",
       "      <td>other</td>\n",
       "      <td>0.950</td>\n",
       "      <td>0.510</td>\n",
       "      <td>1137.000</td>\n",
       "      <td>0.716</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2008-09-15</th>\n",
       "      <td>VARIAN A.G.</td>\n",
       "      <td>NCT00754000</td>\n",
       "      <td>Varian, A Siemens Healthineers Company</td>\n",
       "      <td>The Aim Study: Assessing The Impact Of Margin ...</td>\n",
       "      <td>not_specified</td>\n",
       "      <td>0.940</td>\n",
       "      <td>0.500</td>\n",
       "      <td>1323.000</td>\n",
       "      <td>0.705</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2008-09-25</th>\n",
       "      <td>VARIAN A.G.</td>\n",
       "      <td>NCT00763152</td>\n",
       "      <td>Varian, A Siemens Healthineers Company</td>\n",
       "      <td>The Probe Study - The Prostate Bed Evaluation ...</td>\n",
       "      <td>not_specified</td>\n",
       "      <td>0.710</td>\n",
       "      <td>0.240</td>\n",
       "      <td>310.000</td>\n",
       "      <td>0.490</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2011-07-12</th>\n",
       "      <td>VARIAN A.G.</td>\n",
       "      <td>NCT01396551</td>\n",
       "      <td>Varian, A Siemens Healthineers Company</td>\n",
       "      <td>Evaluating An Anchored Transponder In Lung Can...</td>\n",
       "      <td>other</td>\n",
       "      <td>0.930</td>\n",
       "      <td>0.560</td>\n",
       "      <td>2284.000</td>\n",
       "      <td>0.713</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2015-05-12</th>\n",
       "      <td>ACEA BIOSCIENCES, INC.</td>\n",
       "      <td>NCT02448251</td>\n",
       "      <td>Acea Therapeutics, Inc.</td>\n",
       "      <td>A Phase I, Multicenter, Open-Label Safety, Pha...</td>\n",
       "      <td>phase_1</td>\n",
       "      <td>0.170</td>\n",
       "      <td>0.510</td>\n",
       "      <td>1642.000</td>\n",
       "      <td>0.272</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                    match     trial_id  \\\n",
       "ticker date                                              \n",
       "A      2005-07-22             VARIAN A.G.  NCT00123838   \n",
       "       2008-09-15             VARIAN A.G.  NCT00754000   \n",
       "       2008-09-25             VARIAN A.G.  NCT00763152   \n",
       "       2011-07-12             VARIAN A.G.  NCT01396551   \n",
       "       2015-05-12  ACEA BIOSCIENCES, INC.  NCT02448251   \n",
       "\n",
       "                                        lead_sponsor_name  \\\n",
       "ticker date                                                 \n",
       "A      2005-07-22  Varian, A Siemens Healthineers Company   \n",
       "       2008-09-15  Varian, A Siemens Healthineers Company   \n",
       "       2008-09-25  Varian, A Siemens Healthineers Company   \n",
       "       2011-07-12  Varian, A Siemens Healthineers Company   \n",
       "       2015-05-12                 Acea Therapeutics, Inc.   \n",
       "\n",
       "                                                      official_title  \\\n",
       "ticker date                                                            \n",
       "A      2005-07-22  Beacon® Transponder Implantation And Localizat...   \n",
       "       2008-09-15  The Aim Study: Assessing The Impact Of Margin ...   \n",
       "       2008-09-25  The Probe Study - The Prostate Bed Evaluation ...   \n",
       "       2011-07-12  Evaluating An Anchored Transponder In Lung Can...   \n",
       "       2015-05-12  A Phase I, Multicenter, Open-Label Safety, Pha...   \n",
       "\n",
       "                  phase_category  success_prediction  economic_effect  \\\n",
       "ticker date                                                             \n",
       "A      2005-07-22          other               0.950            0.510   \n",
       "       2008-09-15  not_specified               0.940            0.500   \n",
       "       2008-09-25  not_specified               0.710            0.240   \n",
       "       2011-07-12          other               0.930            0.560   \n",
       "       2015-05-12        phase_1               0.170            0.510   \n",
       "\n",
       "                   duration_prediction  success_composite  \n",
       "ticker date                                                \n",
       "A      2005-07-22             1137.000              0.716  \n",
       "       2008-09-15             1323.000              0.705  \n",
       "       2008-09-25              310.000              0.490  \n",
       "       2011-07-12             2284.000              0.713  \n",
       "       2015-05-12             1642.000              0.272  "
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_clinical.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Trial Information"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_describe = sov.data(\"trials/describe\", full_history=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ticker</th>\n",
       "      <th>date</th>\n",
       "      <th>trial_id</th>\n",
       "      <th>official_title</th>\n",
       "      <th>sponsor_study_id</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>lead_sponsor_name</th>\n",
       "      <th>sponsor_type</th>\n",
       "      <th>phase_category</th>\n",
       "      <th>study_type</th>\n",
       "      <th>enrollment_count</th>\n",
       "      <th>number_of_locations</th>\n",
       "      <th>healthy_volunteers</th>\n",
       "      <th>enrollment_type</th>\n",
       "      <th>study_size_category</th>\n",
       "      <th>condition_keywords</th>\n",
       "      <th>primary_condition</th>\n",
       "      <th>intervention_type</th>\n",
       "      <th>primary_intervention</th>\n",
       "      <th>intervention_name</th>\n",
       "      <th>intervention_arm_group_labels</th>\n",
       "      <th>intervention_description</th>\n",
       "      <th>has_data_monitoring_committee</th>\n",
       "      <th>responsible_party_investigator_affiliation</th>\n",
       "      <th>responsible_party_investigator_title</th>\n",
       "      <th>responsible_party_investigator_name</th>\n",
       "      <th>first_posted_date</th>\n",
       "      <th>last_update_posted_date</th>\n",
       "      <th>start_date</th>\n",
       "      <th>study_completion_date</th>\n",
       "      <th>primary_completion_date</th>\n",
       "      <th>study_locations_city</th>\n",
       "      <th>study_locations_country</th>\n",
       "      <th>study_locations_geopoint</th>\n",
       "      <th>study_locations_facility</th>\n",
       "      <th>study_locations_zip</th>\n",
       "      <th>study_locations_state</th>\n",
       "      <th>standard_age_groups</th>\n",
       "      <th>sex</th>\n",
       "      <th>minimum_age</th>\n",
       "      <th>maximum_age</th>\n",
       "      <th>overall_status</th>\n",
       "      <th>status_category</th>\n",
       "      <th>status_verified_date</th>\n",
       "      <th>primary_outcomes_measures</th>\n",
       "      <th>primary_outcomes_timeframes</th>\n",
       "      <th>primary_outcomes_descriptions</th>\n",
       "      <th>secondary_outcomes_measures</th>\n",
       "      <th>secondary_outcomes_timeframes</th>\n",
       "      <th>secondary_outcomes_descriptions</th>\n",
       "      <th>has_results</th>\n",
       "      <th>conditions</th>\n",
       "      <th>brief_summary</th>\n",
       "      <th>detailed_description</th>\n",
       "      <th>masking</th>\n",
       "      <th>allocation</th>\n",
       "      <th>intervention_model</th>\n",
       "      <th>primary_purpose</th>\n",
       "      <th>has_expanded_access</th>\n",
       "      <th>study_duration_days</th>\n",
       "      <th>trial_duration</th>\n",
       "      <th>references_type</th>\n",
       "      <th>references_citation</th>\n",
       "      <th>references_pmid</th>\n",
       "      <th>collaborators_name</th>\n",
       "      <th>collaborators_class</th>\n",
       "      <th>ipd_sharing</th>\n",
       "      <th>success_prediction</th>\n",
       "      <th>economic_effect</th>\n",
       "      <th>duration_prediction</th>\n",
       "      <th>success_composite</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>513998</th>\n",
       "      <td>ZYXI</td>\n",
       "      <td>2021-08-06</td>\n",
       "      <td>NCT05012462</td>\n",
       "      <td>Clinical Evaluation Of The Cm-1500 During Aphe...</td>\n",
       "      <td>ZMS-1500-2021-Apheresis</td>\n",
       "      <td>Clinical Evaluation Of The Cm-1500 During Aphe...</td>\n",
       "      <td>Zynex Monitoring Solutions</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>other</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>75</td>\n",
       "      <td>1</td>\n",
       "      <td>True</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Small</td>\n",
       "      <td>nan</td>\n",
       "      <td>Fluid Loss</td>\n",
       "      <td>DEVICE</td>\n",
       "      <td>CM-1500</td>\n",
       "      <td>CM-1500</td>\n",
       "      <td>None</td>\n",
       "      <td>The Cm-1500 Is A U.S. Fda Cleared Non-Invasive...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2021-08-19</td>\n",
       "      <td>2022-12-21</td>\n",
       "      <td>2021-09-20</td>\n",
       "      <td>2022-12-20</td>\n",
       "      <td>2022-12-20</td>\n",
       "      <td>Denver</td>\n",
       "      <td>United States</td>\n",
       "      <td>lat: 39.73915, lon: -104.9847</td>\n",
       "      <td>Vitalant Blood Donation</td>\n",
       "      <td>80230</td>\n",
       "      <td>Colorado</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>completed</td>\n",
       "      <td>2022-12-01</td>\n",
       "      <td>Characterize changes in the Relative Index dur...</td>\n",
       "      <td>1-6 hours</td>\n",
       "      <td>The primary objective of the study is to chara...</td>\n",
       "      <td>Characterize changes in blood pressure relativ...</td>\n",
       "      <td>1-6 hours; 1-6 hours; 1-6 hours; 1-6 hours</td>\n",
       "      <td>Characterize changes in blood pressure that oc...</td>\n",
       "      <td>False</td>\n",
       "      <td>Fluid Loss</td>\n",
       "      <td>The Study Is A Prospective, Single-Arm, Non-Ra...</td>\n",
       "      <td>None</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>DIAGNOSTIC</td>\n",
       "      <td>False</td>\n",
       "      <td>456</td>\n",
       "      <td>456.000</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.270</td>\n",
       "      <td>0.080</td>\n",
       "      <td>456.000</td>\n",
       "      <td>0.211</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>513999</th>\n",
       "      <td>ZYXI</td>\n",
       "      <td>2021-11-08</td>\n",
       "      <td>NCT05125848</td>\n",
       "      <td>Clinical Evaluation Of The Cm-1500 During Hemo...</td>\n",
       "      <td>ZMS-1500-2021-Dialysis</td>\n",
       "      <td>Clinical Evaluation Of The Cm-1500 During Hemo...</td>\n",
       "      <td>Zynex Monitoring Solutions</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>other</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>15</td>\n",
       "      <td>1</td>\n",
       "      <td>False</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Small</td>\n",
       "      <td>nan</td>\n",
       "      <td>Fluid Loss</td>\n",
       "      <td>DEVICE</td>\n",
       "      <td>CM-1500</td>\n",
       "      <td>CM-1500</td>\n",
       "      <td>Hemodialysis Single Group Assignment</td>\n",
       "      <td>The Cm-1500 Is A U.S. Fda Cleared Non-Invasive...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2021-11-18</td>\n",
       "      <td>2024-05-01</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>Minneapolis</td>\n",
       "      <td>United States</td>\n",
       "      <td>lat: 44.97997, lon: -93.26384</td>\n",
       "      <td>DaVita Clinical Research</td>\n",
       "      <td>55404</td>\n",
       "      <td>Minnesota</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>completed</td>\n",
       "      <td>2024-04-01</td>\n",
       "      <td>Average Relative Index Value Following a Hemod...</td>\n",
       "      <td>Duration of post-hemodialysis recovery period ...</td>\n",
       "      <td>The primary objective is to characterize the a...</td>\n",
       "      <td>Mean Intrasubject Variability (Standard Deviat...</td>\n",
       "      <td>Duration of standard dialysis procedure (Range...</td>\n",
       "      <td>The secondary objective is to characterize int...</td>\n",
       "      <td>True</td>\n",
       "      <td>Fluid Loss; Dialysis</td>\n",
       "      <td>The Study Is A Prospective, Single-Arm, Non-Ra...</td>\n",
       "      <td>None</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>DIAGNOSTIC</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>0.560</td>\n",
       "      <td>0.290</td>\n",
       "      <td>905.000</td>\n",
       "      <td>0.443</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>514000</th>\n",
       "      <td>ZYXI</td>\n",
       "      <td>2022-07-14</td>\n",
       "      <td>NCT05463198</td>\n",
       "      <td>Evaluation Of Physiological Variables And Dete...</td>\n",
       "      <td>ZMS-1600-Blood Loss Detection</td>\n",
       "      <td>Evaluation Of Physiological Variables And Dete...</td>\n",
       "      <td>Zynex Monitoring Solutions</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>other</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>351</td>\n",
       "      <td>4</td>\n",
       "      <td>True</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Medium</td>\n",
       "      <td>nan</td>\n",
       "      <td>Fluid Loss</td>\n",
       "      <td>DEVICE</td>\n",
       "      <td>CM-1600</td>\n",
       "      <td>CM-1600</td>\n",
       "      <td>Blood Loss</td>\n",
       "      <td>Subjects Undergoing Blood Donation Will Be Con...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2022-07-18</td>\n",
       "      <td>2024-08-13</td>\n",
       "      <td>2022-09-14</td>\n",
       "      <td>2023-05-26</td>\n",
       "      <td>2023-04-27</td>\n",
       "      <td>Denver; Bradenton; Columbus; Chattanooga</td>\n",
       "      <td>United States; United States; United States; U...</td>\n",
       "      <td>lat: 39.73915, lon: -104.9847; lat: 27.49893, ...</td>\n",
       "      <td>Vitalant Research Institute; SunCoast Blood Ce...</td>\n",
       "      <td>80230; 34211; 31904; 37403</td>\n",
       "      <td>Colorado; Florida; Georgia; Tennessee</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>completed</td>\n",
       "      <td>2024-07-01</td>\n",
       "      <td>Change in the Relative Index (RI) After Minor ...</td>\n",
       "      <td>Recovery period following donation (10 minutes)</td>\n",
       "      <td>The objective of this study is to determine if...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>True</td>\n",
       "      <td>Fluid Loss</td>\n",
       "      <td>The Study Is A Prospective, Non-Randomized, No...</td>\n",
       "      <td>None</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>DIAGNOSTIC</td>\n",
       "      <td>False</td>\n",
       "      <td>254</td>\n",
       "      <td>254.000</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.910</td>\n",
       "      <td>0.520</td>\n",
       "      <td>254.000</td>\n",
       "      <td>0.732</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>514001</th>\n",
       "      <td>ZYXI</td>\n",
       "      <td>2023-02-13</td>\n",
       "      <td>NCT05740644</td>\n",
       "      <td>Clinical Evaluation Of The Zynex Monitoring Sy...</td>\n",
       "      <td>PR 2022-516</td>\n",
       "      <td>Clinical Evaluation Of The Zynex Monitoring Sy...</td>\n",
       "      <td>Zynex Monitoring Solutions</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>other</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>20</td>\n",
       "      <td>1</td>\n",
       "      <td>True</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Small</td>\n",
       "      <td>nan</td>\n",
       "      <td>Fluid Loss</td>\n",
       "      <td>DEVICE</td>\n",
       "      <td>CM-1600</td>\n",
       "      <td>CM-1600</td>\n",
       "      <td>Blood Loss and Saline Infusion</td>\n",
       "      <td>Healthy Subjects Undergoing A Manual Blood Los...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2023-02-23</td>\n",
       "      <td>2024-07-16</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaT</td>\n",
       "      <td>Louisville</td>\n",
       "      <td>United States</td>\n",
       "      <td>lat: 39.97776, lon: -105.13193</td>\n",
       "      <td>Clinimark</td>\n",
       "      <td>80027</td>\n",
       "      <td>Colorado</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>completed</td>\n",
       "      <td>2024-06-01</td>\n",
       "      <td>CM-1600 Ability to Detect Minor Blood Loss; CM...</td>\n",
       "      <td>Duration of Recovery Period following blood dr...</td>\n",
       "      <td>The objective of this study is to determine if...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>True</td>\n",
       "      <td>Fluid Loss</td>\n",
       "      <td>This Is A Prospective, Single-Arm, Non-Randomi...</td>\n",
       "      <td>None</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NA</td>\n",
       "      <td>SINGLE_GROUP</td>\n",
       "      <td>DIAGNOSTIC</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.460</td>\n",
       "      <td>0.180</td>\n",
       "      <td>519.000</td>\n",
       "      <td>0.353</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>514002</th>\n",
       "      <td>ZYXI</td>\n",
       "      <td>2023-07-26</td>\n",
       "      <td>NCT05980013</td>\n",
       "      <td>Evaluation Of Physiological Variables And Dete...</td>\n",
       "      <td>ZMS-1500-Pa2023</td>\n",
       "      <td>Evaluation Of Physiological Variables And Dete...</td>\n",
       "      <td>Zynex Monitoring Solutions</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>other</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>120</td>\n",
       "      <td>2</td>\n",
       "      <td>True</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Medium</td>\n",
       "      <td>nan</td>\n",
       "      <td>Fluid Loss</td>\n",
       "      <td>DEVICE; DEVICE</td>\n",
       "      <td>Whole blood donation supine</td>\n",
       "      <td>Whole blood donation supine; Whole blood donat...</td>\n",
       "      <td>Supine Donation Position; Reclined Donation Po...</td>\n",
       "      <td>Subjects Will Undergo A 1-Unit Whole Blood Don...</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>2023-08-07</td>\n",
       "      <td>2024-05-16</td>\n",
       "      <td>2023-08-28</td>\n",
       "      <td>NaT</td>\n",
       "      <td>2024-04-10</td>\n",
       "      <td>Denver; Bradenton</td>\n",
       "      <td>United States; United States</td>\n",
       "      <td>lat: 39.73915, lon: -104.9847; lat: 27.49893, ...</td>\n",
       "      <td>Vitalant Research Institute; SunCoast Blood Ce...</td>\n",
       "      <td>80230; 34211</td>\n",
       "      <td>Colorado; Florida</td>\n",
       "      <td>ADULT; OLDER_ADULT</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>completed</td>\n",
       "      <td>2024-05-01</td>\n",
       "      <td>Impact of subject positioning on percent chang...</td>\n",
       "      <td>At completion of blood draw</td>\n",
       "      <td>Percent change in heart rate, forearm skin tem...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>Fluid Loss; Blood Loss</td>\n",
       "      <td>The Study Is A Prospective, Non-Randomized, No...</td>\n",
       "      <td>None</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NON_RANDOMIZED</td>\n",
       "      <td>PARALLEL</td>\n",
       "      <td>DIAGNOSTIC</td>\n",
       "      <td>False</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NO</td>\n",
       "      <td>0.260</td>\n",
       "      <td>0.050</td>\n",
       "      <td>226.000</td>\n",
       "      <td>0.199</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       ticker       date     trial_id  \\\n",
       "513998   ZYXI 2021-08-06  NCT05012462   \n",
       "513999   ZYXI 2021-11-08  NCT05125848   \n",
       "514000   ZYXI 2022-07-14  NCT05463198   \n",
       "514001   ZYXI 2023-02-13  NCT05740644   \n",
       "514002   ZYXI 2023-07-26  NCT05980013   \n",
       "\n",
       "                                           official_title  \\\n",
       "513998  Clinical Evaluation Of The Cm-1500 During Aphe...   \n",
       "513999  Clinical Evaluation Of The Cm-1500 During Hemo...   \n",
       "514000  Evaluation Of Physiological Variables And Dete...   \n",
       "514001  Clinical Evaluation Of The Zynex Monitoring Sy...   \n",
       "514002  Evaluation Of Physiological Variables And Dete...   \n",
       "\n",
       "                     sponsor_study_id  \\\n",
       "513998        ZMS-1500-2021-Apheresis   \n",
       "513999         ZMS-1500-2021-Dialysis   \n",
       "514000  ZMS-1600-Blood Loss Detection   \n",
       "514001                    PR 2022-516   \n",
       "514002                ZMS-1500-Pa2023   \n",
       "\n",
       "                                              brief_title  \\\n",
       "513998  Clinical Evaluation Of The Cm-1500 During Aphe...   \n",
       "513999  Clinical Evaluation Of The Cm-1500 During Hemo...   \n",
       "514000  Evaluation Of Physiological Variables And Dete...   \n",
       "514001  Clinical Evaluation Of The Zynex Monitoring Sy...   \n",
       "514002  Evaluation Of Physiological Variables And Dete...   \n",
       "\n",
       "                 lead_sponsor_name sponsor_type phase_category  \\\n",
       "513998  Zynex Monitoring Solutions     INDUSTRY          other   \n",
       "513999  Zynex Monitoring Solutions     INDUSTRY          other   \n",
       "514000  Zynex Monitoring Solutions     INDUSTRY          other   \n",
       "514001  Zynex Monitoring Solutions     INDUSTRY          other   \n",
       "514002  Zynex Monitoring Solutions     INDUSTRY          other   \n",
       "\n",
       "            study_type  enrollment_count  number_of_locations  \\\n",
       "513998  INTERVENTIONAL                75                    1   \n",
       "513999  INTERVENTIONAL                15                    1   \n",
       "514000  INTERVENTIONAL               351                    4   \n",
       "514001  INTERVENTIONAL                20                    1   \n",
       "514002  INTERVENTIONAL               120                    2   \n",
       "\n",
       "       healthy_volunteers enrollment_type study_size_category  \\\n",
       "513998               True          ACTUAL               Small   \n",
       "513999              False          ACTUAL               Small   \n",
       "514000               True          ACTUAL              Medium   \n",
       "514001               True          ACTUAL               Small   \n",
       "514002               True          ACTUAL              Medium   \n",
       "\n",
       "       condition_keywords primary_condition intervention_type  \\\n",
       "513998                nan        Fluid Loss            DEVICE   \n",
       "513999                nan        Fluid Loss            DEVICE   \n",
       "514000                nan        Fluid Loss            DEVICE   \n",
       "514001                nan        Fluid Loss            DEVICE   \n",
       "514002                nan        Fluid Loss    DEVICE; DEVICE   \n",
       "\n",
       "               primary_intervention  \\\n",
       "513998                      CM-1500   \n",
       "513999                      CM-1500   \n",
       "514000                      CM-1600   \n",
       "514001                      CM-1600   \n",
       "514002  Whole blood donation supine   \n",
       "\n",
       "                                        intervention_name  \\\n",
       "513998                                            CM-1500   \n",
       "513999                                            CM-1500   \n",
       "514000                                            CM-1600   \n",
       "514001                                            CM-1600   \n",
       "514002  Whole blood donation supine; Whole blood donat...   \n",
       "\n",
       "                            intervention_arm_group_labels  \\\n",
       "513998                                               None   \n",
       "513999               Hemodialysis Single Group Assignment   \n",
       "514000                                         Blood Loss   \n",
       "514001                     Blood Loss and Saline Infusion   \n",
       "514002  Supine Donation Position; Reclined Donation Po...   \n",
       "\n",
       "                                 intervention_description  \\\n",
       "513998  The Cm-1500 Is A U.S. Fda Cleared Non-Invasive...   \n",
       "513999  The Cm-1500 Is A U.S. Fda Cleared Non-Invasive...   \n",
       "514000  Subjects Undergoing Blood Donation Will Be Con...   \n",
       "514001  Healthy Subjects Undergoing A Manual Blood Los...   \n",
       "514002  Subjects Will Undergo A 1-Unit Whole Blood Don...   \n",
       "\n",
       "       has_data_monitoring_committee  \\\n",
       "513998                         False   \n",
       "513999                         False   \n",
       "514000                         False   \n",
       "514001                         False   \n",
       "514002                         False   \n",
       "\n",
       "       responsible_party_investigator_affiliation  \\\n",
       "513998                                       None   \n",
       "513999                                       None   \n",
       "514000                                       None   \n",
       "514001                                       None   \n",
       "514002                                       None   \n",
       "\n",
       "       responsible_party_investigator_title  \\\n",
       "513998                                 None   \n",
       "513999                                 None   \n",
       "514000                                 None   \n",
       "514001                                 None   \n",
       "514002                                 None   \n",
       "\n",
       "       responsible_party_investigator_name first_posted_date  \\\n",
       "513998                                None        2021-08-19   \n",
       "513999                                None        2021-11-18   \n",
       "514000                                None        2022-07-18   \n",
       "514001                                None        2023-02-23   \n",
       "514002                                None        2023-08-07   \n",
       "\n",
       "       last_update_posted_date start_date study_completion_date  \\\n",
       "513998              2022-12-21 2021-09-20            2022-12-20   \n",
       "513999              2024-05-01        NaT                   NaT   \n",
       "514000              2024-08-13 2022-09-14            2023-05-26   \n",
       "514001              2024-07-16        NaT                   NaT   \n",
       "514002              2024-05-16 2023-08-28                   NaT   \n",
       "\n",
       "       primary_completion_date                      study_locations_city  \\\n",
       "513998              2022-12-20                                    Denver   \n",
       "513999                     NaT                               Minneapolis   \n",
       "514000              2023-04-27  Denver; Bradenton; Columbus; Chattanooga   \n",
       "514001                     NaT                                Louisville   \n",
       "514002              2024-04-10                         Denver; Bradenton   \n",
       "\n",
       "                                  study_locations_country  \\\n",
       "513998                                      United States   \n",
       "513999                                      United States   \n",
       "514000  United States; United States; United States; U...   \n",
       "514001                                      United States   \n",
       "514002                       United States; United States   \n",
       "\n",
       "                                 study_locations_geopoint  \\\n",
       "513998                      lat: 39.73915, lon: -104.9847   \n",
       "513999                      lat: 44.97997, lon: -93.26384   \n",
       "514000  lat: 39.73915, lon: -104.9847; lat: 27.49893, ...   \n",
       "514001                     lat: 39.97776, lon: -105.13193   \n",
       "514002  lat: 39.73915, lon: -104.9847; lat: 27.49893, ...   \n",
       "\n",
       "                                 study_locations_facility  \\\n",
       "513998                            Vitalant Blood Donation   \n",
       "513999                           DaVita Clinical Research   \n",
       "514000  Vitalant Research Institute; SunCoast Blood Ce...   \n",
       "514001                                          Clinimark   \n",
       "514002  Vitalant Research Institute; SunCoast Blood Ce...   \n",
       "\n",
       "               study_locations_zip                  study_locations_state  \\\n",
       "513998                       80230                               Colorado   \n",
       "513999                       55404                              Minnesota   \n",
       "514000  80230; 34211; 31904; 37403  Colorado; Florida; Georgia; Tennessee   \n",
       "514001                       80027                               Colorado   \n",
       "514002                80230; 34211                      Colorado; Florida   \n",
       "\n",
       "       standard_age_groups  sex  minimum_age  maximum_age overall_status  \\\n",
       "513998  ADULT; OLDER_ADULT  ALL           18         <NA>      COMPLETED   \n",
       "513999  ADULT; OLDER_ADULT  ALL           18         <NA>      COMPLETED   \n",
       "514000  ADULT; OLDER_ADULT  ALL           18         <NA>      COMPLETED   \n",
       "514001  ADULT; OLDER_ADULT  ALL           18         <NA>      COMPLETED   \n",
       "514002  ADULT; OLDER_ADULT  ALL           18         <NA>      COMPLETED   \n",
       "\n",
       "       status_category status_verified_date  \\\n",
       "513998       completed           2022-12-01   \n",
       "513999       completed           2024-04-01   \n",
       "514000       completed           2024-07-01   \n",
       "514001       completed           2024-06-01   \n",
       "514002       completed           2024-05-01   \n",
       "\n",
       "                                primary_outcomes_measures  \\\n",
       "513998  Characterize changes in the Relative Index dur...   \n",
       "513999  Average Relative Index Value Following a Hemod...   \n",
       "514000  Change in the Relative Index (RI) After Minor ...   \n",
       "514001  CM-1600 Ability to Detect Minor Blood Loss; CM...   \n",
       "514002  Impact of subject positioning on percent chang...   \n",
       "\n",
       "                              primary_outcomes_timeframes  \\\n",
       "513998                                          1-6 hours   \n",
       "513999  Duration of post-hemodialysis recovery period ...   \n",
       "514000    Recovery period following donation (10 minutes)   \n",
       "514001  Duration of Recovery Period following blood dr...   \n",
       "514002                        At completion of blood draw   \n",
       "\n",
       "                            primary_outcomes_descriptions  \\\n",
       "513998  The primary objective of the study is to chara...   \n",
       "513999  The primary objective is to characterize the a...   \n",
       "514000  The objective of this study is to determine if...   \n",
       "514001  The objective of this study is to determine if...   \n",
       "514002  Percent change in heart rate, forearm skin tem...   \n",
       "\n",
       "                              secondary_outcomes_measures  \\\n",
       "513998  Characterize changes in blood pressure relativ...   \n",
       "513999  Mean Intrasubject Variability (Standard Deviat...   \n",
       "514000                                               None   \n",
       "514001                                               None   \n",
       "514002                                               None   \n",
       "\n",
       "                            secondary_outcomes_timeframes  \\\n",
       "513998         1-6 hours; 1-6 hours; 1-6 hours; 1-6 hours   \n",
       "513999  Duration of standard dialysis procedure (Range...   \n",
       "514000                                               None   \n",
       "514001                                               None   \n",
       "514002                                               None   \n",
       "\n",
       "                          secondary_outcomes_descriptions  has_results  \\\n",
       "513998  Characterize changes in blood pressure that oc...        False   \n",
       "513999  The secondary objective is to characterize int...         True   \n",
       "514000                                               None         True   \n",
       "514001                                               None         True   \n",
       "514002                                               None        False   \n",
       "\n",
       "                    conditions  \\\n",
       "513998              Fluid Loss   \n",
       "513999    Fluid Loss; Dialysis   \n",
       "514000              Fluid Loss   \n",
       "514001              Fluid Loss   \n",
       "514002  Fluid Loss; Blood Loss   \n",
       "\n",
       "                                            brief_summary  \\\n",
       "513998  The Study Is A Prospective, Single-Arm, Non-Ra...   \n",
       "513999  The Study Is A Prospective, Single-Arm, Non-Ra...   \n",
       "514000  The Study Is A Prospective, Non-Randomized, No...   \n",
       "514001  This Is A Prospective, Single-Arm, Non-Randomi...   \n",
       "514002  The Study Is A Prospective, Non-Randomized, No...   \n",
       "\n",
       "       detailed_description masking      allocation intervention_model  \\\n",
       "513998                 None    NONE              NA       SINGLE_GROUP   \n",
       "513999                 None    NONE              NA       SINGLE_GROUP   \n",
       "514000                 None    NONE              NA       SINGLE_GROUP   \n",
       "514001                 None    NONE              NA       SINGLE_GROUP   \n",
       "514002                 None    NONE  NON_RANDOMIZED           PARALLEL   \n",
       "\n",
       "       primary_purpose  has_expanded_access  study_duration_days  \\\n",
       "513998      DIAGNOSTIC                False                  456   \n",
       "513999      DIAGNOSTIC                False                 <NA>   \n",
       "514000      DIAGNOSTIC                False                  254   \n",
       "514001      DIAGNOSTIC                False                 <NA>   \n",
       "514002      DIAGNOSTIC                False                 <NA>   \n",
       "\n",
       "        trial_duration references_type references_citation references_pmid  \\\n",
       "513998         456.000            None                None            None   \n",
       "513999             NaN            None                None            None   \n",
       "514000         254.000            None                None            None   \n",
       "514001             NaN            None                None            None   \n",
       "514002             NaN            None                None            None   \n",
       "\n",
       "       collaborators_name collaborators_class ipd_sharing  success_prediction  \\\n",
       "513998               None                None          NO               0.270   \n",
       "513999               None                None        None               0.560   \n",
       "514000               None                None          NO               0.910   \n",
       "514001               None                None          NO               0.460   \n",
       "514002               None                None          NO               0.260   \n",
       "\n",
       "        economic_effect  duration_prediction  success_composite  \n",
       "513998            0.080              456.000              0.211  \n",
       "513999            0.290              905.000              0.443  \n",
       "514000            0.520              254.000              0.732  \n",
       "514001            0.180              519.000              0.353  \n",
       "514002            0.050              226.000              0.199  "
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_describe.tail()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Specific Tickers Select"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_pfizer = sov.data(\"trials/predict\", tickers=[\"PFE\"]) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>date</th>\n",
       "      <th>ticker</th>\n",
       "      <th>trial_id</th>\n",
       "      <th>lead_sponsor_name</th>\n",
       "      <th>official_title</th>\n",
       "      <th>phase_category</th>\n",
       "      <th>success_prediction</th>\n",
       "      <th>economic_effect</th>\n",
       "      <th>duration_prediction</th>\n",
       "      <th>success_composite</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>513354</th>\n",
       "      <td>1999-10-18</td>\n",
       "      <td>WINT</td>\n",
       "      <td>NCT00004500</td>\n",
       "      <td>Windtree Therapeutics</td>\n",
       "      <td>A Multicenter, Randomized, Controlled Trial Co...</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>0.060</td>\n",
       "      <td>0.490</td>\n",
       "      <td>1841.000</td>\n",
       "      <td>0.279</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>512527</th>\n",
       "      <td>1999-10-18</td>\n",
       "      <td>UTHR</td>\n",
       "      <td>NCT00004497</td>\n",
       "      <td>United Therapeutics</td>\n",
       "      <td>None</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>0.950</td>\n",
       "      <td>0.600</td>\n",
       "      <td>5637.000</td>\n",
       "      <td>0.805</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32118</th>\n",
       "      <td>1999-10-29</td>\n",
       "      <td>NVS</td>\n",
       "      <td>NCT00000174</td>\n",
       "      <td>Novartis</td>\n",
       "      <td>None</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>0.920</td>\n",
       "      <td>0.490</td>\n",
       "      <td>2065.000</td>\n",
       "      <td>0.770</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36726</th>\n",
       "      <td>1999-11-01</td>\n",
       "      <td>PFE</td>\n",
       "      <td>NCT00003343</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>A Randomized, Double-Blind, Placebo-Controlled...</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>0.300</td>\n",
       "      <td>0.170</td>\n",
       "      <td>4664.000</td>\n",
       "      <td>0.290</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36723</th>\n",
       "      <td>1999-11-01</td>\n",
       "      <td>PFE</td>\n",
       "      <td>NCT00003720</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>A Multicenter, Dose Escalating Study In Patien...</td>\n",
       "      <td>phase_1</td>\n",
       "      <td>0.910</td>\n",
       "      <td>0.600</td>\n",
       "      <td>4679.000</td>\n",
       "      <td>0.742</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20808</th>\n",
       "      <td>2024-10-25</td>\n",
       "      <td>GSK</td>\n",
       "      <td>NCT06663436</td>\n",
       "      <td>Glaxosmithkline</td>\n",
       "      <td>A Phase 2 Single-Blind, Randomized, Controlled...</td>\n",
       "      <td>phase_2</td>\n",
       "      <td>0.840</td>\n",
       "      <td>0.430</td>\n",
       "      <td>327.000</td>\n",
       "      <td>0.704</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32829</th>\n",
       "      <td>2024-10-27</td>\n",
       "      <td>NVS</td>\n",
       "      <td>NCT06662812</td>\n",
       "      <td>Novartis</td>\n",
       "      <td>Disease Characteristics And Treatment Patterns...</td>\n",
       "      <td>not_specified</td>\n",
       "      <td>0.270</td>\n",
       "      <td>0.070</td>\n",
       "      <td>730.000</td>\n",
       "      <td>0.204</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32830</th>\n",
       "      <td>2024-10-27</td>\n",
       "      <td>NVS</td>\n",
       "      <td>NCT06662825</td>\n",
       "      <td>Novartis</td>\n",
       "      <td>Seg-2022-01 Patient Characteristics And Treatm...</td>\n",
       "      <td>not_specified</td>\n",
       "      <td>0.310</td>\n",
       "      <td>0.070</td>\n",
       "      <td>323.000</td>\n",
       "      <td>0.233</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>511796</th>\n",
       "      <td>2024-10-28</td>\n",
       "      <td>TEVA</td>\n",
       "      <td>NCT06664619</td>\n",
       "      <td>Teva Branded Pharmaceutical Products R&amp;D, Inc.</td>\n",
       "      <td>A 4-Week, Double-Blind, Placebo-Controlled, Pa...</td>\n",
       "      <td>phase_3</td>\n",
       "      <td>0.850</td>\n",
       "      <td>0.440</td>\n",
       "      <td>560.000</td>\n",
       "      <td>0.727</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>513423</th>\n",
       "      <td>2024-10-28</td>\n",
       "      <td>XBIT</td>\n",
       "      <td>NCT06664502</td>\n",
       "      <td>Eyebiotech Ltd.</td>\n",
       "      <td>A Phase 1/2A 2-Part Study Consisting Of An Ope...</td>\n",
       "      <td>phase_2</td>\n",
       "      <td>0.870</td>\n",
       "      <td>0.470</td>\n",
       "      <td>550.000</td>\n",
       "      <td>0.731</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>48998 rows × 10 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "             date ticker     trial_id  \\\n",
       "513354 1999-10-18   WINT  NCT00004500   \n",
       "512527 1999-10-18   UTHR  NCT00004497   \n",
       "32118  1999-10-29    NVS  NCT00000174   \n",
       "36726  1999-11-01    PFE  NCT00003343   \n",
       "36723  1999-11-01    PFE  NCT00003720   \n",
       "...           ...    ...          ...   \n",
       "20808  2024-10-25    GSK  NCT06663436   \n",
       "32829  2024-10-27    NVS  NCT06662812   \n",
       "32830  2024-10-27    NVS  NCT06662825   \n",
       "511796 2024-10-28   TEVA  NCT06664619   \n",
       "513423 2024-10-28   XBIT  NCT06664502   \n",
       "\n",
       "                                     lead_sponsor_name  \\\n",
       "513354                           Windtree Therapeutics   \n",
       "512527                             United Therapeutics   \n",
       "32118                                         Novartis   \n",
       "36726                                           Pfizer   \n",
       "36723                                           Pfizer   \n",
       "...                                                ...   \n",
       "20808                                  Glaxosmithkline   \n",
       "32829                                         Novartis   \n",
       "32830                                         Novartis   \n",
       "511796  Teva Branded Pharmaceutical Products R&D, Inc.   \n",
       "513423                                 Eyebiotech Ltd.   \n",
       "\n",
       "                                           official_title phase_category  \\\n",
       "513354  A Multicenter, Randomized, Controlled Trial Co...        phase_3   \n",
       "512527                                               None        phase_3   \n",
       "32118                                                None        phase_3   \n",
       "36726   A Randomized, Double-Blind, Placebo-Controlled...        phase_3   \n",
       "36723   A Multicenter, Dose Escalating Study In Patien...        phase_1   \n",
       "...                                                   ...            ...   \n",
       "20808   A Phase 2 Single-Blind, Randomized, Controlled...        phase_2   \n",
       "32829   Disease Characteristics And Treatment Patterns...  not_specified   \n",
       "32830   Seg-2022-01 Patient Characteristics And Treatm...  not_specified   \n",
       "511796  A 4-Week, Double-Blind, Placebo-Controlled, Pa...        phase_3   \n",
       "513423  A Phase 1/2A 2-Part Study Consisting Of An Ope...        phase_2   \n",
       "\n",
       "        success_prediction  economic_effect  duration_prediction  \\\n",
       "513354               0.060            0.490             1841.000   \n",
       "512527               0.950            0.600             5637.000   \n",
       "32118                0.920            0.490             2065.000   \n",
       "36726                0.300            0.170             4664.000   \n",
       "36723                0.910            0.600             4679.000   \n",
       "...                    ...              ...                  ...   \n",
       "20808                0.840            0.430              327.000   \n",
       "32829                0.270            0.070              730.000   \n",
       "32830                0.310            0.070              323.000   \n",
       "511796               0.850            0.440              560.000   \n",
       "513423               0.870            0.470              550.000   \n",
       "\n",
       "        success_composite  \n",
       "513354              0.279  \n",
       "512527              0.805  \n",
       "32118               0.770  \n",
       "36726               0.290  \n",
       "36723               0.742  \n",
       "...                   ...  \n",
       "20808               0.704  \n",
       "32829               0.204  \n",
       "32830               0.233  \n",
       "511796              0.727  \n",
       "513423              0.731  \n",
       "\n",
       "[48998 rows x 10 columns]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_clinical.sort_values(\"date\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#https://clinicaltrials.gov/study/NCT06628310"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
